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Summary 
 
The alternative oxidase (AOX) is the terminal protein in the alternative oxidation 
pathway found in plants, fungi and some protozoa. One of the more prominent 
protozoa that contain AOX within the bloodstream form is Trypanosoma brucei, the 
causative agent of human African trypanosomiasis (HAT), in which the parasite has 
demonstrated to be totally dependent upon the protein for continued respiration. 
Given the lack of AOX in mammalian cells, the protein represents an attractive 
chemotherapeutic target for trypanosidal activity.  
Ascofuranone is a known inhibitor of AOX, but its complex synthesis precludes it 
from industrial production. To this end colletochlorin B, an analogue of 
ascofuranone, was synthesised and its inhibitory efficacy against AOX examined. 
IC50 values obtained demonstrate that removal of the problematic furanone ring does 
not reduce inhibitor efficacy to a large degree. Derivatives of colletochlorin B were 
synthesised to assess the importance of structural moieties present. The compounds 
were also tested against the cytochrome bc1 complex, an important respiratory chain 
complex, and compared with known fungicides. Using these compounds assays 
against fungal species has yielded promising results for the use of colletochlorin B as 
a lead fungicide.  
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Recombinant wild type trypanosomal alternative oxidase (TAO) and Sauromatum 
guttatum alternative oxidase (SgAOX) have been expressed in E.coli. in addition to a 
number of mutants. Respiratory activities of these mutants were measured in order to 
assess the importance of highly conserved amino acids, with all mutants showing a 
decline in specific activity. Three of the mutants generated were also shown to affect 
the apparent affinity for oxygen, the implications of which are discussed. 
Recent crystallisation of TAO has enabled a more detailed examination of the 
structure of all AOXs. Work is presented relating structure to the overall function of 
the protein, taking into account conservation throughout the entire AOX family. 
Comparisons to other di-iron proteins revealed a conserved His-Asp-Tryp motif that 
could facilitate proton coupled electron transport. A full catalytic cycle based on 
these findings has been postulated.  
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1 Introduction 
1.1 Respiration overview 
 
The utilisation of energy from macromolecules is a necessity for all life forms. While 
the amount of energy released from large molecules would be excessive for cellular 
processes, the energy is effectively stored and quantised into smaller packets in the 
form of ATP, allowing for biological reactions to be modulated around a common 
energy source [1]. The majority of cellular ATP is generated via the breakdown of 
carbohydrates; under aerobic conditions glucose is broken down via the glycolytic 
process within the cytosol of the cell, generating 2 ATP, 2 pyruvate and 2 NADH 
[2].  
The pyruvate generated is transported into the mitochondrial matrix to form acetyl-
CoA, which feeds into the Kreb’s cycle. Condensation of acetyl-CoA with 
oxaloacetate forms citrate, which, via a series of enzymatic reactions regenerates 
oxalacetate, forming 3 molecules of NADH in the process. NADH and succinate, an 
intermediate formed during the Krebs cycle, are used as reducing equivalents for the 
electron transport chain (ETC).  
For each molecule of glucose present, 2 molecules of ATP are generated during the 
glycolytic process, alongside 10 molecules of NADH. The oxidation of NADH and 
succinate within the ETC gives a theoretical yield of 36 molecules of ATP from the 
respiratory chain per glycolytic turnover, but observable yields are ~30 per cycle [3], 
with losses being attributed to proton leakage across the membrane [4].  
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1.2 Electron transport chain 
 
The ETC consists of enzyme complexes associated with the inner mitochondrial 
membrane that ultimately facilitate the transfer of electrons from reducing 
equivalents to oxygen via a series of thermodynamically favourable reactions. The 
free energy generated is used to translocate protons from the matrix into the 
intermembrane space (IMS), generating a proton gradient across the membrane, 
effectively storing the energy as a chemiosmotic potential. This potential is 
subsequently used to couple ADP with a phosphate group to form ATP within ATP 
synthase, an otherwise energetically unfavourable reaction [5].   
Figure 1-1 contains the currently accepted electron transport chain and crystal 
structures of each complex accrued to date. While complexes I-V are ubiquitous 
throughout higher mitochondria, plant mitochondria also contain external and 
internal NADH dehydrogenases, often referred to as rotenone insensitive 
dehydrogenases due to their effective bypassing of inhibition of complex I as an 
entry point for electrons from NADH. A brief overview of the main complexes 
within the electron transport chain has been included to give context to the 
discussion with respect to AOX. 
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Figure 1-1:- Crystal structures of the components of the electron transport chain within plant mitochondria. internal NADH dehydrogenase (NDI), external NADH 
dehydrogenase (NDI structure used due to no crystal structure available to date) and AOX are not present in the mammalian ETC. Green arrows depict direction of electron 
flow to and from the quinone pool (UQ) and cytochrome C (Cyt.C). Black arrows represent proton pumping across the membrane. Crystal structures used are as follows : 
Complex I (PDB:3MPS [6]) complex II (PDB:3VRS[7]) complex III (PDB:3H1J [8]), complex IV (PDB:1OCO [9]) NDI (PDB:4GAP [10]) AOX (PDB:3VV9 [11]) ATP 
synthase (F0 (PDB(1C17 [12]), Fi(PDB:1E79 [13])) The Stator has been omitted from ATP synthase, but crystal structures are available (PDB :2A7U [14]). MIM and IMS 
refer to the mitochondrial inner membrane and intermembrane space respectively. Adapted with permission from [15]
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Complex I  
NADH/H
+ 
+ Q + 4H
+
matrix → NAD
+
 + QH2 + 4H
+
IMS 
        
NADH dehydrogenase (complex I) utilised the NADH formed during the Krebs 
cycle to reduce an equivalent of quinone to quinol. This multi-protein complex spans 
the inner mitochondrial membrane, allowing for the translocation of 4 protons from 
the mitochondrial matrix into the intermembrane space in the process, generating a 
proton gradient. The overall structure of the protein is L-shaped, consisting of a 
hydrophilic arm within the mitochondrial matrix, and a hydrophobic membrane 
spanning region.  
Initial reaction with NADH occurs on the hydrophilic arm, with transfer of electrons 
and protons to flavin mononucleotide (FMN), a prosthetic group within complex I. 
The electrons are then transferred via a series of iron-sulphur clusters into the protein 
core, where they are transferred to quinone to form quinol. The electron flow from 
FMN to the quinol is coupled to proton translocation within the hydrophobic domain 
[16], with examination of the crystal structure of the hydrophobic stretch indicating 
that proton translocation is triggered by protein reduction, with a proton transferred 
through each domain sequentially from the core [17].  
Extensive reviews covering facets of complex I are available [18], including high 
resolution crystal structures of the hydrophilic arm [19], the membrane spanning 
domain [17] and the mechanistic insights that have been gained from the 
aforementioned structures [20, 21]. 
Complex II 
Succinate + Q → Fumarate + QH2 
 
Succinate dehydrogenase (complex II) fulfils a similar role to complex I with respect 
to the electron transport chain (ETC), in so much as it acts as an independant entry 
point into the ETC. Succinate is generated during the Krebs cycle, and reduction to 
fumarate couples the cycle into the ETC. Unlike complex I, complex II does not 
5 | P a g e  
 
shuttle protons across the membrane, and therefore does not aid in generation of a 
proton gradient.  
Complex II is made of 4 distinct proteins, 2 hydrophilic subunits on the matrix side 
(SDHA and SDHB, that contain the FAD cofactor and iron sulphur clusters 
respectively), and 2 hydrophobic subunits (SDHC and SDHD) that span the inner 
mitochondrial membrane. Succinate reacts at SDHA, transferring protons and 
electrons to oxidase FAD to FADH2. The electrons are then transferred via a series 
of iron-sulphur clusters within SDHB towards the Fe3S4 cluster, where they are 
transferred sequentially onto ubiquinone bound in the cleft between SDHC and 
SDHD. A comprehensive review by Iverson on the catalytic mechanism of complex 
II is available [22]. 
 
Quinol and the quinone pool  
 
Figure 1-2:- Quinones used throughout the ETC. The length of the isoprene tail can be increased to 10 
units, with Q1H2 depicted. Menaquinone is favoured by anerobes, and plastoquinone is the electron 
carrier in chloroplasts. 
 
Quinols within the ETC act as mobile proton and electron carriers, transporting 
electrons from complexes I and II to complex III. The hydrophobic nature of the 
isoprenoid tail makes the compound extremely lipophilic, leading to an accumulation 
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within the phospholipid bilayer commonly referred to as the quinone pool. The 
identity of the quinone is dependent upon the membrane in which it is found; 
quinone is preferred in aerobes, with menaquinones being the preferential electron 
carrier under anaerobic conditions. A further example is found within chloroplasts, 
where plastoquinone is the preferred electron carrier.  
 
Complex III 
QH2 + 2 cytochrome cox + 2H
+
mat → Q + 2 cytochrome cred + 4H
+
IMS 
 
The overall function of complex III is facilitation of electron transfer from quinol 
onto cytochrome c, a mobile protein found within the IMS that shuttles electrons to 
complex IV. As with complex I, complex III pumps protons across the membrane, 
leading to an increase in proton gradient.  
While the above equation for the overall reaction within complex III implies the use 
of only 1 molecule of quinol, there are in fact 3 separate molecules of quinol/quinone 
involved in the “Q” cycle originally proposed by Mitchell [5] .Reviews of the 
structure function relationship with respect to the Q cycle are available [23, 24]. 
Quinol initially binds at the Qo site in cytochrome b, where it transfers an electron to 
the Fe2S2 cluster, losing two protons in the process (which are subsequently 
transferred into the IMS) leaving a semiquinone radical. This electron is 
subsequently shuttled into the haem within the cytochrome c1 subunit, where it is 
used to reduce an equivalent of cytochrome c. The second electron from the 
semiquinone is transferred via a series of haem groups to a quinone molecule bound 
within the Qi site, generating a semiquinone and releasing the initial quinol as a 
quinone. This process is then repeated, converting the semiquinone bound at the Qi 
site to a quinol and generating a second equivalent of reduced cytochrome c.  
Full reviews on complex III are available, alongside more specific structural 
modelling of the interaction between the Qo and Qi sites [25] and examination of the 
electron transfer via structural mutations [26]. 
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Complex IV 
4 cytochrome cred + 8H
+
mat + O2 → 4 cytochrome cox + 2H2O + 4H
+
IMS 
 
Complex IV is the terminal electron acceptor in the ETC, using the electrons 
provided by cytochrome c to reduce oxygen through to water, while pumping 
protons across the membrane. The overall structure can be broken down into two 
distinct subunits, with subunit I containing the oxygen binding Fe-Cu centre, and 
subunit II containing CuA, a binuclear copper centre. Cytochrome c binds to CuA, 
with electron transfer towards the Fe-Cu core facilitated via a proximal haem group.  
The oxygen reduction cycle is well studied [27, 28], with a resting Fe
2+
Cu
+
 state 
rapidly reducing oxygen via homolytic cleavage to form an Fe
4+ 
=O Cu
2+
-OH core, 
and the generation of a tyrosyl radical in close proximity. Subsequent transfer of 
electrons from cytochrome C and protons from the matrix via well defined proton 
channels allow the protein to return to its fully reduced state. A full review on the 
catalytic cycle is available [29]. 
 
 Alternative pathway 
The alternative oxidase (AOX) is the terminal protein in the alternative oxidation 
pathway within the mitochondria of a variety of plant, fungi and protozoa. The 
pathway is often referred to the cyanide resistant pathway, due to its early discovery 
of cyanide resistant respiratory activity in plant mitochondria [30]. The AOX is also 
resistant to nitric oxide [31], a potent inhibitor of complex IV. The latter is important 
for both fungi and bacteria, as it gives resistance to typical host immune responses of 
NO release upon cell death. 
The pathway branches from the regular ETC at the ubiquinone pool [32, 33], 
effectively circumventing complexes III and IV to directly reduce of oxygen to water 
[34], oxidising 2 equivalents of quinol in the process. This pathway is less energy 
efficient, with no proton translocation occurring as an energy sink [35], with the 
excess energy generated instead dissipated as heat. The utilisation of external and 
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internal NADH dehydrogenase within plants [36] and succinate dehydrogenase 
allows the alternative pathway to be completely independent of proton pumping. 
The separation of the alternative pathway from the cyctochrome c dependant 
pathway is made apparent from the complex association within supercomplexes. 
Supercomplexes are an aggregation of complexes I III and IV, arranged in close 
proximity to increase efficiency due to reduction of the diffusional constant for 
electron carriers. While supercomplexes form within plant mitochondria, it has been 
demonstrated that the alternative oxidase is not associated [37]. The lack of 
association of complex II, external NADH dehydrogenase and AOX has been 
attributed to a partitioning effect, creating a distinct separation between the two 
pathways. Further evidence can be found from 2-D gel electrophoresis experiments 
performed on Arum maculatum spadicies, where the authors were unable to locate 
complex I that was not part of a supercomplex [38]. Similar experiments performed 
revealed a smear that was attributed to AOX, believed to be indicative of an 
arrangement of numerous AOX proteins rather than an aggregation of monomers 
that had associated under electrophoretic conditions [39].  
Comprehensive reviews are available of AOX covering structural considerations 
[15] and homeostatic roles [40] . Up-to-date reviews of the organisation and 
regulation of complexes within the plant ETC are also available [41] . 
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1.3 Functions of the alternative oxidase 
 
1.3.1 Thermogenesis 
 
The functions of the alternative oxidase are diverse and dependent upon the nature of 
the tissue in which they are found. Whilst the protein is found in all plant 
mitochondria [42], it is found in especially high concentrations within the spadix of 
plants from the Araceae family, such as Sauromatum guttatum and Amorphophalus 
titanum. Such tissues are thermogenic, raising the temperature of the spadix above 
local ambient temperatures. The heat generated is used to volatilises primary amines, 
with the intention of attracting flies for pollination purposes [43, 44], or alternatively 
to melt the surrounding ice during germination in skunk cabbage. Increased rates in 
mitochondrial respiration have been demonstrated to directly correlate to the 
increased levels of heat generated by thermogenic plant tissue [45], with AOX being 
responsible for 90% of respiratory flux during heating [46]. Thermogenesis has also 
been demonstrated to coincide with a 10-fold increase in AOX expression levels 
within the sacred lotus [47]. The uncoupled nature of the alternative pathway from 
proton translocation and hence ATP generation leads to the excess energy being used 
to generate heat.  
 
1.3.2 Homeostasis 
 
The expression of AOX from Sauromatum guttatum into Schizosaccharomyces 
pombe demonstrates that AOX is energy inefficient relative to the cytochrome c 
dependant pathway, reducing growth levels when compared to wild type [48]. One 
of the major proposed roles for AOX is for mitochondrial homeostasis [40], with 
phylogenetic analysis highlighting its position with other di-iron oxygen scavengers 
[49]. Expression of AOX is increased at times when the regular ETC is under stress, 
such as inhibition of complexes downstream of the quinone pool by fungicides [50], 
and during aging in potato tuber [51]. 
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Reactive oxygen species (ROS), such as superoxides and peroxides, are detrimental 
to cell longevity and have been implicated in both apoptosis and senescence.A 
majority of ROS are generated within the mitochondria [52, 53], via single electron 
reduction of oxygen to a superoxide species. Complex I is a major source of ROS 
[54] within mitochondria during reverse electron transport caused by a highly 
reduced quinone pool [55-57] due to high succinate dependant respiration. A highly 
reduced quinone pool induces inhibition of complex I, generating a high 
NADH/NAD+ ratio which in turn generates high levels of reduced FMN, thought to 
be one of the main sources of superoxide production. Inhibition of complex I with 
rotenone at the quinone site generated increased levels of superoxide[58], effectively 
mimicking inhibition of complex I via a highly reduced quinone pool. Expression of 
AOX  therefore reduces superoxide levels due to aiding oxidation of the quinone 
pool[59], allowing for more optimal throughput of the ETC by effectively acting as 
an energy overflow. Optimal Vmax for partitioning into the alternative pathway has 
been shown to require a high redox potential with respect to the quinone pool, with 
the pathway not being utilised until the quinol to quinone ratio is greater than 0.4 
[60, 61]. 
The second homestatic role for AOX is to lower the effective concentration of 
oxygen within the mitochondria. There is a direct correlation between [O2] and [O2
•-
] 
at concentrations lower than 5 µM [62], approximately the concentration found 
within fully functional mitochondria. AOX is able to act as an effective oxygen 
scavenger, with its relatively low Km for oxygen (12.3 µM [63] in mung bean and 
13.2 µM in soybean [64] alternative oxidases, compared to 0.1 µM for cytochrome c 
oxidase [65]) allowing it to reduce the levels of oxygen at high concentrations, but 
not act as a preferential binding site over the regular ETC proteins under optimal 
conditions.  
Mitochondria contain  a number of mechanisms to prevent ROS becoming 
problematic within the cells.For example, protein based systems such as superoxide 
dismutase convert superoxide through to hydrogen peroxide [66], which can then 
safely be converted to water via glutathione peroxidases. The expression of AOX is a 
preventative measure, lowering the cumulative causative effects that contribute to 
the production of ROS.  An increase in hydrogen peroxide levels have been shown to 
induce AOX expression [67], suggesting it plays a secondary role to regular ROS 
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scavengers until the peroxidases  are saturated. Indeed, it has been shown that  
inhibition of AOX using propyl gallate or SHAM in mitochondria already expressing 
the protein leads to an increase in peroxide levels [68]. 
The plant AOX is activated by pyruvate [69], with addition of pyruvate increasing 
the Vmax [70],whilst not affecting the affinity for quinol From a homeostatic 
perspective, an increase in pyruvate levels would indicate an increase in glycolysis 
over the ability for the citric acid cycle to maintain turnover, either due to inhibition 
of complexes further down the cycle, or a high NADH/NAD+ ratio preventing the 
conversion of pyruvate to actyl-CoA.  Use of pyruvate as a post-translational 
regulatory mechanism acts as an effective feed-forward mechanism; stimulation of 
the AOX via pyruvate leads to a reduction of the quinone pool, which in turn allows 
for increased activity of complex I and a decrease in the NADH/NAD+ ratio. 
 
1.4 Trypanosomes 
 
Trypanosomes (specifically T. b. rhodensiense and T. b. gambiense) are the 
causative agent of human African trypanosomiasis (HAT), with T. vivax responsible 
for Nangana in livestock. HAT was reported in 1997 to affect 450,000 people in sub-
Saharan African [71], but more recent figures have shown a decline in infection to 
~30,000 [72]. The disease is fatal if left untreated.  
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Figure 1-3:- Chemical structures of drugs used to treat HAT. 
 
The transfer of the parasite via the tsetse fly vector makes preventative efforts 
ineffective, and use of variable surface glycoproteins (VSG) by trypanosomes [73]  
enable evasion of the hosts immune response. Current treatments for the disease 
result in undesirable side-effects or only prove effective during the early stages of 
infection. Suramin and pentamide were some of the earlier treatments developed, 
and are only effective in early stages of infection due to their inability to cross the 
blood brain barrier [74]. Melarsaprol is effective in late stages of the disease, but 
causes reactive encephalopathy in 19% of patients [75]. Eflornithine is the most 
recent to be developed [76], targeting the ornithine decaraboxylase, preventing cell 
division within the trypanosomes [77]. The compound is less problematic within 
human tissue, due to its higher rate of metabolism is mammalian cells preventing the 
toxic build-up that kills trypanosomes. Application of all treatments to date 
necessitates trained professionals, requiring intravenous therapy over the course of 
12 days [78]. The most recent and effective treatment to be developed, a Nifurtimox-
eflornithine combination therapy (NECT), has an improved application over 
previous drugs, only requiring treatment over the course of 7 days [79]. 
The bloodstream form of the trypanosome downregulates the cytochrome pathway 
[80] leaving it dependent upon glycolysis for energy production [81]. The 
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Trypanosomal alternative oxidase (TAO) is used to generate quinone, which in turn 
is utilised to convert G-3-P to DHAP, allowing for regeneration of the cytosolic 
NAD+  necessary for continued glycolysis [82]. Given the dependant nature of 
trypanosomes on TAO for ATP generation (ref), TAO has been identified as a 
chemotherapeutic target for treatment of HAT [83].  
 
1.5 Inhibition of AOX 
 
  
Figure 1-4 : Chemical structures of SHAM and propyl-gallate, known inhibitors of AOX. 
 
Figure 1-4 shows the chemical structures of Salicylic hydroxamic acid (SHAM) and 
propyl gallate, the more studied inhibitors of AOX. SHAM is the least potent of the 
two, with an IC50 of 40µM in Arabidopsis thaliana [84] and a Ki value of 53 µM in 
purified A. maculatum mitochondria [85]. Initial reports of SHAM inhibition 
suggested that inhibition was due to chelation of the iron centre, but competitive 
inhibition with respect to quinol [85] would suggest this not to be the case. Assays 
have demonstrated that while inhibition is specific to AOX with respect to the ETC 
[86], it is non-specific within cellular tissues, inhibiting tyrosinase and peroxidase 
[87].  
Attempts to treat trypanosomiasis within the mouse [88] and goat [89] models with 
SHAM proved unsuccessful. Addition of glycerol increased activity against 
trypanosomes by inhibition of the glycerol production pathway [90], but the SHAM 
concentrations necessary were above toxicity levels, causing a 44% mortality rate 
[91] . The lack of ability to remove trypanosomes from the host was largely 
attributed to the low solubility of the compound, lowering bioavailability in the 
tissues where it was required.  
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A number of structural analogues were tested by Grady and colleagues to find 
improved inhibitors. Initial screening against trypanosomes [92] revealed a number 
of potential scaffolds, with the paraalkyloxybenzhydroxamic acids being taken 
further [93]. Investigation into this system revealed that an increased chain length 
improves inhibitory proprieties of the compounds, likely due to an increase in 
lipophilic character, but was detrimental to the inhibition profile due to a decrease in 
solubility. It was also determined that the acidity of the hydroxamic moiety was not a 
contributing factor, and that addition of an electron withdrawing group para to the 
hydroxamic acid improved inhibition.  
Esters of 3,4-dihydroxybenzoic acid also proved to be potent inhibitors of AOX, 
with compounds being 400 times more effective then SHAM [94], but unfortunately 
retained the same solubility issues.  Replacement of the ester with an amide bond 
improved solubility of the compound while retaining efficacy at higher chain 
lengths; such compounds were able to cure infection in 17 out of 19 mice when used 
in conjunction with glycerol, with fatalities in the remaining 2 [95]. It is also worth 
noting that an increase in chain length also altered the mode of inhibition; a chain 
length up to 4 demonstrated competitive inhibition with respect to the quinol 
substrate, but larger than 10 resulted in non-competitive inhibition [96].Alternative 
attempts to improve on the issues faced by SHAM were made by introduction of 
both a prenyl chain and a carbohydrate to improve solubility. While these additions 
did improve the Ki value of the compound, they were detrimental to the overall 
inhibition profile [97]. 
Gallates, esters of 3,4,5-trihydroxybenzoic acid, are also a family of known  AOX 
inhibitors [98] with a Ki of 2 µM [94]. A structure function study of gallate 
inhibition against mung bean AOX demonstrated that an increase in tail size 
increased the binding efficacy towards the protein, and that hydroxide functionality 
para to the ester was necessary for inhibition [99].  
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Figure1-5:- Natural products isolated from Ascochyta viciae and Cylindrocarpon sp. 
 
Ascofuranone belongs to a family of compounds from the fungus Ascochyta viciae 
[100, 101] which includes ascochlorin (Figure1-5). Such compounds received keen 
interest due to their nature as antibiotics with hypolipidemic activity [102, 103] and 
antitumor activity [104, 105]. Derivatives of ascochlorin, specifically the AS-6 (-
OCH2COOH at the position 4), have shown improved insulin responses in obese 
mice [106, 107]. More recent studies have indicated that ascochlorin confers 
antifungal activity against Candida albicans, the causative agent of thrush [108]. It is 
thought that the colletochlorins are likely an intermediate along the biosynthetic 
pathway to ascochlorin [109]. 
Ascofuranone is one of the more potent inhibitors of AOX, with an IC50 of 4 nM. 
The compound has trypanosidal activity both in vitro [110] and in vivo [111, 112], 
with successful treatment within the mouse model demonstrating the specificity of 
the compound. In contrast, Ascochlorin has been shown to be a potent inhibitor of 
the bc1 complex [113], binding at both the Qo and Qi sites. 
Investigation into the structure of ascofuranone and the Ilicicolin family revealed 
that the furanone ring is not necessary for binding, and that removal of chlorine 
reduces the binding affinity to AOX [114]. One of the more interesting effects of 
chlorine was towards the cytochrome bo and bd complexes; removal of chlorine 
increased inhibition towards the bd complex, whilst reducing efficacy towards the bo 
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complex. More recent structure-function analysis of ascofuranone [115] confirmed 
that the furanone ring is not necessary for inhibition, and that only the first isoprene 
unit is necessary for protein recognition. 
 
1.5.1 Synthesis of ascofuranone and ascochlorin 
 
 
 
Figure 1-6:- Total synthesis of ascofuranone using the method devised by Joullie and colleagues 
[116]. 
 
One of the first successful total syntheses of ascofuranone was performed by Joullie 
and colleagues [116, 117] (Figure 1-6). Synthesis of the compound was afforded via 
separate synthesis of the fully substituted 5-chloroorsinaldehyde, which was coupled 
to the tail with 10% KOH. This method was demonstrated to be applicable to the 
synthesis of the colletochlorins, but ascochlorin was not attempted.  
The second route published by the Mori group [118, 119] used an alternative 
approach, coupling the bromonated tail to 1,5-dimethoxy-3-methylcyclohexa-1,4-
diene with tBuLi to obtain the intermediate in 33% yield. Successive 
functionalisation with 2.2 equivalents N-chlorosuccinimide followed by 
aromatisation with DBU and formylation using EtMeBr and CH(OEt)3 obtained 
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ascofuranone in 2% overall yield from the coupling step. This method was also 
demonstrated to be applicable to the synthesis of ascochlorin, obtaining the 
compound in similar yields.  
 
  
Figure 1-7: Coupling of the protected benzaldehyde and the tail group and subsequent deprotection 
used by Saimoto [120] 
 
The route taken by Saimoto [120-122] is a more elegant synthesis, making use of the 
SEM protecting group to allow for cleaner coupling of the benzaldehyde to the tail 
section. The protected head and tail sections of the compound (Figure 1-7) were 
synthesised in 5 and 6 synthetic steps respectively, with a cuprate based cross-
coupling achieving the product in 70% yield. Subsequent deprotection of the 
carbonyls followed by removal of the SEM group with P2I4 gave an overall yield of 
39% with respect to the protected benzaldeyde. The author also demonstrated that 
removal of the SEM group was possible using TBAF in HMPA in the case of 
colletochlorin B, but failed to yield the deprotected compound with ascofuranone.    
 
1.6 Fungicides  
 
The alternative oxidase has been identified as a potential biological mechanism for 
resistance development [123] with evidence that inhibition of the bc1 complex leads 
to an induction of the AOX expression  [50]. Strobilurins are some of the most 
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widely used fungicides available, and have been shown to inhibit the cytochrome bc1 
complex at the Qo site [124]. Candida albicans has been shown to carry two AOX 
genes [125]; AOX1a is expressed at all times, while AOX1b is dependent on fungal 
growth stage while also being induced by H2O2 and Antimycin A (a cytochrome bc1 
QI inhibitor). As with the plant examples cited previously, inhibition of the ETC 
downstream from the quinone pool in fungal species leads to induction of AOX 
[126, 127]. Induction of AOX during inhibition of the regular ETC allows for 
continued ATP generation from glycolysis and Krebs cycle turnover plus ATP 
generation via proton-pumping activity of complex I.   
While the effects of AOX inhibitors alone are negligible, they have been 
demonstrated to have a synergistic effect when used in conjunction with Qo 
inhibitors such as azoxystrobin [128]. Removing the ability of Magnaporthe grisea 
to express AOX demonstrated an increased susceptibility to fungicides during 
mycelial growth both in vitro and in planta, but not during the sporulation period 
[129], suggesting that the alternative pathway is only activated in later stages of 
fungal development. It was reasoned that due to high energy requirements during the 
sporulation period, expression of AOX would not rescue the fungus due to its low 
energy throughput [130], and is therefore not inducible during this growth stage.  
Resistance to Qo fungicides largely develop due to point mutations within the Qo 
site. The first to arise after commercial treatment with the strobiliurins were the 
G143A and F129L mutants, which gave resistance factors >1000 and ~ 100 
respectively [131]. Inhibition of the Qi site with antimycin A showed no alteration in 
EC50, demonstrating that resistance was due to alterations in the Qo site alone. These 
mutants cause considerable reduction in ETC turnover, reducing cytochrome c 
reduction rates to 80% of the wild type [132]. However, this does not decrease 
fungal viability [133], given that cell growth is not inhibited until the rate is <20% of 
the full turnover capacity.  
1.7 Structure 
 
Initial modelling of AOX performed by Siedow and colleagues [134, 135] was based 
on sequence comparison to the di-iron carboxylate family, using multiple sequence 
alignment to highlight the conserved ExxH motifs that are common as non-haem 
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iron binding residues. The model consisted of a 4 helix bundle which acted as a 
scaffold for the di-iron centre, ligated by 3 glutamates, 2 histidines and an aspartate 
residue, based on the Methane monooxygenase (MMO) and Ribonucleotide 
reductase (RNR) binding motifs. The model also consisted of two transmembrane 
helices that spanned the membrane, with an additional hydrophobic stretch into the 
IMS.   
A second model was later proposed by Anderson and Nordlund [136] and refined by 
Berthold [137]. The model replaced the aspartate with a fourth glutamate based on 
amino acid spacing in the primary structure, which placed iron binding ligands on all 
4 of the proposed helices. The binding of the helices to the membrane was refined 
based on hydrophobicity plots, removing the transmembrane nature and instead 
associating to the inner membrane.  
A number of mutational studies have been performed on AOX in order to ascertain 
the roles of conserved amino acids. Mutation of the proposed iron binding residues 
in both plant AOX [138, 139] and TAO [140, 141] completely abolished enzymatic 
activity, with iron supplementation being necessary for growth of AOX dependant 
cell lines [140]. Further confirmation that AOX was indeed a di-iron protein came in 
the form of EPR analysis revealing a characteristic signal at g=15 in A. thaliana 
[139], and g=16 in S. guttatum [142], that were comparable to other di-iron 
carboxylate proteins [143]. 
Given the apparent lack of cofactors within AOX, it was reasoned that there were 
likely aromatic amino acid residues that were responsible for electron transport. An 
extensive sequence alignment across the entire AOX family revealed three fully 
conserved tyrosines (Y253, Y266 and Y275 SgAOX numbering) with Y299 being 
semiconserved [144]. Mutation of tyrosine to phenylalanine removes the hydroxide 
functionality from the amino acid, while retaining the ring, allowing for examination 
of the importance of the alcohol to function. The location of Y253 and Y275 within 
the proposed hydrophobic cleft from the Anderson-Nordlund model [137] that 
constituted a proposed quinone binding site led to mutation of  these residues to 
phenylalanine [138, 145], with Y275F leading to almost a complete loss of activity 
(~10% activity remained). The importance of this residue was confirmed in 
recombinant T.Vivax [141] whereby the haem deficient E.coli strain, dependent upon 
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successful intergration of a functional AOX for a terminal respiratory chain protein, 
failed to grow. Respiratory activities of the Y266 and Y299 both retained 10% of 
wild type activity, indicating that while they are still important residues, they are 
unlikely to be involved in electron transport.   
Sequence alignment of a number of known quinol binding proteins revealed a 
number of features that were apparent within the AOX in the region of the proposed 
hydrophobic crevice [146], with particular focus on the HR  pair (261 and 262 
SgAOX numbering). Subsequent mutation of these residues [145], alongside Q242 
and N246, gave activity levels of less than 10% of wild type activity, confirming that 
they are important to the overall function of the protein.  
 
 
Figure 1-8:- Crystal structure of TAO dimer (PDB accession code 3VV9). Di-iron centre shown as 
brown spheres, with helical numbering added for reference. 
 
A crystal structure of the TAO has recently been solved [11], confirming a number 
of the previously discussed structural predictions. TAO exist as a homodimer, with 
each monomer containing 6 helices (helical labelling depicted in Figure 1-8). The di-
iron centre is located within the centre of 4 longer helices arranged in an antiparallel 
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fashion, conforming to the 4 helix bundle which is found within other di-iron 
proteins such as MMO and RNR. The remaining two helices (1 and 4) are the 
proposed membrane binding helices, anchoring the protein onto the membrane. The 
facets of the crystal structure and the implications of highly conserved regions will 
be discussed in detail in Chapter 3. 
1.8 Structural regulation 
 
Two interlinked post-translational regulatory mechanisms have been identified 
within the plant AOX that control activity of the protein; deactivation via disulfide 
bond formation between monomers, and regulation of activity via alpha keto acids. 
Two cysteine residues 50 amino acids apart are fully conserved throughout the plant 
species, with C122 (SgAOX numbering) the likely source of disulphide bond 
formation [147]. While the cause of bond formation in unknown at present, chemical 
reduction of the disulfide bond with DTT was shown to increase protein activity, 
while reoxidation by diamine rendered the enzyme inactive [148]. The authors also 
indicated that dimerisation was not solely due to disulfide bond formation, as cross 
linkers targeting lysines gave the corresponding dimer band during western blot 
analysis. Within the mitochondria, it is thought that NADPH [149] is able to reduce 
the disulphide bond via a mitochondrial thioredoxin [150]. 
The activity of AOX is increased by alpha keto acids, with particular emphasis on 
pyruvate [69]. As discussed previously, a build-up of pyruvate would indicate a 
malfunction of the ETC, and activation via pyruvate correlates to proteins role as a 
homeostatic regulator. Activation via pyruvate is believed to occur via a mechanism 
of thiohemiacetal generation [151, 152] through reacting with the cysteine residue 
responsible for disulphide bridge formation, thus preventing deactivation of the 
protein via covalent dimerisation [153]. Work performed on purified A. maculatum 
mitochondria confirmed that a lack of pyruvate within a sample does lead to a 
deactiviation of the protein [154], with subsequent addition of pyruvate failing to 
restore activity. The lack of activity restoration would indicate that while it does 
increase the activity of the protein, it is not able to reduce the disulphide bond, 
suggesting that its role is protein stabilisation. Conversion of this cysteine to a 
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glutamate residue to mimic a thiohemioacetal gave a protein that was permanently in 
its active form, while also demonstrated insensitivity to pyruvate [147]. 
A study on tomato isoforms that contained a common cysteine to serine mutation 
revealed that mutation to a serine alters activation to succinate [155]. This has also 
been confirmed independently via point mutation to serine in soybean and 
Arabidopsis AOX [153], and mutation to alanine in tobacco AOX [156] conferred 
activation via succinate as opposed to pyruvate. This would potentially fall into the 
same feedback role as pyruvate from a homeostatic standpoint, but would allow for 
activation to occur earlier in feedback loop.   
A second region has also been identified for a potential role in pyruvate activation, 
with a highly conserved QDC region within SgAOX becoming an ENV motif in the 
more pyruvate dependant isoforms [154, 157]. This motif exchange was also found 
in thermogenic spadices, with isoforms expressed later in the spadix growth cycle 
conferring a QNT motif [158]. The reduction in regulation is likely to allow for 
continued heat production during thermogenesis, as regulation of activity would 
effectively lower heat production due to a reduced enzymatic turnover. These 
regulatory mechanisms are not present in the trypanosomal and fungal species [159], 
which is indicative to the need for constant turnover and availability within these 
species. 
1.9 Research aims 
 
Ascofuranone has been established as a potent inhibitor of AOX, and ascochlorin 
demonstrates inhibitory properties of the cytochrome bc1 complex. Both compounds 
contain structural motifs that make synthesis of optically pure compounds a lengthy 
process. The aims of the inhibitor research are twofold; to design an analogue that 
retains the inhibitory efficacy of the aforementioned compounds that is either 
specific to AOX for treatment of HAT, or a dual mode inhibitor that could be used as 
a fungicide. The results of this area of research are discussed in Chapter 5. 
Sequence alignment of AOX species throughout the plant, fungal and trypanosomal 
kingdom has revealed a large extent of conservation throughout the entire family 
[144], with particular focus of the conservation around the 4-helix bundle. This 
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information when used in conjunction with the recently published crystal structure 
[11] allows for determination of a wealth of information from both a structural and 
mechanistic perspective, and is the subject of discussion in Chapter 3.   
Site-directed mutagenesis studies using a haem-deficient E.coli strain have been 
demonstrated to be an efficient method of overexpression of alternative oxidases 
[140, 141, 160]. A number of conserved amino acids have been mutated, and their 
effects with respect to respiratory activity and oxygen kinetic parameters have been 
examined. The use of all information gathered from these studies, alongside 
structural comparisons to other di-iron proteins, has allowed for the postulation of a 
working catalytic cycle for alternative oxidases.  
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2 Materials and methods 
2.1 pET vector system  
 
The pET vector system is a useful tool for expression of recombinant proteins within 
an E.coli based system.  The pET-15b vector (Figure 2-1) has previously been 
optimised within the lab for expression of AOX[161].  
 
 
Figure 2-1:- plasmid map for the pET-15b vector. 
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Plasmid Encoding Creator 
SgAOX-pET15b Sauromatum guttatum AOX 
wild type  
Dr Mary Albury, University 
of Sussex 
TAO-pET15b Trypanosoma brucei brucei 
wild type 
Dr Mary Albury, University 
of Sussex 
SgAOX-pET15b: mutants 
D163A, R159A, L177A, 
T179A, N216A, L269A  
Y299F 
 
Sauromatum guttatum AOX 
mutants 
Dr Mary Albury, University 
of Sussex 
TAO-pET15b mutants: 
T124A 
Trypanosoma brucei brucei 
mutant 
Dr Mary Albury, University 
of Sussex 
Table 2-1: Plasmids created by Dr. Mary Albury for the expression of wild type SgAOX and TbTAO 
and their corresponding mutants using the pET-15b expression system 
A library of plasmids were created (Dr. Mary Albury – University of Sussex Table 
2-1) for transformation into E.coli using the pET-15b vector system (Novagen).  The 
pET-15b vector contains encoding for addition of an N-terminal His tag, resistance 
to ampicillin and allows for induction of protein expression via isopropyl β-D-1-
thiogalactopyranoside (IPTG). 
E.coli strain FN102 was transformed using the aforementioned plasmids. Strain 
FN102 is a haem deficient strain developed and kindly provided by Professor Kita 
(University of Tokyo). Transformation and growth of the E.coli was carried out 
using a modified protocol of that described in [160]. 
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2.2 Culture medium 
K-broth (KB) 
Chemical Concentration g/L 
Trytone peptone 10 
Yeast extract 5 
Casamino acid 5 
K2HPO4 10.4 
KH2PO4 3 
Trisodium citrate 0.74 
Ammonium sulphate 2.5 
 
Supplement – A 
Chemical Concentration g/L 
Magnesium Sulphate 0.05 
Iron Sulphate 0.025 
Iron Chloride 0.025 
Table 2-2:- Contents of K-broth and supplement A,  
Table 2-2:- Contents of K-broth and supplement A, Table 2-2 contains the recipe for 
KB and supplement A, used as the growth medium for haem deficient E.coli. The 
KB was mixed and sterilised prior to culture growth via autoclave, with supplement 
A added 30 minutes before the addition of E.coli.Luria Broth and Luria Agar (Miller, 
Sigma Aldrich) were prepared as per manufacturer’s instructions, with additives 
added as described in text.  
 
2.2.1 Competent cells 
 
E.coli (strain FN102) was plated onto Luria Agar (100µg/ml 5-Aminolevulinic acid 
(ALA), 50 µg/ml Kanamycin (Kan)) and incubated overnight at 37°C. A single 
colony of fresh E.coli cells were used to inoculate 5ml LB containing 100µg/ml 
ALA, 50µg/ml Kan and left in an orbital shaker at 37°C overnight. 1ml of this 
culture was used to inoculate 100ml of LB and was incubated at 37°C until OD650 
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was 0.5. The culture was chilled on ice before centrifugation at 1000g for 5 minutes 
at 4°C. The pellet was resuspended in 50ml 0.1M CaCl2. This was repeated twice 
and the final pellet chilled on ice for 30 minutes. The final pellet was resuspended in 
5ml 0.1M CaCl2. Competent cells can be stored at -80°C by resuspending the cells 
into a solution containing 10% glycerol, 0.075M CaCl2, and aliqouting into 0.5ml 
prior to flash freezing in a dry ice industrial methylated spirit bath.  
2.2.2 DNA Transformation  
 
DNA transformation was performed as described by Mandel and Higa [162]. Two 
100µl aliquots of competent cells were chilled on ice. 2µl of DNA was added to one 
aliquot, and 2µl of water added to the second as a control. The cells were gently 
mixed and left on ice for a further 30 minutes, prior to being heat shocked at 42°C 
for 2 minutes and returned to the ice.  After 20 minutes 900µl LB was added and the 
cells were incubated at 37°C for 30 minutes. 100µl was plated out onto Luria Agar 
containing 100µg/ml ALA, 50 µg/ml Kan, 50 µg/ml ampicilin, and the remaining 
cells were pelleted and plated out onto a separate plate. The plates were allowed to 
grow overnight at 37°C in an incubator.  
2.2.3 Protein expression in E.coli 
 
A colony was taken from freshly transformed cells and streaked onto a Luria Agar 
plate containing 100µg/ml ALA, 50 µg/ml Kan, 50 µg/ml ampicilin and placed in an 
incubator at 37°C for 12hours overnight. A loop of cells was then used to inoculate 
two 50ml starter cultures of KB containing 100µg/ml ALA, 50 µg/ml Kan, 50 µg/ml 
ampicilin and placed in an orbital shaker at 30° for 4 hours. The starter cultures were 
centrifuged at 5 000g for 10 minutes, and resuspended in ~10mls fresh KB 
containing no additives. This was repeated twice to remove any excess ALA, and 
resuspended in a final volume of 5ml KB. The OD600 of the resuspended cells was 
measured, and added to the main culture flasks containing KB, supplement A and 
glucose to give a starting OD600 of 0.01. The flasks were transferred to an orbital 
shaker at 37°C and OD600 were taken hourly until a reading of 0.1 was obtained 
(~3hours). At OD600 0.1 the cells were induced with IPTG (final concentration 25 
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µM for SgAOX and mutants, 100 µM for TAO) and the cultures left to grow 
overnight (~14hours). 
2.2.4 Membrane harvest 
 
Cells were centrifuged at 8000g and supernatant discarded before resuspension in 
50mM TRIS-HCl (containing 10mM pyruvate for SgAOX) pH 7.4 at a volume of 
5ml per 1g wet weight. Protease inhibitor cocktail tablets (1 tablet per 50ml volume 
– cOmplete - Roche) were added to the cells. The mixture was homogenised prior to 
being passed twice through a French press (Thermospectronic) at 10kPa. The lysate 
was centrifuged at 15000g for 15mins to remove the cell debris, and the supernatant 
spun at 200000g for 1 hour in an ultracentrifuge. The membrane pellet was 
resuspended in an appropriate volume of 50mM TRIS-HCl and homogenised.   
 
Membrane samples could be stored for extended periods of time by snap freezing in 
liquid nitrogen and storing at -80°C.  
 
2.3 Purification 
 
Purification of the SgAOX was achieved using a modified protocol of the TAO 
purification procedure [163]. 
   
Chemical Solubilisation buffer Wash Buffer Elution buffer 
TRIS-HCl pH 7.4 50mM 50mM 50mM 
pyruvate 10mM 10mM 10mM 
DDM 1% (w/v) 0.5% (w/v) 0.5% (w/v) 
C12E8 - 0.5% (w/v) 0.5% (w/v) 
Glycerol 20% (v/v) 20% (v/v) 20% (v/v) 
Magnesium 
sulphate 
- 100mM 100mM 
Imidazole - 20mM 250mM 
Table 2-3:- Buffer contents for protein purification. Buffers were prepared on day of purification and 
stored on ice until use.  
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2.3.1 Protein Solubilisation 
 
E.coli membrane samples were placed on ice for 30 minutes, before being added 
dropwise to an equal volume of solubilisation buffer ( Table 2.3 ref not 
working))with constant agitation to ensure adequate mixing. This was kept on ice for 
30 minutes with stirring. The mixture was transferred into ultracentrifuge tubes and 
centrifuged at 200,000g for 1 hour. The supernatant containing the solubilised 
protein was taken forward, and the pellet resuspended in 50mM Tris-HCl to allow 
for protein estimation and activity measurements.  
2.3.2 Protein purification 
 
A volume of cobalt affinity chromatography resin (Sigma-Aldrich) equal to the 
solubilised protein volume was spun at 2300g for 1 minute and the ethanol aspirated 
off. The beads were resuspended in solubilisation buffer at 3 times the bed volume 
and equilibrated on ice for 10minutes with occasional agitation. The beads were spun 
at 2300g and the buffer removed. The solubilised protein was added to the beads and 
allowed to bind for 1 hour on a rotor spinning at 2rpm in a cold room.  
For bed volumes less then 500µl a batch process was used. The beads were placed in 
a 1.5ml eppendorf and spun at 2300g for 1 minute, and the supernatant removed and 
kept as flowthrough. A volume of wash buffer equal to 5 times the bed volume was 
added to the eppendorf and the sample was agitated on ice for 5 minutes before 
being spun and the wash being removed and retained. This was repeated before a 
final addition of the elution buffer equal to three times the bed volume was added 
and spun as before.  
 
For bed volumes greater than 500µl 
 
The beads were then applied to a plastic column and allowed to settle before the 
remaining solubilised protein was run off and collected as flow-through for testing. 
The beads were then washed twice with 5 times bed volume of wash buffer with the 
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washes being collected for analysis. The protein was then eluted with 3 times bed 
volume Elution buffer. 
 
2.3.3 Top loaded protein purification 
 
An alternative method was also used whereby the equilibrated beads were applied to 
the column and allowed to settle. Excess equilibration buffer was run off and the 
solubilised protein was applied to the top of the column. The liquid level was 
lowered to above the top of the column and allowed to bind in the cold room for 30 
minutes, before being washed twice with 5 times the bed volume with wash buffer 
and eluted.  
 
2.3.4 Protein precipitation  
 
Precipitation of the purified protein was necessary for obtaining an accurate protein 
estimation as it was found that the detergents were interfering with the estimation kit. 
The purified protein was added to 4 x volume of ice cold acetone in a 1.5ml 
centrifuge tube and incubated at -20°C for 1 hour. The protein was pelleted in a 
benchtop centrifuge (6,000g – 20minutes), and the acetone removed. Pellets were 
dried in a 37°C water bath for 1 hour before resuspension in 5% (w/v) SDS 0.1M 
NaOH prior to protein estimation.  
 
2.4 Protein estimations 
 
Protein estimations were carried out with Pierce BCA protein assay kit (Thermo 
Scientific) following manufacturer’s instructions. Samples were diluted as 
appropriate (50:1 in water for membrane and mitochondrial samples, as precipitated 
for purified protein) and 100 µl added to 1ml BCA working reagent (50:1 A:B from 
kit), with triplicates of all samples being prepared. BSA standards were prepared at 
concentrations of 0, 0.1, 0.2, 0.4, 0.6, 0.8 and 1 mg/ml in duplicates using the same 
ratio of sample to BCA working reagent. The solutions were thoroughly mixed, and 
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allowed to incubate at 37°C for 30 minutes. After incubation the absorbance at 
562nm of each sample and standard was measured, with BSA standards used to plot 
a standard curve for determination of sample protein concentration.  
 
2.5 Mitochondrial preparations 
2.5.1 Arum maculatum mitochondria 
 
Approximately 100g of spadices were harvested from Arum maculatum and stored 
on ice. After cooling, the spadicies were sliced and placed into 500ml ice cold 
grinding buffer (0.3M mannitol, 20mM MOPS, 2mM EDTA, 7mM cysteine,2mM 
pyruvate, 0.2% (w/v) BSA pH 7.5) before homogenisation in a blender (waring). The 
homogenate was passed through muslin before centrifugation (10mins, 200g). The 
supernatant was then taken and recentrifuged (10mins, 17000g) and the pellet 
resuspended in wash buffer (0.3M mannitol, 20mM MOPS, 2mM EDTA, 2mM 
pyruvate, 0.2% (w/v) BSA, pH 7.5). This was respun under the same conditions and 
the final pellet was resuspended in ~2ml wash medium. 
 
The mitochondria were layered onto a Percoll gradient (21% (v/v) percoll, 0.3M 
sucrose, 5mM MOPS, 0.1% (w/v) BSA, 2mM pyruvate) and centrifuged for 30mins 
at 13,000g with no deceleration to purify the mitochondria. The mitochondrial layer 
was transferred to new centrifuge tubes and centrifuged for 10 mins at 13,000g 
before resuspension in wash medium.  
 
For storage purposes, the samples were slow frozen at -20°C for an hour before 
being transferred to a -80°C freezer for long-term storage.  
 
2.5.2 Potato mitochondria 
 
Potato mitochondria were prepared as the A. maculatum mitochondria described in 
2.5.1. 1kg of potato tuber (purchased from Waitrose) were necessary to obtain 
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enough mitochondria. The mitochondria were not purified on a Percoll gradient as it 
was found to be detrimental to activity. 
 
2.6 Fungal plate assays 
 
A S.cervisiae cell line containing wild type cytochrome bc1 , G143A, K228M and the 
double mutant were kindly provided by Brigitte Meunier (Centre de Génétique 
Moléculaire). Cells were plated onto yeast-extract peptone D-glucose (YPD) agar 
(2% yeast extract, 2% (w/v) bacteriological peptone, 2% (w/v) glucose, 2% (w/v) 
agar) and allowed to grow in an incubator at 37°C overnight. A loop of cells was 
then taken and placed into a 5ml YPD liquid culture (2% (w/v) peptone, 2% (w/v) 
yeast extract, 2% (w/v) glucose) and incubated at 30°C for 2 days. 1µl was 
transferred into 5ml yeast-extract peptone glycerol (YPG) media (2% (w/v) peptone, 
2% (w/v) yeast extract, 2% (v/v) glycerol) and stirred. 5µl was then plated onto YPG 
plates (as media, with 2% (w/v) agar) and allowed to grow at 37°C for 3 days.  
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2.7 Gels  
2.7.1 SDS PAGE gel 
Reagent Contents Notes 
2 x Loading dye 0.1M Tris-HCl pH 6.8 
10mM EDTA 
2% (w/v) SDS 
5% (w/v) glycerol 
0.05% (w/v) bromophenol 
blue  
 
 
10 x Running buffer  0.1M TRIS-HCl, pH 6.8 
10mM EDTA 
2% (w/v) SDS 
5% (w/v) glycerol 
0.05% (w/v) bromophenol 
blue 
 
10 x TBST (Tris-buffered 
saline tween) 
140mM NaCl 
20mM Tris-HCl pH 7.6 
0.1% (v/v) Tween-20 
Diluted to 1 x working with 
distilled water 
10 x Transfer buffer 1.92M glycine 
13mM TRIS pH 7.2 
Diluted to working reagent 
by 8 parts distilled H20, 1 
part methanol (typical 
volume of 1 liter for single 
transfer setup) 
Blot rinse 10mM TRIS pH 7.2 
5mM EDTA 
 
Block  2 % (w/v) milk powder 
3%(w/v) BSA 
In 1 x TBST 
Table 2-4:- Contents of Reagents used in SDS gels and Western Blots. 
 
2.7.1.1 Sample preparation 
Purified protein samples required precipitation (as described in 2.3.4) prior to SDS 
gels to allow for concentration of the sample. Membrane samples were diluted with 
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distilled water to a final concentration of 3µg/1µl. This was added to 50µl of 2 x 
loading dye (Table 2-4) and denatured in a hot block at 90°C for 3 minutes. 
2.7.1.2 Gel preparation 
 
Reagent Volume/ml 
H20 5.65 
Stacking buffer (0.5M Tris-HCl, pH 6.3) 2.5 
10% SDS 0.1 
30% acrylamide:bisacrylamide 1.65 
10% APS 0.1 
TEMED 0.01 
Total volume 10ml 
Table 2-5:- Contents of the stacking gel for SDS-page gels. Total volume is sufficient for 4 gels 
 
Reagent Volume/ml 
H20 11.88 
Resolving buffer (1.5M Tris-HCl pH 8.8) 7.5 
10% SDS 0.3 
30% acrylamide:bisacrylamide  10 
10% APS 0.3 
TEMED 0.02 
Total volume 30ml 
Table 2-6:- contents of the stacking gel for SDS-page gels. Total volume sufficient for 4 gels  
 
Gels were cast in a Biorad Mini Protean kit, giving 10cm x 8cm x 1mm gels. Two 
glass plates were separated by a spacer and assembled into the plate holder. The 
plates were filled with distilled water for 5 minutes to ensure there was no leakage, 
and the water was emptied from the setup. Resolving gel was prepared as in Table 
2-5, with addition of components in order on the list. Upon addition of TEMED, the 
mixture was thoroughly mixed and used to fill the plates to 2/3rds of the plate height. 
This was overlaid with propanol and allowed to set for 30 minutes. Once set, the 
propanol was removed and the gel was overlaid with stacking gel (contents described 
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in Table 2-6) and a comb was inserted. The stacking gel was allowed to set, and the 
unit was disassembled. The gels could be stored for up to 3 weeks if soaked in 
running buffer (Table 2-4) in the fridge.  
 
2.7.1.3 Gel electrophoresis  
 
Two gels were attached to an electrophoresis rig and submerged in 1 x SDS running 
buffer. 10 µl of the previously prepared samples (15µg) were loaded into the gel 
with rainbow markers (colourplus prestained, 7-175kDa, Biolabs) and the powerpack 
was attached. The gels were run at 150V for 1 hour, or until the dye front reached the 
bottom of the gel. The gels were removed from the electrophoresis rig and rinsed 
with distilled water. One of the gels was then stained with GelCode Blue 
(ThermoScientific) following manufacturer’s instructions. The gel was removed 
from the glass plates and the loading section removed. The gel was placed in a 
plastic container on an agitator and washed 3 times with distilled water for 15 
minutes. GelCode Blue was added to the sample for 1 hour. This was removed and 
the gel destained in distilled water overnight.  
 
2.7.2 Western Blot analysis 
  
The second gel of the pair was used for western analysis. The gel was removed from 
the glass plates and washed with 1 x transfer buffer. A transfer cassette, complete 
with 2 sponges, 2 pieces of 3mm transfer paper and nitrocellulose membrane were 
also equilibrated in 1 x transfer buffer (Table 2-4). The cassette was assembled, 
rolling a testtube over the top of the sponges to ensure exclusion of air bubbles. This 
was then placed into a transfer rig with 2 ice packs in a cold room, and the tank was 
filled with 1 x transfer buffer. A power pack was connected to the transfer rig and 
was run for 1 hour at 100V, changing out the ice packs if melted to maintain a low 
temperature and prevent denaturing or the nitrocellulose membrane. After 1 hour, the 
rig was disassembled and the nitrocellulose placed into a plastic box.   
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To ensure transfer of protein, the nitrocellulose membrane was stained with ponceau 
solution, marking the lanes and markers for later reference. The solution was rinsed 
off with 1 x TBST (Table 2-4). The membrane was then soaked in 20ml block 
solution (2% (w/v) milk powder, 3% BSA (w/v) in 1x TBST) for 2 hours at room 
temperature on an agitator, before 10µl of primary antibody (anti-AOX[164], 
dilution 1:5000) was added. This was left on an agitator for 1 hour before a quick 
wash with 1xTBST, followed by 6 x 5 minute washes in1x TBST. A second 20ml 
aliquot of block solution was added to the film and 10 µl of secondary antibody 
(rabbit anti-mouse with HRP conjugate, Dako BioProducts, 1:20,000 dilution) was 
allowed to bind for 1 hour followed by another series of 1xTBST washes. This was 
followed by a final 15minute wash in 1 x blot rinse (Table 2-4), and the membrane 
was dried with blotting paper before transferring into saran wrap for detection.    
 
2.7.3 Detection 
 
A chemiluminescence kit (ECL Detection Kit, GE Healthcare) was used for 
detection purposes. The membrane was transferred to the dark room and exposed to 
1ml reagent 1 for 3 minutes, followed by 1ml reagent 2 for 1 minute. Excess liquid 
was removed using blotting paper, and the membrane was rewrapped in saran wrap, 
ensuring no bubbles were trapped. The membrane was attached to the inside of an 
exposure cassette and the light turned off, at which point a piece of X-ray film 
(Fujifilm Super RX Medical X-ray film) was inserted into the cassette and exposed 
to the membrane for 1 minute. The film was then removed from the cassette and 
developed in an autorad developer (Konika SRX-101A). The positions of the lanes 
and markers were noted in the film. If a longer exposure was necessary, a second 
piece of film could be added to the cassette and exposed for the desired time.  
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2.8 Analytical techniques 
 
2.8.1 General 
All inhibitors were made to a stock solution of 10mM in DMSO, with serial dilutions 
in propanol.  
 
Media contents Used for 
Plant medium A 300mM manitol  
1mM MgCl2  
10mM KCl   
5mM K2HPO4  
20mM MOPS  
pH 7.2 
 
Plant mitochondria 
Tris 50mM Tris-pH 7.4 
10mM Pyruvate 
Recombinant membrane  
Purified recombinant 
   
Table 2-7:- contents of buffers used for assays 
 
2.8.2 Oxygen electrode 
 
Oxygen concentration in solution was measured voltametrically using a Rank 
oxygen electrode. The electrode consists of a silver anode and platinum cathode, 
with conduction between the two achieved using saturated KCl. The electrode is 
polarized at ~0.6V, whereby changes in measured voltage are due to the following 
reactions:- 
(anode)  4Ag → 4Ag+ + 4e- 
(cathode) O2 + 4e
-
 + 4H
+
 → 2H2O 
The electrode is separated from the reaction chamber via an oxygen permeable 
membrane, with a magnetic stirrer used to ensure even oxygen distribution between 
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the reaction and electrode chambers. The reaction chamber is sealed with the 
exception of a capillary tube that allows the addition of substrates via micro syringe. 
The electrode was calibrated against air saturated distilled water (250 µM at 25°C) 
for 100%, and addition of sodium dithionite for 0%.  
2.8.3 Spectrophotometric enzyme assays 
 
Spectrophotometric assays were run using a Cary 400 UV spectrophotometer, using 
the packaged software. All spectrophotometry were performed using a quartz cuvette 
with a 1ml path length. 
 
Kinetic assays 
Compound Wavelength 
measured(nm) 
Extinction coefficient 
/AM-1cm-1 
Quinol (Q1H2) 278 17000 
Duroquinol (H2O) 250 7.1 
NADH 339 6200 
DCPIP 600 21000 
   
Table 2-8:- Wavelengths and extinction coefficients used for the kinetic assays. 
Spectrophotometric kinetic assays were run using the Kinetics package (Cary 
WinUV biopackage). The spectrophotometer was set to the wavelength defined in 
Table 2-8, and blanked against the solvent. The substrate was added and the kinetic 
scan started for 1 minute to allow for the collection of auto-oxidation rates. The 
protein was then added, and a change in absorbance over time was determined.  
 
Scanning assays 
 
Scanning for specific wavelengths was done using the Scan package (Cary WinUV 
biopackage). The sample was baselined against the solvent, and the sample could be 
added to the cuvette and scanned for the desired wavelengths. Scanning assays were 
predominantly used for determination of substrate concentration using the extinction 
coefficients in Table 2-8. 
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2.9 Crystal structures analysis 
 
Crystal structures used 
PDB accession 
number 
Protein Description Reference 
3VV9 TAO No inhibitor 2.9 Å [11] 
3VVA TAO Contains Ascofuranone derivative 
2.6 Å 
[11] 
3W54 TAO Contains colletochlorin B 
2.3 Å 
[11] 
1FYZ MMO Reduced structure 2.15 Å [165] 
1MTY MMO Oxidised structure 1.7 Å [166] 
1R65 RNR Reduced structure 1.95 Å [167] 
1RIB RNR Oxidised structure 2.2 Å [168] 
1PIM RNR-D84E Reduced structure 2.0 Å [169] 
1PIU RNR-D84E  Oxidised structure 2.2 Å [169] 
3H1L Chicken bc1 Bound Ascochlorin 3.2 Å [113] 
1SQB Bovine bc1 Bound azoxystrobin 2.7 Å [170] 
1LKO Rubrerythrin Reduced structure 1.6 Å [171] 
    
Table 2-9:- PDB accession codes for crystal structures used. Protein codes refer to the following 
proteins : Trypanosomal alternative oxidase (TAO), methane monooxygenase (MMO) ribonucleotde 
reductase (RNR), ribonucleotides reductase D84E mutant (RNR-D84E), Cytochrome bc1 complex 
(bc1). 
 
Table 2-9 contains the details for the crystal structures used throughout this 
thesis.Crystal structures were visualized using PyMOL version 1.3 
(www.pymol.org), with analysis of protein cavities was undertaken using the 
CAVER 3.0 plugin[172]. Docking was carried out using the VINA autodock system 
packaged on www.mcule.com, and visualized for clarity using PyMOL.  
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2.10 Chemical synthesis   
 
General procedures 
Reactions were monitored via thin layer chromatography (TLC) using precoated 
silica sheets with fluorescent indicator UV254. Compound detection was achieved by 
developing the plates by staining with a potassium permanganate solution 
(potassium permanganate (3g) + potassium carbonate (20g) + 5% (w/v) aqueous 
NaOH (5ml) + water (300ml)) with subsequent heating revealing the compounds as 
yellow spots.  
Chromatographic purification was performed using silica gel 60A ‘Davisil’ (35-
70µM particle size). Solvents for chromatography were used as received, with the 
exception of ethyl acetate which was distilled prior to use. 
Anhydrous ether was prepared via distillation for a minimum of 72 hours over 
sodium potassium alloy. 
1
H NMR, 
13
C NMR and multidimensional spectra were recorded on a Varian 
VNMRS spectrometer (600MHz). Chemical shifts in 
1
H and 
13
C were referenced to 
residual proton resonance of the solvent CDCl3 (7.26ppm), CD3OD (3.31ppm) and 
C3D6O (2.05ppm).  
HR-ESI-MS spectra were recorded on a Brucker Daltonics Apex III with MeOH as 
solvent. Mass spectroscopy was performed by Dr. Alaa Abdul-Sada (University of 
Sussex). 
 
2,4-dihydroxy-6-methyl-benzaldehyde (1) 
 
 
 
Orcinol (5g, 40mmol) and Zn(CN)2 (7.1g, 60mMol) were placed into a 3 necked 
flask with mechanical stirrer under N2. Anhydrous ether (50ml) was added, and the 
reaction was saturated with HCl gas. After 2 hours, the ether was decanted off and 
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water (50ml) was added to the reaction mixture. This was heated to 100°C where the 
product crashed out of solution. The crude product was collected via Büchner 
filtration, and recrystallised from water to yield the pure aldehyde (4.6g) in 76% 
yield.  
 
1
H NMR (CDCl3): 12.38 (1H, s, OH), 10.11 (1H, s, CHO) 6.23 (2H, s, CH 
signals overlap) 5.52 (1H, s, OH) 2.54 (3H, s, CH3) 
13
C NMR (CDCl3):    192.6 (CHO) ,164.3 (COH), 160.7 (COH), 141.3 (CCH3) 
125.2 (CH) , 113.8 (CCHO) , 101.2 (CH), 17.86 (CH3) 
 
3-chloro-4,6-dihydroxy-2-methyl-benzaldehyde (2) 
 
  
 
4,6-dihydroxy-2-methyl-benzaldehyde (527mg, 3.5mMol) was put under N2 and 
dissolved in anhydrous ether (60ml) on an ice bath. SO2Cl2 (1.35ml, 4.7mmol) was 
diluted in ether (15ml) and then added dropwise over 15 minutes. The reaction was 
left to stir overnight, and quenched with the addition of water. The ether layer was 
washed with 0.1M NaHCO3 and water, then dried over MgSO4 and dried under 
vacuum. The crude solid was then purified via flash chromatography (toluene: ethyl 
acetate 2:1 → 1:1) to obtain the product (434mg) in 72% yield. 
 
1
H NMR (C3D6O)  12.52 (1H, s, OH) 10.22 (1H, s, CHO) 6.42 (1H, s, CH) 2.67 
(3H, s, CH3) 
13
C NMR (C3D6O) 194.2 (CHO), 160.5 (COH), 141.7 (CCH3), 114.6 (CCl) 113.4 
(CCHO), 101.3 (CH), 13.8 (CH3) 
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(E)-1-bromo-3,7-dimethylocta-2,6-diene (3) 
 
 
Geraniol (0.56ml, 3mMol) was added to a round bottomed flask containing 
anhydrous diethyl ether (10ml) on ice under a nitrogen atmosphere. After stirring for 
10minutes, phosphorus tribromide (0.123ml, 1.2mM) was added dropwise via 
syringe. The solution was allowed to stir for one hour before quenching with 
aqueous sodium hydrogen carbonate. The aqueous layer was extracted twice with 
diethyl ether. The organic layer was dried over magnesium sulphate and the ether 
removed under vacuum to yield geranyl bromide in quantitative yield. The same 
method was used for the synthesis of 3-3-dimethylallyl bromide, with care taken 
during rotary evapouration due to its decreased vapour pressure. Compound identity 
confirmed with appearance of C-Br stretch using IR spectroscopy. 
 
(E)-3-chloro-5-(3,7-dimethylocta-2,6-dienyl)-4,6-dihydroxy-2-
methylbenzaldehyde ---Colletochlorin B (4) 
 
  
3-chloro-4,6-dihydroxy-2-methyl-benzaldehyde (150mg, 0.8mmol) was dissolved in 
10% KOH (0.9ml, 0.8mmol) yielding a deep red solution. The reaction was placed 
on an ice bath, and geranyl bromide (0.39ml, 1.6mmol) was added. The reaction was 
stirred vigorously overnight, and extracted with ether. The organic layer was washed 
with NaHCO3 and brine, before being concentrated under vacuum. The resultant oil 
was purified via flash chromatography (petrol ether 60-80 : ether   10:1 → 3:1) to 
obtain pure colletochlorin B (52mg) in 20% yield. Synthesis of colletochlorin D was 
afforded in the same manner, substituting geranyl bromide for 3-3-dimethylallyl 
bromide giving a yield of 30%. 
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1
H NMR (C3D6O)  12.88 (1H, s, COH) 10.22 (1H, s, CHO) 5.24 (1H, t, JH-H 7.2) 
5.06 (1H, t, JH-H 7.13, CH)   3.39 (2H, d, JH-H 7.14, ar-CH2) 
2.65 (3H, s CH3) 2.05 (m, 2H CH2) 1.96 (t,2H, JH-H 7.2 CH2) 
1.77(3H, s, CH3) 1.60 (3H, s, CH3) 1.55 (3H, s, CH3) 
 
13
C NMR (C3D6O)  194.4 (CHO) ,161.8 (COH) ,157.4 (COH), 138.3 
(CHC(CH3)CH2)),  135.2 ((ar)CCH3), 130.7 (CCH3(CH3)), 
123.1(CH2CH), 121.4(CH2CH2CH), 114.5 (CCHO), 113.3 
(CCl), 109.9(ar-CCH2CH), 39.5 (CH2CH2CH), 26.4 
(CH2CH2CH), 24.8 (CHCCH3) , 21.6(ar-CH2CH), 16.7 
(CCH3CH3),15.3(CCH3CH3), 13.6 (ar-CH3) 
 
Predicted m/z C18H23ClO3Na :- 345.1233 
Detected m/z C18H23ClO3Na  :- 345.1228 
 
(E)-4-chloro-2-(3,7-dimethylocta-2,6-dienyl)-6-formyl-5-methyl-1,3-phenylene 
diacetate (Acetylated) (5) 
 
 
 
 
Colletochlorin B (16mg, 50µMol) was added to a flask containing pyridine (0.5ml). 
After stirring for 10minutes, Acetic anhydride (0.5ml) was added and the reaction 
was left to stir overnight. The reaction mixture was evapourated to dryness, then 
coevapourated with toluene followed by DCM to obtain pure actylated compound in 
quantitative yield.  
1
H NMR (CDCl3) 10.27 (1H,s, CHO), 5.06 (1H, t, JH-H 6.87 CH) 4.98 (1H, t, JH-
H 6.13 CH) 3.21 (2H, d, 5.62 ar-CH2) 2.67 (3H,s,ar-CH3). 2.62 
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(3H, s CH3) 2.35 (6H, s , COCH3 x 2) 2.03 (m, 2H CH2) 1.97 
(m, 2H, CH2) 1.72 (3H,s,CH3)1.66 (3H,s,CH3) 1.58 
(3H,s,CH3) 
 
 
 (E)-4-chloro-2-(3,7-dimethylocta-2,6-dienyl)-6-(hydroxymethyl)-5-
methylbenzene-1,3-diol –reduced colletochlorin B (6) 
 
 
Colletochlorin B(14mg, 44µMol) in ethanol (0.5ml) was transferred into a flask 
containing a suspension of NaBH4 (1mg in 0.5ml ethanol) and left to stir for 1 hour. 
The mixture was coevaporated 3 times with methanol, before purification via flash 
chromatography (2:1 petrol ether:ether) to obtain the reduced compound (7mg) in 
50% yield. 
Rf = 0.21 (4:1 petrol ether:ether) 
 
1
H NMR (CDCl3) 7.12 (1H, s, OH) 5.73 (1H, s OH) 5.27(1H, t, JH-H 7.01 CH ) 
5.07 (1H, t, JH-H 6.36 CH) 4.84 (2H, s CH2OH) 3.44 (2H, d, 
JH-H  6.95) 2.09 (2H, m CH2) 2.04 (2H, m CH2) 2.35 (3H, s 
CH3) 1.81 (3H, s CH3) 1.67 (3H, s CH3) 1.60(3H, s CH3) 
13
C NMR (CDCl3)  153.9(COH), 149.3(COH), 137.9 (CCH3), 
131.7(CCH3(CH3)), 131.4(CHC(CH3)CH2), 123.9 (CH2CH), 
121.4(CH2CH2CH), 117.2 (CCl), 113.2 (ar-CCH2CH2), 
59.8(CH2OH), 39.7(CH2CH2CH), 29.6 (CH2CH2CH), 
26.4(CH3), 23.0(CH3), 16.1(CH3), 15.9 (ar-CH3) 
 
 
Predicted m/z C18H23ClO3Na :- 347.1390 
Detected m/z C18H23ClO3Na :- 347.1378 
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3-chloro-4,6-dimethoxy-2-methylbenzaldehyde (7) 
 
 
 
3-chloro-4,6-dihydroxy-2-methyl-benzaldehyde (150mg, 0.3mMol) and potassium 
carbonate (336mg, 2.6mMol, 7.2eq) were stirred in acetone (15ml) for 20minutes to 
form a suspension. Methyl iodide (0.288ml, 4.6 mMol, 15eq) was added and the 
suspension was refluxed for 24hours. The suspension was evaporated to dryness 
under reduced pressure and dissolved in 10ml ethyl acetate. The organic phase was 
washed with 3 x 5ml water, dried over magnesium sulphate and re-evapourated. The 
crude product was purified via flash choromatography (toluene:ethyl acetate 4:1) to 
obtain the product in 40% yield. 
 
1
H NMR (CDCl3)  10.42 (1H, s CHO) 6.37 (1H, s CH) 3.94 (3H, s OCH3) 
3.89(3H, s OCH3) 2.63(3H, s ar-CH3) 
13
C NMR (CDCl3)  190.1 (CHO), 163.3 (COMe), 159.6 (COMe), 140.8 (CCH3), 
117.6(CCl), 116.5(CCHO), 93.3 (CH), , 56.3(OCH3), 
56.2(OCH3), 16.8 (CH3). 
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3 Structural analysis of TAO 
3.1 Introduction 
 
Recent crystallisation of TAO [11] allows for a more in-depth examination as to the 
role of highly conserved amino acids within the alternative oxidase family, and can 
defined as being either structurally or mechanistically important, with a majority of 
conserved residues performing both roles. TAO is a useful model system for plant 
AOX given its simpler nature; the lack of regulatory mechanisms [159] allow for 
identification of the mechanistically important regions without complications caused 
by the presence or absence of activators at an allosteric site.  
While sequence comparison between TAO and SgAOX reveals that there is only 
~30% sequence homology, homology modelling [161] demonstrates that the highly 
conserved residues remain spatially equivalent. Those amino acids that are 
conserved are predominantly located on the 4 helix bundle surrounding the di-iron 
core, with the unconserved region that can be seen in Figure 3.1 being part of helix 1 
and the N-terminal arm. As such, the discussion around the conserved residues will 
be broken down into two sections; the core structure, which includes all residues that 
constitute the 4 helix bundle, and the predominantly unconserved regions, which 
consist of the N-terminal region and helix 1.  
A number of crystal structures are available containing inhibitors of TAO, including 
colletochlorin B (PDB : 3W54) , an ascofuranone derivative (3-chloro-4,6-
dihydroxy-5-[(2E,6E,8S)-8-hydroxy- 3,7-dimethylnona-2,6-dien-1-yl]-2-
methylbenzaldehyde – PDB:3VVA) and ferulenol (unpublished data – kindly 
provided by Professor Kita, University of Tokyo). Examination of these crystal 
structures and comparisons to the uninhibited structure (PDB:3VV9) reveals features 
that are likely indicative of the effects of substrate recognition.  
This chapter contains an extensive overview of the structure of the trypanosomal 
alternative oxidase, and examines the nature of the highly conserved regions of 
amino acids that can be found throughout the alternative oxidases.  
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3.2 AOX sequence alignment 
 
Figure 3-1:- sequence alignment of a cross section of known AOX species, including plant, trypanosomal and fungal . Sequences used in descending order: SgAOX (P22185), 
Trypanosoma brucei brucei (Q26710), Nicotiana tabacum (Q41224),Arabidopsis Thalina-AOX1a (Q39219),Botryontinia fucketliana-noble rot fungus (Q8NJ59),Glycine max 
soybean AOX1a (Q07185) Ventura inaequalis-apple scab fungus (Q9P429). Alignment performed using ClustalOWS algorithm, with colouring indicating regions of high 
conservation.  
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3.3 Roles of highly conserved residues based on crystal structure 
analysis 
AA sequence SgAOX 
numbering 
TAO 
numbering 
Region role 
W 118 65 N-terminal  
H 140 77 N-terminal  
D 148 85 Helix 1  
R 159 96 Helix 1 Substrate 
binding 
D 163 100 Helix 1 Substrate 
bind 
R 173 118 Helix 2 Substrate 
binding 
LETVA 177-181 122-126 Helix 2 Varied 
VPGMV 183-187 128-132 Helix 2 Varied 
H 193 138 Helix 2  
SLR 196-198 141-143 Helix 2 Varied 
GWI 205-207 150-152 Helix 3 Varied 
L 210 155 Helix 3  
EA 213-214 158-159 Helix 3  
E 215 160 Helix 3  
NERMHL 216-221 161-166 Helix 3  
F 224 169 Helix 3  
P 230 175 Between 3 + 
4 
Interhelix 
bend 
R 235 180 Helix 4  
Q 242 187 Helix 4  
Y 253 198 Helix 4 Interhelical 
binding  
L 254 199 Between 4 
and 5 
 
SPR 256-258 201-203 Between 4 
and 5 
Interhelix 
bend 
HR 261-262 206-207 Helix 5  
GYLEEEA 265-271 210-216 Helix 5 Varied 
YT 275-276 220-221 Helix 5 Redox 
active tyr 
D 283 228 Helix 5  
G 285 230 Helix 5  
P 293 240 Between 5 
and 6 
 
A 296 243 Between 5 
and 6 
 
YW 299-300 246-247 Short helix Structural 
D 310 257 Helix 6 Structural 
RADEA 316-320 263-267 Helix 6 Varied 
HR 322-323 269-270 Helix 6 Iron ligating 
Histidine 
VNH 325-327 272-274 Helix 6 Interhelical  
P 343 290 C terminal   
Table 3-1:- Highly conserved amino acids throughout the sequence alignment, and their predicted 
roles within the structure based upon crystal structure analysis.   
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Table 3-1 contains a list of the highly conserved amino acids throughout the AOX 
family. One of the most prominent features from examination of the conserved 
residues within the structure is the lack of conservation within the membrane binding 
helices. Of the 71 conserved amino acids, only 6 of them are found in helix 1 and 4. 
(N.B. for discussion purposes, the TAO numbering will be used, with the SgAOX 
numbering included in the table as reference for Chapter 4. Within the discussion, 
residues and helices labelled with * signifies components from the neighbouring 
monomer)  
The large groupings of conserved acids are consistent with those responsible for iron 
ligation, namely LETVA, NERMHL, GYLEEEA, RADEA and the HR regions. 
Given the importance of the iron ligation system, it is unsurprising that these regions 
are responsible for ~40% of the conserved species.  
The SLR region is found at the end of helix 2 and is a multifunctional region. S141 
forms a hydrogen bond with R163 (of NERMHL) to maintain the dimer formation 
between helices α2 and α3*. This bond is reciprocal at the other end of the protein, 
with identical bond formation between helices α2* and α3, effectively locking the 
helices together. The role of the R143 is less defined, given its location on the 
underside of the helix. There is potential for hydrogen bond formation to Q187 helix 
on α4*, but given the variability on the poses between monomers it is more likely 
that both amino acids are part of the membrane anchoring system for the protein. 
L142 is also of dual purpose, effectively capping the dimer interface with a 
hydrophobic residue, and locking the helix into place with the leucine at 166 from 
the NERMHL region.  
 
The membrane face of helix 2 is coated with hydrophobic residues (valines 180, 183 
and 187) that provide additional interaction with the mitochondrial membrane. While 
the conserved residues on helix 1 and 4 are mainly polar in nature and will bind 
directly to anchor points within the membrane, the valines are able to provide 
repulsion from the water layer upon the membrane, preventing the protein from 
dropping further into the membrane.  
 
The conserved tyrosine towards the tail end of helix 4 is part of a hydrogen bond 
network spanning 4 helices. It appears that one of the main functions is for structural 
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stability, both maintaining the helical turn caused by P202 and stabilising the 
distances via hydrogen networks to H206, which is further stabilised by N273 (helix 
6) and E158 (Helix 3). While a majority of amino acids have a highly conserved 
rotamic position, the terminal glutamate of this hydrogen binding network appears to 
be fixed in two positions perpendicular from one-another dependent upon monomer, 
and the location of the proximal crystallised water. It is tempting to speculate that 
this is a potential water channel away from the active site and into the water layer 
upon the membrane, given the flexible nature of the glutamate would allow for 
rotational movement to carry the water away from the di-iron centre. 
 
H274 is the main focal point of interhelical interaction, forming hydrogen bonds the 
both R207 and E214, effectively locking the helices together. While Y211 is found 
within this region, it appears its role is to hold the histidine in place, effectively 
preventing movement towards helix 1.At the other end of the helix, a highly 
conserved H-bond is formed between T221 and R263. The high conservation of 
these residues tends to suggest that their role is stabilisation of the position of Y220 
in the region of the active site. Given the position of this tyrosine, it is likely to be 
the redox active tyrosine, and will be discussed in detail in Chapter 6. The terminus 
of the interface is capped with the semi-conserved D228 R256 interaction, which is 
also interacting with E71 upon the short helix. While TAO is the only part of the 
AOX family to contain a carboxylate at this position, alcohol containing amino acids 
are used by other species that are likely to undertake the same role.  
The YW pair on short helix 1 is being used to stabilise the histidines around the 
active site. Hydrogen bonding between Y246 and N161 orientate the helix to allow 
for an H-bond network to be drawn directly between W247 to the iron ligating H165 
via D265. D265 is held in position by W65, a semi-conserved residue. This region is 
identical to that seen in RNR, where it has been identified as part of a proton coupled 
electron transport (PCET) network. Comparisons between the structures and their 
mechanistic implications are discussed in Chapter 6.  
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3.4 Membrane binding, dimer interface and N-terminal arm 
 
Figure 3-2:- Surface representation of a monomer from the TAO crystal structure, depicting the 
hydrophobic residues in orange. Membrane interface depicts the underside of the protein, and the di-
iron core (magenta spheres) can be seen via the cavity. Residues coloured red are proposed to be 
responsible for membrane binding. N-terminal arm removed from dimer interface diagram for clarity.  
 
The surface of the protein is largely hydrophilic, with the regions of hydrophobicity 
depicted as orange in Figure 3-2. As can be seen from the diagram, the underside of 
the protein is largely hydrophobic in nature, indicating that these residues are likely 
to reside under the polar headgroups of the phospholipid bi-layer.  
The residues highlighted in red are proposed membrane binding residues, with an 
arginine on each corner of the protein anchoring the structure to the membrane.  Of 
the residues highlighted for interacting with the phospholipid headgroups, R143, 
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R180 and R203 are all fully conserved. Q187 is also within the region of R180, but 
has a more ambiguous role. While it could potentially be used for membrane 
binding, it also appears to be forming a hydrogen bond to R143*, forming the corner 
for the dimer-interface.  
The N-terminal arm precedes helix 1, and can be seen interlocking the two dimers 
together. This region is the least conserved among AOX’s, with the sequence 
alignment demonstrating very few conserved residues, and coupled with the largely 
unstructured nature make links to amino acid function tenuous at best.  
The crystal structure shows this section contains 3 short helices, with 1 helix 
interacting with each monomer and 1 residing in the interhelical domain. The first 
short helix is held in place by a hydrogen bond network formed between D228, R256 
and E71. D228 can be seen hydrogen bonding to both the terminal NH2 unit and the 
amine link of R256, which in turn binds to E71 on the short helix. Of these 3 
residues only D228 is fully conserved, with R256 being relatively well conserved 
within the plant and trypanosomal species. Substitutions of E71 within other species 
conserve effective functionality, replacing the glutamate with serine and threonine in 
the plant and fungal species respectively. The retention of functionality within the 
side-chain and substitutions of shorter chain length is likely indicative of a 
requirement for tighter binding between the 4-helix bundle and N-terminal region in 
these species. 
The second short helix can be seen in the dimer interface, and appears to be holding 
the position of the R163/S141 pair via a hydrogen bond to E57. Again while not 
fully conserved, the glutamate at this position is conserved in all plant and 
trypanosomal species. The more interesting feature within this area is the position of 
W65. As with the previously mentioned W247 it is within H-bond distance to D265, 
potentially allowing it to be part of the PCET network. Comparison to the homology 
model places W126 (SgAOX numbering) in the same region, which is fully 
conserved through the plant species. It is plausible that this would allow a total of 2 
electrons to pass through this region into the core, but the second tryptophan is 
speculative given that its placement within the plant species could be incidental 
given the large number of tryptophans within this region (3 tryptophan residues can 
be found between aa118-126). The third helix is held in place by hydrogen bond 
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formation between S42 and D278*, and appears to be the only interaction between 
this region of the N-terminal arm and the second monomer.  
 
3.5 Hydrophobic cavity 
 
 
Figure 3-3:- Largest cavity generated using the CAVER software in the crystal structure of TAO 
(PDB code 3VV9), showing a cavity leading directly to the di-iron centre from between helices 
1(yellow) and 4 (orange). Spheres in the centre represent the di-iron core. 
 
CAVER [172] analysis revealed a number of tunnels leading through towards the di-
iron centre, highlighting a number of pathways large enough for molecular travel. 
One of the main determinants of whether the tunnel is traversable for substrate is the 
size of the bottleneck within the tunnel, and the nature of residues lining the cavity. 
One of the more sizeable cavities is depicted in Figure 3-3. The cavity is located in 
underside of the protein between helices 1 and 4, with the surrounding residues being 
hydrophobic in nature. The cavity links the di-iron centre directly to the quinone 
α 1 
α 2 
α 3 
α 4 
α 5 
α 6 
cavity 
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pool in the IMS, giving direct access to the quinol and reducing distance between 
substrates.   
Given the lipophilic nature of the quinol tail section, a hydrophobic cavity would be 
necessary for substrate recognition (and indeed molecular orientation within the 
active site), as has been demonstrated with the cytochrome bd and bo quinol 
oxidases[173].  
 
 
Figure 3-4:- Cross section of cavity showing the 6.3 Å bottleneck formed by the conserved residues 
L212 and L122 (TAO numbering). Magenta sphere in the background indicates that bridging Oxygen 
within the active site. 
 
The bottleneck found between the highly conserved L122 and L212 is 6.3 Å in size 
(Figure 3-4), large enough to accommodate the passage of quinol (6.0 Å OH-OH 
diameter). While the tunnel lacks full conservation, the hydrophobic nature is still 
intact, with F99 being substituted by leucines and isoleucines, and F121 being 
replaced by methionine in the majority of cases. There is only one point of polar 
contact within the cavity walls at R96, which is conserved in all plant and 
trypanosomal species.  
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A crystal structure was also obtained containing Colletochlorin B within the 
hydrophobic cavity (PDB:3W54). While inhibitor binding within the site does not 
directly confirm the nature of the binding orientation as that of the substrate, the 
structural similarities between Colletochlorin B and quinol would suggest this is the 
most likely conformation. Docking studies performed demonstrated quinol is able to 
bind with the head group occupying the same space as that of the inhibitor within the 
crystal structure, with varying degrees of tail positions available with little degree of 
variation in the final fit score.  
 
 
 
Figure 3-5:- Docking of quinol into the active site (PDB:3W54) with the highest score obtained (z=-
8.6). Picture A shows position of quinol tail, conforming to the same spatial region as that of the 
hydrophobic pocket from CAVER analysis. B depicts the head group of the quinol, with 1-OH 
interacting with T219 and R118, and 4-OH interacting with the di-iron centre.  
 
Figure 3-5 depicts quinol within the hydrophobic pocket. The key interactions with 
the protein occur at 1-OH, with hydrogen bond formation to T219 and R118 
(heteroatom distances of 3.2 Å and 3.7 Å respectively). 4-OH is seen to be 
interacting with the di-iron hydroxyl bridge, with an O-O distance of 2.7 Å. The 
second anchor point is interesting from a reactivity standpoint, as without the di-iron 
A B 
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hydroxyl group the quinol would be unlikely to dwell within the active site. This 
would suggest that the di-iron centre has to be in the correct part of its oxidation 
cycle for reaction with quinol, and that quinol does not dock with the protein and 
wait for the oxidation cycle.  
Crystal data obtained with an ascofuranone derivative within the active site 
(unpublished data professor Kita, University of Tokyo) indicated that there was a 
separate cavity orthogonal to the hydrophobic cavity, lying between helices 1 and 5. 
While from the internal area of the protein the cavity is still there, it lacks access to 
the protein exterior. While it is possible that a conformational change would 
accommodate the opening of the passage, membrane modelling (Dr. C. Elliott, 
unpublished results) would place the opening along the membrane surface, providing 
a non-ideal approach for quinol. This second tunnel could potentially act as an exit 
system for either quinol or water, providing an alternative route out of the active site.  
 
3.5.1 Water transport 
 
The smaller tunnels have the potential to be part of a water transport network, given 
that the product of enzymatic reaction is two molecules of water facilitation of their 
removal would allow for continued turnover. While the water may be a necessity for 
reaction with the quinol, facilitation of removal from the active site will be a 
necessity once the reaction has been completed.  
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Figure 3-6:- water distribution throughout the crystal structure, shown with the 4 monomers of  AOX 
inhibited with colletochlorin B overlaid (PDB: 3W54). Yellow spheres denote water within the 
structure, red spheres are water on the surface, and iron is shown as orange spheres in the centre. 
Helix 6 removed for clarity. 
 
Examination of the crystal structure allows for confirmation of water channels, and 
when combined with the CAVER data of potential tunnels within the crystal allows 
verification of their purpose. While the water distribution throughout each monomer 
is erratic, overlaying the monomers shows highly concentrated pockets of water. A 
majority of the water molecules within the crystal are ligated to the surface of the 
protein, but a cluster of internal water molecules can be seen running alongside the 
interior of helix 2 (depicted as yellow spheres in Figure 3-6). A potential outlet from 
the protein has been highlighted as purple spheres, but given the small size cavity it 
is impossible to define these as water from the active site and could be a factor of 
crystallisation around the protein.  
Of the 9 residues within ligation distance of the crystallised water, 8 are fully 
conserved, including a number that were not included in the section 3.3., namely 
I152, L155 E158,Y198 and H206.  There are two possible functions for this tunnel; 
it could either be used to shuttle water away from the active site to allow for faster 
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catalytic turnover, or potentially as a proton delivery network towards the core. The 
former is the most likely scenario, given that each monomer only contains 2 or 3 
water molecules each that would not constitute a full proton transfer network. The 
pKa values determined from the PropKa experiment [174] demonstrate a directional 
raise in pKa from the di-iron centre to Y198, from 2 to 12, which would direct 
protons towards the tyrosine. There is a potential second entrance to this channel 
from the W46 region that would facilitate proton transfer along the pKa gradient, but 
given the short distance between channel and solvent it could be an artefact of 
crystallisation and therefore cannot be given a definitive role.  
 
3.6 Ligation around the di-iron sphere – uninhibited structure 
 
As predicted by structural models [136], the ligation sphere around the di-iron core 
under oxidised conditions consists of two bridging glutamates (E162 and E266), two 
glutamates binding in bi-dentate fashion, with one ligating to each iron (E123 and 
E213), and two histidines (H165 and H269). The glutamates are arranged in such a 
way that each helix contains an iron binding ligand, cementing the remainder of the 
structure around a fully functional active site.  
 
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe2/Fe2) 
E266 
(Fe1/Fe2) 
H165 H269 
A 2.2 / 2.0 2.3/2.1 2.2/2.0 1.8/2.2 3.3 3.8 
B 1.9/2.1 1.9/1.8 2.2/1.8 2.2/2.5 3.4 3.8 
C 2.2/2.0 2.5/2.3 2.3/2.5 2.0/2.1 3.3 4.4 
D 2.4/1.9 2.5/1.9 2.3/2.0 1.8/2.1 4.0 4.3 
Table 3-2:- distance measurements for the primary iron ligation sphere. All measurements taken in 
Angstroms. Measurements taken between heteroatoms and the iron. Two numbers indicate bidentate 
binding, with iron definition defined in the column heading. Measurements made using PyMOL.  
 
As can be seen in Table 3-2, binding distances between glutamates and irons have 
modest variability, with the exception of E213 and E266 bonds to Fe2 in monomer 
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B. The more interesting feature of the iron ligation sphere is the lack of ligation to 
the histidines.   
 
Figure 3-7:- di-iron core of TAO (PDB:3VV9) from different monomers . Cyan figure on the left is 
monomer A, with the yellow on the right is monomer B. Large orange sphere corresponds to iron, 
with the small red sphere corresponding to oxygen. 
Monomer Fe(1) – Fe(2) Fe(1) – O Fe(2)-O  
A 3.0 2.5 2.1  
B 3.0 3.1 2.2  
C 3.5 3.7 2.0  
D 3.4 3.2 2.1  
Table 3-3:- Interatom distance measurements from TAO crystal structure (PDB:3VV9). All 
measurements taken in Angstoms, with Fe(1) being defined as that ligated by E213 , and Fe(2) by 
E123. Measurements made using PyMOL. 
 
Figure 3.7 demonstrates the typical arrangement of the primary ligation sphere 
around the di-iron core. Of note is the perturbation in the iron location between 
monomeric units. While the position of Fe1 seems extremely well defined in space, 
Fe2 migrates ~0.5 Å further from Fe1 in monomers C and D, a 17% increase in 
inter-iron distance. The effects of this can be seen in the arrangement of the ligating 
hydroxyl group, conferring a mono-dentate ligation to Fe2 instead of the bridging 
species that can be seen on monomer A, with Fe1-OH distance of 3.7 Å large for 
interaction.  
 
Fe2 
Fe2 
Fe1 
Fe1 
E123 
E162 
E213 
E266 
H269 H165 
E123 
E162 
E213 
E266 
H269 H165 
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3.7 Comparison between inhibited and uninhibited structures 
 
Comparisons between the inhibited and uninhibited crystal structures allows for 
examination of the effects of molecular binding upon the active site. Colletochlorin 
B has similar structural motifs to that of quinol, and therefore will give a reasonable 
indication of the interaction between the binding site and substrate. While a majority 
of the structures have been published, the structure containing ferulenol, a recently 
discovered competitive inhibitor of AOX, was kindly provided by Professor Kita for 
analysis.  
3.7.1 Binding positions for inhibitors 
 
 
Figure 3-8:- Binding of Colletochlorin B (PDB:3w54). Amino acids shown are those within 6 Å of 
the inhibitor, with labelled amino acids indicating potential interaction with the inhibitor. Figure A 
depicts the head group interactions with the protein, with 2-OH within hydrogen bond distance to 
T219, R118 and R96. Figure B depicts the location of the isoprenoid tail.  
 
Colletochlorin B has few points of contact with the protein itself, which is surprising 
given the highly substituted nature of the head group. The main interaction appears 
to be the 2-OH, within hydrogen bond distance to both T219 (2.5 Å) and R118 (2.6 
A B 
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Å). A potential hydrogen bond can also be seen between the aldehyde and C119. 
Further refinement of the crystal structure has suggested that the inhibitor is able to 
rotate along the axis, with 2-OH and 4-OH effectively exchanging positions. 
Orientation in this manner would be more in line with SAR studies performed that 
suggested the 4-OH position was more significant for inhibition of TAO then 2-OH 
[115] . This would also place the aldehyde within H-bonding distance to Fe-OH, 
effectively adding a second anchor point (and therefore more stable binding) for the 
inhibitor.   
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe2/Fe2) 
E266 
(Fe1/Fe2) 
H165 H269 
A 2.1/2.1 1.9/2.0 2.1/2.3 2.3/1.9 2.4 4.1 
B 2.2/2.3 2.1/2.0 2.4/2.1 2.2/2.3 2.6 3.9 
C 2.2/2.2 2.1/2.9 2.3/2.2 2.0/1.8 2.3 4.5 
D 2.3/2.2 2.0/2.0 2.1/2.2 2.2/2.1 2.4 4.1 
Monomer Fe(1) – Fe(2) Fe(1) – O Fe(2)-O  
A 3.5 1.9 2.2  
B 3.3 2.2 1.7  
C 3.5 2.3 2.1  
D 3.2 2.3 1.9  
Table 3-4:- ligation around colletochlorin B inhibited di-iron core (PDB:3W54). All measurements 
taken in Angstroms. Measurements taken between heteroatoms and the iron. Two numbers indicate 
bidentate binding, with iron definition defined in the column heading. Measurements made using 
PyMOL. 
 
One of the more prominent effects of inhibition is the rotation of a portion of helix 1. 
Once bound to the inhibitor, R118 also forms a new hydrogen bond with D100, 
causing rotation in the position of R106. Given the assignment of R106 as a potential 
membrane binding residue, this implies that binding of the substrate within the active 
site causes a conformational change that would lower the effective binding to the 
membrane. It is also possible that this rotation is a feature of crystal preparation, and 
that either position is the correct orientation. R106 is also important within the 
second hydrophobic cavity proposed by Shiba et.al. (2013)[11], as the rotation in the 
inhibited structure blocks entrance to the second cavity.  C199 also demonstrates 
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independent rotation towards the inhibitor, causing modest change in the helix itself. 
It is worth noting that the cysteine is not a conserved residue, and that interaction 
does not necessarily implicate it as the main binding point within other AOX 
species, but the position of a potential radical carrier in close proximity to the 
proposed redox active tyrosine is unlikely to be coincidental. 
 
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe2/Fe2) 
E266 
(Fe1/Fe2) 
H165 H269 
A 2.1/2.5 2.1/2.0 2.5/2.4 2.2/2.1 2.2 4.4 
B 2.4/2.1 2.3/2.0 2.2/2.3 1/9/1.9 2.5 4.2 
C 2.3/2.4 2.0/2.0 2.3/2.1 2.2/2.2 2.3 4.0 
D 2.3/2.2 2.4/2.4 2.6/2.2 2.1/1.9 2.3 4.5 
Monomer Fe(1) – Fe(2) Fe(1) – O Fe(2)-O  
A 3.8 1.8 2.4  
B 3.1 2.3 2.1  
C 3.5 2.4 1.8  
D 3.7 2.4 2.1  
Table 3-5:- Ligation around the 3-chloro-4,6-dihydroxy-5-[(2E,6E,8S)-8-hydroxy- 3,7-dimethylnona-
2,6-dien-1-yl]-2-methylbenzaldehyde inhibited core (pdb:3VVA). Measurements made using PyMOL 
 
The data in Table 3-4 and Table 3-5 gives the iron ligation distances in the 3W54 
and 3VVA structures respectively. Given that the difference between these two 
inhibitors is at the extremity, it is unsurprising both active sites have similar 
architectures. When compared to Table 3-2 the largest difference that can be seen is 
the lower H165 bond distance, indicating that the presence of an inhibitor within the 
cavity has caused a migration of the iron.  
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Inhibitor binding – orthogonal cavity 
 
Figure 3-9:- Binding of 3-chloro-4,6-dihydroxy-5-[(2E,6E,8S)-8-hydroxy- 3,7-dimethylnona-2,6-
dien-1-yl]-2-methylbenzaldehyde via the orthogonal cavity. Potential Hydrogen  bond acceptors for 
the benzaldehyde ring R96 and Y220 marked and depicted in figure A. Figure B depicts the 
interaction of the terminal OH and S103. Amino acids shown all within a 6 Å radius of inhibitor.  
 
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe2/Fe2) 
E266 
(Fe1/Fe2) 
H165 H269 
A 1.9/2.4 2.1/2.1 2.5/2.5 2.0/1.9 2.1 4.2 
B 2.2/2.5 2.0/1.8 2.0/2.5 2.3/2.0 2.6 4.1 
Monomer Fe(1) – Fe(2) Fe(1) – O Fe(2)-O  
A 3.2 1.8 1.8  
B 3.1 1.8 1.8  
Table 3-6: Ligation around the inhibited core where the inhibitor approaches from the orthogonal 
cavity. 
 
A second crystal structure of the ascofuranone analogue from 3VVA was also made 
available for analysis. This structure shows the inhibitor within the second cavity 
between helices 1 and 5, and demonstrates different binding properties to those of 
the published crystal. Within this crystal, the inhibitor is forming hydrogen bonds 
between 4-OH and R96, and 2-OH and C119. The increase in angle caused by the 
A B 
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second binding point has raised the profile of the aldehyde to be placed inbetween 
Tyr-220 and Fe2 (distances Tyr-OH – O 3.7 Å, Fe(1)-O 3.2 Å).  
The crystal structure shows more extreme rotation along helix 1, with displacement 
of residues constituting a full helical turn. The same cannot be seen on helix 5, with 
reasonable alignment shown between residues, giving credence to rotation of helix 1 
being due to inhibitor binding. A necessitation for helical rolling as part of the 
substrate binding mechanism could potentially explain the lack of membrane binding 
residues in this region of the structure, given that each other corner of the protein 
underside is firmly fixed to the membrane.  
Ferulenol 
 
Figure 3-10:- Binding of ferulenol within TAO. Key binding residues are labelled, with the di-iron 
core shown as spheres. A and B give views of the pharmacophore and tail respectively. 
 
Ferulenol is unique among the inhibitors, in that it demonstrates purely competitive 
inhibition with respect to ubiquinol ( Dr. D. Inakoa, University of Tokyo, 
unpublished observations). As such it allows for direct conformation that the space 
in which it is residing would be that occupied by the quinol. The crystal structure 
shows binding similar to that seem in the quinol docking experiments in section 3.5, 
with the carbonyl within hydrogen bond distance of T219, R96 and R118 (3.6 Å, 3.3 
A 
B 
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Å and 2.7 Å respectively) and additional potential interaction between the ring 
oxygen and the R118 amine. 
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe1/Fe1) 
E266 
(Fe1/Fe2) 
H165 H269 
A 2.4/2.7 2.0/2.1 2.3/2.3 2.1/2.0 2.1 3.9 
B 2.2/2.3 2.0/2.4 2.1/2.4 2.3/1.9 3.1 4.2 
C 2.3/2.2 1.7/2.7 2.1/2.1 2.2/2.2 2.9 4.5 
D 2.7/2.0 1.8/2.6 2.2/2.4 1.9/2.0 3.4 3.6 
Monomer Fe(1) – Fe(2) Fe(1) – O Fe(2)-O Fe(1) – H2O 
A 4.2 2.2 2.6 2.9 
B 3.3 2.0 2.1 2.9 
C 3.3 2.0 2.3  
D 3.3 2.1 2.1  
Table 3-7:- Ligation around the inhibited core with ferulenol in the active site. 
 
Within all inhibited structures, the iron atom positions have improved definition over 
their uninhibited counterparts, which could  demonstrate a degree of interaction with 
the inhibitor, or is alternatively a feature of improved crystal resolution allowing for 
better spatial alignment of the metal centre. The position of the ligating OH is also 
more conserved, adopting a consistent bridging position between the irons in all 
cases examined. The mode of inhibition appears to be unimportant with respect to 
changes within the core; both competitive and non-competitive inhibitors display the 
same adaption to molecular interaction within the cavity.  
 
3.8 Summary 
 
While this chapter has covered a fairly exhaustive list of conserved amino acids 
within the AOX family, it does not necessarily encompass all residues that may be 
responsible for functionality. This can be seen clearly in the case of C199, whereby 
rotation would indicate a degree of interaction with the inhibitor. 
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The interaction of the N-terminal arm is a region that could likely be better defined 
once crystal structures are available of other AOX’s. While it does have a number of 
binding points to both monomeric units, its function appears to be solely for 
placement of the second tryptophan into the PCET network. It is likely to also have 
secondary functionality as an effective covering on the core helix bundles, with both 
N-terminal regions running parallel across the dimer. It is interesting to question 
what effect this would have on the activity of the monomer, as while the position of 
the typtophan is fixed by first two shorter helices to the monomer, the rest of the N-
terminal region could potentially add kinetic strain onto this coupling if it is not 
stabilised by the second TAO unit. The hydrophobic nature of the dimer interface 
would suggest that the protein would be highly unstable in its monomeric form. It 
has been demonstrated within the lab that the N-terminal region is vital for activity, 
as truncation of this region confirming that it does indeed play an important role 
within the protein (Dr. M. Albury, unpublished observations). 
Comparisons of the inhibited and the uninhibited structures have revealed a number 
of facets that are indicative changes upon substrate binding. The alterations to the di-
iron core structure could indicate changes that would occur upon the approach of 
quinol, or it could also be an indication of an intermediate if a proton or electron has 
been transferred from the inhibitor to the protein.  The movement of helix 1 could 
also indicate a co-operative binding mode for the quinols, with a second cavity 
opening once the first is in place. As was previously discussed, this second cavity is 
debateable, with it only being accessible in a select few monomeric units, and the 
placement of the opening outside of the intermembrane space would make access to 
the quinone pool difficult.  
 
 
 
 
 
 
67 | P a g e  
 
4 Expression of recombinant AOX and mutants in haem-
deficient E.coli  
 
4.1 Introduction 
 
Site directed mutants have been a key facet in understanding the structure function 
relationship of highly conserved amino acids within proteins. A number of mutants 
of both SgAOX [138, 157, 175] and TAO [140, 141] have been expressed in both S. 
pombe and E. coli, confirming that structural features such as the iron binding motifs 
and tyrosines that are important for enzymatic activity.  
The electron transport chain of E. coli differs from those previously discussed in 
Chapter 1. While the overall function still produces a proton gradient for driving 
ATP synthesis, E. coli lacks complexes III and IV, instead using the terminal 
cytochrome oxidases bd and bo. Like AOX, both cytochromes catalyse the reduction 
of oxygen via the oxidation of two equivalents of quinol, with cytochrome bo being 
expressed at times of high oxygen concentration [176] and cytochrome bd under 
anoxic conditions and lag phase growth [177]. 
FN102 has previously been used to express TAO from T.vivax [178] and T.b.brucei 
[160]. The strain lacks glutamyl-tRNA reductase [160], removing its ability to 
synthesise haem for use in the cyctochrome bd and bo complexes, therefore lacking 
terminal oxidases. Growth of the E. coli consequently relies on the successful 
integration of AOX into the membrane for the survival of the cell. The use of the 
FN102 strain allows for a greater degree of overexpression relative to more 
conventional strains for expression of membrane bound protein (such as strain C41) 
due to the dependency on the E. coli on AOX for continued respiration. 
The use of an E. coli based system proves advantageous over expression within 
S.pombe as it allows for more facile membrane isolation and protein purification. 
Isolation of the membrane removes cytosolic proteins, reducing the number of 
contaminants for potential unwanted substrate interaction while simultaneously 
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increasing the accuracy of protein estimations, and therefore calculated specific 
activities.  
 
4.1.1 Mutants 
 
Figure 4-1:- Positions of the mutants studied within the TAO structure. SgAOX numbering used for 
reference, with the di-iron core shown in the centre as spheres.  
 
The conserved amino acids that were mutated and are subsequently discussed within 
this chapter are depicted in Figure 4-1. L177A and T179A flank the iron ligating 
glutamate, and while the side chains both perform different roles, alteration of this 
highly conserved region is likely to cause perturbation within the di-iron core. 
T179A has been proposed to be part of the dimer interface, forming hydrogen bond 
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to the carbonyl within the backbone of L142. While not fully conserved, its only 
substitution is by serine in the fungal species. Given the retention of the alcohol 
moiety, the addition of the methyl group of threonine is unlikely to affect 
interactions with the dimer interface. It is more likely that the addition of steric bulk 
adds a directional component to the alcohol, preventing rotation toward the helix.  
L177 is part of the bottleneck within the hydrophobic cavity alongside L267, and 
mutation to alanine removes the bulky isobutyl side chains, potentially widening the 
channel while retaining hydrophobic character. 
Y299 and N216 are part of the highly conserved hydrogen bonding network that was 
proposed in chapter 3 to maintain the position of W300. Conversion of the tyrosine 
to phenylalanine removes the phenolic hydroxyl group, while retaining the phenol 
ring, allowing for assessment as to whether the hydroxyl or phenol section of the 
amino acid are important for enzymatic function. N216 is the other end of the pair, 
forming a hydrogen bond with Y299 in order to hold W300 in place. As with L177, 
N216 is adjacent to an iron binding glutamate, therefore could also influence the di-
iron core.    
D163 and R159 are part of the proton bonding network between helicies 1, 2 and 5 
that were highlighted in chapter 3 for their role in the proposed quinol binding site. 
R159 forms hydrogen bonds with E220 and S274 (2.5 Å and 3.1 Å respectively), 
whereas D163 bonds to R173 with a distance of 2.4 Å.  
 
4.2 Growth and harvest of the E. coli membrane  
 
Transformation and growth of the E. coli was performed as described in Chapter 2. 
Growth curve analysis using OD600 measurements prior to induction with IPTG 
indicated that there was no dependence on AOX mutation, with an average doubling 
time of 0.9 hours found across all mutations indicating that the cells were able to 
grow sufficiently prior to being rescued via AOX expression. 
Association of mutant and wild type AOX to the membrane was confirmed via 
western blot analysis (Figure 4-2). There appears to be no visible preference between 
monomer (32kDa band) or dimer formation (~64kDa) for wild types or mutants. It is 
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worth noting that while dimers are visible, it does not necessarily mean they are in 
the deactivated dimer form (i.e. dimerisation via the cysteines), with dimerisation 
possible via ionic interaction along the dimer interface discussed in chapter 3.   
 
Figure 4-2: SDS-page (left) and western blot (right) analysis of mutants of AOX and TAO. All lanes 
loaded with 15ug of protein from membrane fractions, with gels run as described in Chapter 2, with 
western analysis performed using an antibody raised against AOX. Tracks from left to right show :- 1-
SgAOX wild type, 2-R159A, 3-D163A, 4-L177A, 5-T179A, 6-N216A, 7- L267A 8-Y299F,9-blank, 
10-TAO, 11-T124a (TAO mutant)  
 
Figure 4-2 are representative SDS-page and western gels of each mutant generated. 
Each membrane bound sample contains a band in the western at ~32kDa, 
corresponding to AOX monomer. Each lane was loaded with 15ug of protein; 
therefore the difference in band luminescence correlates to the concentration of AOX 
within the membrane sample. The bands visible at ~64kDA correlates to AOX dimer 
formation, with oligomers visible at higher molecular weights in lanes 1,3,4 and 5. 
While the darker bands visible for the TAO preparations would suggest that they 
have improved expression over the plant variant, they are not directly comparable 
due to differences in concentration of IPTG used for induction. It was found that 
while 25 µM IPTG was sufficient for growth of rSgAOX and mutants, rTAO was 
unable to sustain E. coli growth at concentrations less than 100 µM IPTG.  
Efficacy of the membrane preparation was confirmed via western blot analysis, with 
the French Press cell debris pellet containing low levels of AOX, and undetectable 
levels remaining within the ultracentrifugation supernatant (data not shown). The 
low levels remaining within the cell debris can be attributed to unbroken cells. While 
this could be remedied by increasing the number of passes through the French Press, 
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it would be detrimental to the overall membrane quality due to the increased time 
that the protein would be in contact with proteases within the cell lysate. 
 
4.3 Membrane bound respiratory measurements using NADH 
Mutation Specific activity 
nmols O2 min
-1
 
mg
-1
 
Relative activity 
% 
Number of 
isolations 
rSgAOX 230 ± 56 100  6 
T179A 66 ± 36 28  3 
D163A 72 ± 12 31 3 
R159A 56 ± 19 24  3 
Y299F 74 ± 40 32  3 
N216A 54 ± 4 23  3 
L177A 118 ± 32  51 2 
L267A 94 ± 3 41 2 
Table 4-1:- Mean specific activity values ± standard deviations of rSgAOX mutants in membrane 
form from replica assays. Assays were carried out using an oxygen electrode containing  400 µL 
50mM TRIS-HCl pH 7.4, 10mM pyruvate, 4 µM antimycin A with 1.25mM NADH as the substrate. 
Activities were compared and expressed as a percentage of wild type activity, with the number of 
samples run given. 
 
NADH dependant oxygen uptake for membrane bound wild type (rSgAOX) and 
mutants are presented in Table 4-1. All samples were preincubated with antimycin A 
in order to inhibit any potential cytochrome contaminants within the ETC, ensuring 
that data collected is a direct result of AOX activity. Measurements were collected 
using an oxygen electrode to determine oxygen uptake of the E. coli, with an excess 
of NADH added to maximise reduction rates of the quinone pool and addition of 
pyruvate to ensure the protein was in its active form. All mutants demonstrated 
significant decreases in activity when compared to that of the wild-type activity. 
The Y299F and T179A mutants allow for internal controls for comparison between 
this study and those performed on S. pombe mitochondria, with similar activity 
percentages for each, giving values of 44% and 40% reduction in specific activity 
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levels respectively [175]. While the data agrees statistically, this is likely indicative 
of the large standard deviation around the mean in this study. 
 
Figure 4-3- graphical representation of the variability in membrane bound specific activity. Bars 
represent specific activity of rSgAOX membrane samples, with horizontal lines representing mean 
average +/- standard deviation respectively. Graph A contains all preparations, whereas graph B 
shows the data with the outliers removed (preparations 6,7,9 and 10 from graph A). Averages and 
standard deviations are 263 ± 140 and 230 ± 56 respectively.  
 
The large variation found with oxygen uptake is demonstrated in Figure 4-3. While 
the averages of 263 and 230 nmols O2 min
-1
 mg
-1 
do not vary wildly between the 10 
sample and the 6 sample mean averages, the lower standard deviation in the latter 
gives a more accurate value. There are a number of factors that could contribute to 
sample variability, not limited to the overexpression of the protein being independent 
of the existing electron transport chain (i.e. the expression of alternative oxidase is 
dependent on available sources of iron and amino acids rather then stochiometrically 
linked to the NADH dehydrogenase). If AOX is expressed to a level where the 
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reduction level of the quinone pool cannot reach optimal conditions for AOX activity 
then activity measured will be not be representative of the true Vmax.  
It was found that an addition of duroquinol increased activity of the protein, 
indicating that the quinone pool is the cause of deviation. Disruption of the 
membrane via French Press during the harvesting procedure could lead to a loss in 
internal quinol, making quinol concentration the limiting factor. To mediate this 
initial rates were taken as opposed to steady state measurements, as measurements 
taken at a constant rate would be dependent upon both the quinone pool redox poise 
and the total concentration of quinols. It is also possible that the quinone pool within 
the E.coli membrane was problematic for AOX; the quinone pool for E. coli favours 
a mixture of menaquinones and demethylmenaquinones once cytochrome bd is 
expressed [179], and given the overnight growth it is likely that this had occurred. 
While this is the case with the wild type expression, it can be seen (with the 
exception of Y299F) that introduction of a mutation into the protein structure 
reduces variability within the respiration rates. This would suggest that alternative 
oxidase turnover for the mutants have become rate limiting, allowing for more 
accurate determination of specific activity under otherwise non-ideal conditions.   
4.4 TAO and SgAOX comparison 
 
Mutation Specific activity 
nmols O2 min
-1
 
mg
-1
 
Relative activity 
% 
Number of 
isolations 
rTAO 309 ± 45 100 4 
T124A 244 ± 75 79 3 
rSgAOX 230±56 100 6 
T179A 66 ± 36 28 3 
Table 4-2:- Specific acitivities for recombination TAO and T124A mutation. Activities of rSgAOX 
and T179A (equivalent mutation within the plant species) included for reference. Data collected under 
same conditions as those listed in Table 4-1  
The examination of the equivalent mutation in plant AOX and TAO reveals 
dissimilar results with respect to the percentage of remaining activity. T124A and 
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T179A flank the iron binding glutamate within their respective proteins, with the 
crystal structure of TAO revealing that the amino acid side chain is directed away 
from the active site, playing a dual role of helical maintenance within the active site 
and participating in the dimer interface. The differences between effects on activity 
are likely due to increased dependence of SgAOX on dimer formation, as 
trypanosomal AOX has been shown to be a monomer in its native form [180].  
4.4.1 Membrane bound respiratory measurements using quinol  
 
Mutation Specific activity 
µmol Q1H2 min
-1
 mg
-1
 
Relative activity 
% 
Number of 
isolations 
rSgAOX 1.5 ± 0.6 100  4 
T179A 0.51 ± 0.3 34 3 
D163A 0.29 ± 0.01  19 2  
R159A 0.81 ± 0.1  54 4 
Y299F 0.63 ± 0.1 42 3 
N216A 0.56 ± 0.04 37 3 
L177A 0.21± 0.00  14 2 
L267A 0.36 ± 0.1 24 2 
Table 4-3: Specific activity of membrane bound rSgAOX and mutants measured 
spectrophotometrically. Assays were performed in 1ml Tris-HCl pH 7.4, 10mM pyruvate,with 150µM 
Q1H2 as substrate, with the change in absorbance at 278nm measured to determine rate of quinol 
conversion. 
 
Respiratory activity of membrane bound AOX was also determined using quinol as a 
substrate. The conversion of quinol to quinone was measured spectrophotometrically 
at 278nm, with initial rate data collected. In a majority of cases, the data presented in 
Table 4-3 demonstrates a marked reduction in deviation when compared to the data 
collected from the oxygen electrode.  
When compared to the data in Table 4-1, two major factors are apparent; the 
percentage activity of the mutants does not correlate completely to measurements 
made on the oxygen electrode, and the quinol activity is larger than the oxygen 
uptake measurements. While stochiometrically the Q1H2 depletion rate should be 
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double the rate of oxygen uptake, rates for quinol oxidation are ~10-fold of oxygen 
uptake. With both of these factors taken into account, it would suggest that the use of 
quinol as a substrate gives a true Vmax for the protein in the membrane bound form, 
with the data collected using the oxygen electrode representing typical physiological 
conditions. 
 
4.5 Purification 
 
Purification of the plant alternative oxidase was afforded by a modified protocol of 
that used for the TAO purification procedure [163], as per the method described in 
Chapter 2. The pET-15b vector system encodes for an N-terminal His-tag, allowing 
for purification via cobalt affinity chromatography. Detergent screens revealed that 
1% n-dodecyl-β-d-maltopyranoside (DDM) gave improved solubilisation of plant 
AOX, and as such subsequent wash and elution buffers were adjusted to a 0.5% 
(w/v) octaethylene glycol monododecyl ether (C12E8) / 0.5% (w/v) DDM mix.  
 
 
Figure 4-4: SDS-page gels showing the use of stepwise purification of rSgAOX from membrane 
fractions. Tracks from left to right:- Mr - markers, 1 - membrane, 2 - solubilised membrane, 3 - 
insoluble fraction, 4 - flow through, 5 - wash, 6-20 – eluate fractions. The visible band in from 
fraction 8 onwards was confirmed as alternative oxidase via western blot anaylsis. 
 
Figure 4.3 demonstrates that we were able to obtain extremely pure samples using a 
graduated (100-250mM in 50mM increments) increase in imidazole concentration 
within the elution buffer. The visible bands in lanes 10-20 at ~32kDa correspond to 
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AOX, with confirmation of protein identity via western blot analysis. While pure, the 
samples were dilute and not suitable for assay purposes so a simpler technique was 
used whereby a second wash was used to ensure removal of non-specifically bound 
matter and a single elution of 250mM imidazole presented a useable protein 
concentration.  
 
Fraction Total activity  
µmol Q1H2 min
-1
 
Total protein  
mg 
Specific activity 
Q1H2 min
-1 
mg
-1
 
Membrane 7.3 9.2 0.8 
Pellet 3.7 3.1 1.5 
Soluble 7.8 5.2 1.2 
Flow through 3.5 3.1 1.13 
Wash 2.6 1.4 1.9 
Elution 0.65 0.36 1.8 
Table 4-4:- typical purification table for mutant rSgAOX purification (data presented from Y299F). 
Fractions refer to stages of protein purification. Activities measured spectroscopically using 150 µM 
Q1H2 in 1ml Tris-HCl pH 7.4 with 10mM pyruvate.  
 
Summation of the total activity flow through, wash and elution fractions from the 
data in Table 4-4 gives a value of 6.75 µmol Q1H2 min
-1
, showing that 86% of the 
total activity of the soluble protein is retained through the purification process. The 
same process with the total protein confers a value of 94% indicating that modest 
protein was retained by the column and that statistical variability in the protein 
estimation performed could account for the loss of protein.  
The flow through and wash fractions contain protein that was either unable to bind to 
the resin, or weakly bound protein that was eluted with 50mM imidazole. While 
western blot analysis of the flow through fraction was shown to contain AOX, 
further attempts to purify this fraction proved unsuccessful, suggesting that either the 
His-tag had been cleaved from the protein prior to binding to the column, or the tag 
itself was inaccessible. Given the wrap-around nature of the N-terminal region, the 
later seems more likely.  
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High levels of activity within the wash are indicative of improper His-tag binding to 
the column. Attempts were made to increase the binding to the column via increasing 
binding time, increasing the resin to solubilised protein ratio, and altering the 
temperature, but proved unsuccessful. While it did appear that decreasing the volume 
of wash buffer to 1 times the bed volume increased protein content within the 
elution, analysis of the fraction revealed that this reduced the purity of the protein 
and as such was not a viable method.   
 
Sample Specific 
activity 
membrane 
µmol Q1H2 
min
-1
 mg
-1
 
Specific 
activity 
elution 
fraction  
µmol Q1H2 
min
-1 
mg
-1
 
Purification 
factor 
Percentage 
of wild 
type 
Isolations 
rSgAOX 1.5 ± 0.6 16 ± 3.1  10.6 100 4 
T179A 0.51 ± 0.3 1.16 ± 0.2 2.3 7.3 3 
D163A 0.29 ± 0.01  0.29 ± 0.03  1 2.9 2 
R159A 0.81 ± 0.1  0.2 ± 0.1 0.25 1.3 3 
Y299F 0.63 ± 0.1 1.47 ± 0.3  2.3 9.2 3 
N216A 0.56 ±0.04 1.26 ± 0.3  2.3 7.9 3 
L177A 0.21±0.00  0.24 ± 0.01  1.1 1.5 2 
L267A 0.36 ± 0.1 0.23 ± 0.00 0.63  2.3 2 
Table 4-5:- Specific activities of the elution fractions from cobalt affinity purification of rSgAOX and 
associated mutants. Activities measured spectroscopically using 150 µM Q1H2 in 1ml Tris-HCl pH 
7.4 with 10mM pyruvate. Specific activity of the membrane fraction is from Table 4-3, and 
purification factor refers to the ratio of elution specific activity to membrane specific activity.  
 
The specific activities determined for the pure AOX fractions are shown in Table 
4-5. The purification factor gives an indication as to the relative increase in specific 
activity from the membrane bound form, and the values obtained indicate that all 
mutants demonstrate a significant loss in purification relative to the wild type. While 
it would be tempting to speculate that the mutations have affected the stability of the 
protein to an extent whereby removing them from the membrane and passing them 
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down a column leads to widespread destabilisation and potential unfolding of the 
protein, the retention of activity within the flow through, wash and elution fractions 
relative to the soluble would suggest that this is not the case. However, it is likely 
that R159A and L267A suffered from destabilisation, as upon solubilisation they 
were the only mutants tested that demonstrated a reduction in specific activity.  
One of the more apparent factors is that purification of the mutants induces a much 
larger reduction in specific activity when compared to the wild type. All mutants 
have specific activities less than 10% of wild type levels, significantly lower values 
then those determined in the membrane bound form.  
There appears to be an inverse correlation between the purification factor and 
specific activities of all samples, which could be indicative of a requirement for 
increased protein expression for survival of the cell due to low rate of turnover. A 
low purification factor would suggest that a larger proportion of protein within the 
membrane bound sample is AOX, although it is a combination of factors such as 
mutant stability and how robust it is to solubilisation and purification conditions.   
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4.6 Effectors of AOX 
 
 
Figure 4-5: Data to show the increase in specific activities of purified rSgAOX upon the addition of 
effectors. Blue bars indicate purification using buffers that did not contain pyruvate, and red contained 
pyruvate in the buffer. Effector concentrations were 10mM pyruvate, and 0.25% (v/v) EDT-20. 
Activity measurements performed using the same conditions described in Table 4-3. 
 
While pyruvate is well documented in increasing the catalytic activity of AOX [69, 
154, 158], a response that can be mimicked in micochondria isolated from A. 
italicum using EDT-20 [70], and purified TAO [163].  As such, both compounds 
were tested against the purified sample to allow for assessment of their impact on 
SgAOX. As can be seen in Figure 4-5, the further addition of pyruvate to sample 
containing pyruvate within the purification buffers did not further increase the 
respiratory activity, while addition of pyruvate to a sample lacking pyruvate 
increased activity by a factor of 3. The more interesting effects were seen upon 
addition of EDT-20, whereby the pyruvate-free sample demonstrated a marked 
increase in activity over its counterpart. Further addition of pyruvate to this sample 
did not increase activity, suggesting that stimulation of activity is competitive 
between the two effectors.   
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4.7 Oxygen Kinetics 
 
Figure 4-6:- Method for determination of oxygen Km values. Graph A shows the trace obtained from 
the oxygen electrode. Graph B is the derivative graph, displaying Michalis-Menten kinetic 
dependance upon the oxygen concentration. Graph C is the Eadie-Hoffstee for the data within the 
oxygen dependant region. Blue data indicates the data used for oxygen Km values, and red data 
indicates the region of data below the 10 nmol O2 cutoff set, whereby the sensitivity of the electrode 
became a contributing factor.   
 
Oxygen kinetics were measured via the method described by Crichton [175]. 2ml of 
TRIS was used to ensure enough dissolved oxygen was within the cell for the 
reaction to reach a steady state, which can be seen in graph B of Figure 4-6. The 
graph clearly demonstrates a kinetic dependency upon the substrate prior to 
200seconds, followed by a steady rate and reduction due to limiting oxygen 
concentrations within the system.  
 
 
A B 
C 
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Sample Oxygen KM / µM Isolations 
rSgAOX 13.1 ± 0.3 3 
L177A 8.9 ± 0.6 2 
T179A 6.1 ± 0.4 3 
L267A 16.5 ± 1.2 2 
Y299F 13.1 ± 0.1 3 
D163A 5.9 ± 0.4 2 
R159A 10.8 ± 0.2 3 
N216A 6.0 ± 0.4 2 
rTAO 12.6 ± 0.4 3 
T124A 5.6 ± 0.7 3 
Table 4-6:- Oxygen Km’s for membrane bound rSgAOX and mutant samples. Data obtained using the 
method described in Figure 4-6. Samples were run in 2ml Tris-HCl pH 7.4 with 50mM pyruvate and 
1.25mM NADH on an oxygen electrode. rTAO and T124A mutation are from the trypanosomal 
species and added for comparison. 
 
One of the interesting features of graph C (Figure 4-6) is the area highlighted in red. 
While it is below the 10nmols O2 cutoff for reliable results on the electrode, it 
appears to be linear in character and could potentially be a second KM. It is worth 
noting that while it can clearly be seen as linear in the graphs used here, this section 
does not always present a linear correlation. Given that decrease in turnover would 
increase the quinol:quinone ratio, this could potentially indicate an increased affinity 
for oxygen at a high quinone pool redox poise. The red region presents a KM of 1.4 
µM, much closer to the 1.3 µM determined spectrophotometrically [65], which could 
potentially explain the discrepancies between the reported results. It is also possible 
that this region is due to residual cytochrome bd or bo, given their lower KM for 
oxygen. Km’s of this magnitude have been detected in soybean mitochondria, where 
the altered value was attributed to AOX isozymes present within the system [181]. 
Apparent oxygen Km data for plant wild type demonstrates similar values to those 
collected from mungbean (12.3 µM [63]) and soybean (13.2 µM [64]) collected 
polarographically, and is comparable to data collected previously from this group 
with the recombinant system in S. pombe (20 µM [175]). While it is possible that a 
change in medium and cell type could alter the ability for oxygen to diffuse into the 
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active site, it is unlikely that this can contribute to the differences in results due to 
the similarities of the T179A values obtained in this study relative to those 
determined previously.   
The data inTable 4-6 demonstrates that those mutations which are close to the di-iron 
core all reduce the Km for oxygen. What is useful is that the data discriminates 
between iron atoms; L177A and T179A both demonstrate Km’s lower than the wild 
type value and flank the glutamate binding to Fe2, and N216A neighbours the 
bridging glutamate, also giving a lower O2 Km. While the latter would imply that 
there is no discrimination between the irons, the addition of the lack of change with 
the L267A Km would suggest this mutation is having a larger effect on Fe2 then 
Fe1. The similarity between the Y299F value and that of the wild type would also 
suggest that the change in N216A is likely to be due to interactions with the iron 
core rather than perturbation of the PCET network. The lack of change to the oxygen 
Km for Y299F is surprising; given the conclusion drawn in Chapter 3 with its part in 
stabilising the PCET network, and this networks role in the initial binding stages of 
oxygen, it was expected to lower the Km for oxygen considerably.  
While the oxygen Km for R159A does not appear statistically significant when 
compared to the wild type, when combined with D163A it would suggest otherwise. 
What is interesting about this pair is that if the placement of these residues within 
TAO is indeed the same as in plant AOX, R159 is closer to the core then D163, 
indicating that it is unlikely due to direct effects upon the iron core. One theory that 
could potentially fit the data would be the destabilisation of the hydrogen bond 
formed between D163 and R173 causing movement in the helix. It has previously 
been shown that C172A also leads a reduction in oxygen Km [175], and a similar 
value was obtained with T179A. This would explain the lower value detected in 
R159A as secondary effects upon D163A, removing the second stabilisation point 
for the aspartic acid. If a mutation of R173 is active, it would be interesting to see 
whether the same result is obtained. 
One of the more important results for this study is that both wild-types and their 
respective mutations of the threonine demonstrate similar affinities for oxygen, 
demonstrating that the immediate active site and electronic effects of amino acids 
that will affect the reactivity towards oxygen around the iron are equivalent.  
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Sample Oxygen KM 
rSgAOX 14 ± 1 
rTAO 8.9 ± 2 
T179A 6.7 ± 2 
T124A 11 ± 4 
Table 4-7:- Oxygen Km data for samples taken without the addition of pyruvate to the sample. All 
measurements and standard deviations taken as mean averages from 3 replicants. 
 
Membrane samples were prepared without pyruvate to allow for assessing the effects 
upon oxygen kinetics. As discussed in Chapter 1, pyruvate has been demonstrated to 
have regulatory effects on the plant AOX , whereas TAO shows no activity 
dependence upon pyruvate [182]. 
 
The data in Table 4-7 demonstrates that while lack of pyruvate within the plant 
sample does not alter the Km to oxygen by a significant degree, it increases the 
standard deviation around the mean. The increase in variance would suggest that 
activation by pyruvate aids continued turnover of the active site, allowing for a more 
regular binding affinity for oxygen. Results would suggest that pyruvate is inhibitory 
to the oxygen binding within rTAO, given the significant increase in Km upon its 
addition to the sample.  
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4.8 Summary 
 
Sample O2 electrode  
activity % 
Quinol activity % Purified activity 
% 
T179A 28  34 7.3 
D163A 31 19 2.9 
R159A 24  54 1.3 
Y299F 32 42 9.2 
N216A 23  37 7.9 
L177A 51 14 1.5 
L267A 41 24 2.3 
Table 4-8:- combined percentage activities of rSgAOX mutants relative to the wild types under 
different measurement conditions. Original data and measurement conditions can be found in the 
descriptions of Table 4-1,Table 4-3, and Table 4-5 respectively. 
 
Table 4-8 shows the lack of correlation between the specific activity measurements 
under different conditions. Measurements made using quinol as a substrate are more 
indicative of the true Vmax for each sample given that both quinol and oxygen are in 
excess, with measurements made on the oxygen electrode closer to conditions found 
within a biological system. The mutants which show a decrease in relative activity 
with quinol as the substrate when compared to oxygen uptake measurements 
(D163A, L177A and L267A) are all located within the hydrophobic cavity, and as 
such are liable to interfere with the substrate’s ability to bind within the active site. 
There is potential that the L177A and L267A mutants alleviate the problems 
associated with the change in quinone type found within the E. coli membrane; if 
there were indeed times of growth under anoxic conditions and therefore generation 
of menaquinol as a substrate, the widening of the hydrophobic cavity could allow for 
easier access to the di-iron core for the bulkier substrate, consequently masking the 
reducing effects of mutation.  
Interestingly, the most significant increase was R159A, which could indicate an 
opening of the orthogonal cavity discussed in Chapter 3. While measurements made 
using NADH as the substrate would be constrained to the quinol pool within the 
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membrane, and therefore reduced access to the second cavity, addition of quinol into 
solution would not be under the same limitations and could therefore dock via the 
second cavity. If this was the case, it would be expected that D163A would also 
fulfil the same trend, but instead it has shown a decrease in rate. This could 
potentially be due to steric bulk; an arginine to alanine mutation removes a bulky 
side-chain, whereas the aspartic acid mutation simply removes the carboxylic acid. 
Removal of the larger side-chain would allow access to the active site that could 
effectively mask a reduction in rate, whereas removal of the carboxylic acid 
destabilised R159 and the surrounding region leading to the loss of turnover.   
The loss of mutant activity in the purified protein relative to the specific activities 
measured in membrane bound is not unprecedented; data included in the 
supplementary data of the TAO crystallisation paper [11] indicated all mutants 
retained 5% or less when compared to the wild type TAO. Further studies into the 
stability of the purified protein could provide answers as to the extreme reduction in 
specific activities measured. Circular dichroism measurements would give 
indications as to whether the mutations within the structure impede the proteins 
ability to fold or form helices. 
While it has been postulated as to why each mutant would affect AOX activity, it is 
difficult to generate direct evidence as to whether these claims are true. The oxygen 
Km measurements have indicated that a number of mutations reduce the Km for 
oxygen, while simultaneously demonstrating a decrease in overall activity. Under the 
assumption that the lowered Km would correlate to an increase in binding affinity, it 
would suggest that these mutations either slow the rate of intermediate conversion 
with respect to the oxygen reduction cycle, or reduce the ability of the iron core to 
react with quinol. Examination of the reactivity of T179A, D163A and N216A using 
stop flow techniques could potentially allow for the detection of intermediates in 
these mutants that would otherwise not be visible in wild type due to low half lifes. 
Indeed, preliminary EPR measurements of the T179A mutant have revealed the 
build-up of a semiquinone species within the sample, but the reason for this build-up 
is unclear at this time.  
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5 Inhibition of the alternative oxidase and bc1 complex by 
natural products 
5.1 Introduction 
 
The alternative pathway is well established as being resistant to inhibitors of the 
regular ETC, including cyanide, NO, azide and cytochrome bc1 inhibitors such as 
antimycin A. Given the dependant nature of the trypanosomes on TAO, and the lack 
of AOX within mammalian cells, it has been identified as a potential 
chemotherapeutic target for human African trypanosomiasis (HAT) [83]. SHAM 
[97, 183], octyl gallate [94] and ascofuranone [110] have all demonstrated inhibitory 
properties towards the alternative oxidase, with the latter being the most potent.  
Ascofuranone proves problematic from a synthetic standpoint, in that synthesis 
requires 11 steps, with a number of synthetic steps producing intermediates in lower 
than 20% yield. To improve on this, colletochlorin B was selected as a reasonable 
replacement, containing the pharmacophore whilst removing the problematic 
furanone ring and reducing the necessary synthetic steps to 4. A structure function 
analysis has also been performed on the necessity of the aldehyde for inhibition, 
alongside effects of the compound tail on inhibition of both AOX and the bc1 
complex.  
Use of inhibitors towards AOX would not solely be useful for HAT treatment. The 
alternative pathway  has been identified as a potential biological mechanism for 
fungicidal resistance development [123] with evidence that inhibition of the 
cytochrome bc1 complex leads to an induction of AOX expression [50]. While 
respiration via the alternative pathway would lead to a decrease in ATP levels, it 
allows the cell to develop resistance to fungicides via random point mutations.  
With these two main functions for inhibitors of the AOX in mind, the development 
of both an inhibitor that would specifically inhibit TAO for use in treatment of HAT, 
and a dual mode inhibitor that would inhibit both AOX and the cytochrome bc1 
complex for use as a fungicide.  
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5.2 Compound Synthesis 
 
 
Scheme 5-1:- Mori’s synthesis of colletochlorin B [118] 
 
Synthesis of the ascofuranone derivative colletochlorin B was performed according 
to Mori’s synthesis [118], with a few minor adjustments. In short, orcinol was 
formylated under Gatterman conditions [184] to obtain the aldehyde in 84% yield. 
Chlorination using sulfuryl chloride resulted in the desired isomer at 80% yield, 
which was then alkylated with geranyl bromide in 10% potassium hydroxide 
overnight. The compound was purified via flash chromatography using a gradient 
(petrol ether:ether 10:1 → 4:1), and recrystallised from chloroform to obtain 
colletochlorin B in 20% yield.  
The use of freshly prepared geranyl bromide increased the yield from 5%, with 
quantitative preparation from geraniol and phosphorous tribromide. The same 
experimental procedure was used to synthesise colletochlorin D, substituting 3-3-
dimethylallyl bromide at the final alkylation step to afford the compound in 30% 
yield. 
Comparing TLC analysis prior to chromatography to post-column showed a marked 
difference between product distribution. It is likely that the acidic nature of the silica 
proved detrimental to compound stability, with evidence in the literature that 
exposure to highly acidic conditions results in chromane ring formation [115]. 
Attempts to isolate the degradation products were unsuccessful, with proton NMR 
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analysis suggesting a mixture of isomers. Neutralisation of the silica using 0.5% 
triethylamine prior to chromatography did not appear to improve the yield. 
 
 
Scheme 5-2:- Alkylation step of colletochlorin B synthesis, showing the formation of the anion. A 
lack of driving force for alkylation to the central carbon as depicted above leads to the formation of 
ether via direct alkylation onto the oxygen.  
 
A number of side products were formed during the alkylation step, which can largely 
be attributed to ether formation onto the phenol. Given the poor yield of the final 
alkylation steps a number of attempted improvements were made. Protecting group 
strategies using acetyl and methyl protecting groups failed to yield the desired 
alkylated product using both potassium hydroxide and sodium hydride. The lack of 
reactivity of the protected compounds suggest that the reaction proceeds via 
generation of a phenolic based anion prior to the push of electron density through the 
unsubstituted carbon, with regeneration of the aromaticity driving the reformation of 
the alcohol after alkylation, as depicted in Scheme 5-2. 
Preparation of the acetylated compound was afforded by stirring colletochlorin B in 
a 1:1 mixture of acetic anhydride and pyridine to obtain the product in quantitative 
yields after stirring overnight. Reduction of the acetylated compound with sodium 
borohydride in ethanol gave a mixture of 2 compounds. Even with two distinct Rf 
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values (~0.6 and ~0.4) attempts to purify these compounds via flash chromatography 
proved unsuccessful. It is likely that these 2 compounds can be attributed to a 
migration of the acetyl group onto the newly formed alcohol, which would explain 
the lack of ability to separate the two compounds due to interconversion between 
species. Attempts to deprotect the compounds proved unsuccessful under mild 
conditions, with harsher conditions causing compound degradation.  
The reduced form of colletochlorin B could be made via direct reduction using 
sodium borohydride in ethanol at room temperature for 1 hour. The reaction mixture 
was coevapourated 3 times with methanol to remove the borohydride, and purified 
using flash chromatography. Attempts to improve the yield of the reaction proved 
unfruitful, as the compound proved unstable and decomposed with both increases in 
heat and reaction time. Resolvating the compound also proved problematic, with low 
solubility in organic solvents.  Attempts to dissolve the compound into organic 
solvents with nucleophilic character (methanol and ethanol) at 40°C produced the 
decomposition product, which on further examination appeared to be the addition of 
a methoxy group to the compound. The generation of a quinone methide in situ 
appears to be the most likely reason for compound instability, with methanol acting 
as a nucleophile towards the newly generated electrophilic site.  
 
5.3 Results and discussion 
 
Fitting of curves 
Sigmoidal curves were fitted to the data according to the formula a+((b-
a)/1+((x/c)^d))), where ‘a’ was the value for the bottom of the curve, ‘b’ the top (in 
the case of 100% inhibition for compounds 0 and 100 respectively) ‘c’ the IC50 value 
(midpoint of the curve) and d was the slope. Curves were optimised according to a 
least mean square fit method.  
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5.4 Inhibition of the alternative oxidase 
 
5.4.1 Arum maculatum mitochondria – effects of inhibitors  
 
Figure 5-1 Dose response curves collected for AOX dependant respiration from A. maculatum 
mitochondria. Data was collected using an oxygen electrode, containing 400 µl plant medium A, 
0.033mg mitochondrial protein, 1.25mM NADH and 4 µM Antimycin A to inhibit cytochrome bc1 
activity. IC50’s for ascofuranone, ascochlorin and colletochlorin B were 9nM, 90nM and 125nM 
respectively. SHAM and octyl gallate added for clarity  
 
The spadices of Arum maculatum were picked locally and mitochondria isolated as 
described in Chapter 2. NADH dependant respiration was measured using an oxygen 
electrode in conjunction with Antimycin A to determine the alternative pathway 
respiratory rate. Unlike the E.coli membrane bound samples described in Chapter 3, 
addition of excess duroquinol to the assay did not increase the respiratory activity, 
indicating that quinol levels were at saturation. 
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Data collected was normalised to an uninhibited rate of 60nmols O2 
consumed/minute. Using mitochondrial protein estimation between preparations 
proved problematic from a normalisation standpoint given the increasing alternative 
oxidase expression levels later in the season does not necessarily correlate to an 
increase in protein levels. Degradation between assay runs indicating a loss of 
activity are also not taken into account if protein levels were the sole basis for 
comparison between preparations. 
 
Compound Normalised IC50 
Colletochlorin B 67±17 nM 
Ascofuranone 7 ± 5 nM 
Ascochlorin 70 ± 18 nM 
SHAM 17 µM 
Octyl gallate 670 nM 
Table 5-1 IC50 data collected from alternative oxidase dependant respiration in Arum maculatum 
mitochondria. Standard deviation included for inhibitors tested against more than one mitochondrial 
isolation. Values are averages ± standard deviation for 4 (CB) or 3 (Ascofuranone and Ascochlorin) 
replicants. SHAM and Octyl gallate are single experiments for comparison. 
 
SHAM and octyl gallate are known inhibitors of the alternative oxidase [85, 94, 185, 
186], showing competitive [84] and non-competitive inhibition respectively with 
respect to quinol. Both compounds have been demonstrated to inhibit in a non 
specific manner, with SHAM inhibiting tyrosinase and peroxidase [87], and octyl 
gallate inhibiting Δ6 desaturase [187].  
 Table 5-1 demonstrates that the experimental IC50 values determined are 
comparable to literature values for SHAM (40 µM against Arabidopsis thaliana 
mitochondria [84]) and octyl gallate (350nM[84]). While colletochlorin B, 
ascochlorin and ascofuranone contain the same pharmacophore, the IC50 for 
ascofuranone is significantly lower, suggesting that the furanone moiety aids in 
binding the compound to the active site. While ascochlorin also contains 
functionality at the end of the chain, it does not appear to affect binding in either a 
beneficial or detrimental manner. Azoxystrobin was also tested, but showed no 
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inhibition at concentrations of 500 µM, confirming that when used as a fungicide, 
the fungal alternative pathway will remain unhindered.   
In order to ensure that inhibition was specific for the alternative oxidase, the activity 
of NADH dehydrogenase was measured as described in Materials and Methods. No 
change in DCPIP reduction rates were detected upto inhibitor concentrations of 5 
µM, indicating that inhibition of the electron transport chain must be occurring at the 
alternative oxidase.  
 
5.4.1.1 Arum maculatum mitochondria – derivatives of colletochlorin B 
 
 
Figure 5-2:- colletochlorin B derivatives tested against Arum maculatum mitochondria. 
 
Compound IC50 
Colletochlorin B 67 nM 
Colletochlorin D 110 nM 
Reduced Colletochlorin B 4 µM 
Acetylated Colletochlorin B 92 µM 
Head group 28 µM 
Table 5-2:- IC50 values for colletochlorin B derivatives against Arum maculatum mitochondria. Data 
collected using the method described in Figure 5-1, data depicted is an average of 2 preparations. 
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The synthesised derivatives shown in Figure 5-2 were also tested for inhibitory 
efficacy against Arum maculatum mitochondria, with results given in Table 5-2. 
Loss of an isoprene unit from the tail of colletochlorin B to form colletochlorin D 
had a relatively small effect on the inhibitory efficacy of the compound, requiring 
double the concentration to reach 50% inhibition. However complete removal of the 
tail unit increased the IC50 into the µM range. Given the mimetic nature of the tail to 
that of quinol, it is likely that it is necessary for binding site recognition and 
orientation within the active site. This has been demonstrated with quinol analogues 
in their reaction with cytochrome bo [173], whereby reduction of the double bond 
reduced binding affinity for the complex. It may also be indicative that removal of 
the isoprenoid tail reduces the lipophilicity of the compound, preventing it from 
entering the cellular membrane as efficiently and therefore reaching the site of 
inhibition. 
Acetylation of the two alcohol groups has the largest impact on inhibition. This is 
unsurprising given the nature of inhibitor binding discussed in Chapter 3, whereby 
the phenol groups anchor the inhibitor into the active site. Reduction of the aldehyde 
also demonstrated a large increase in IC50 concentration, which would suggest that it 
is more important for binding then the crystal structure would suggest. It is entirely 
possible that the decrease in compound stability is the cause of reduced inhibitory 
properties, with degredation of the compound prior to reaching the active site.  
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5.4.1.2 Trypanosomes 
Compound IC50 nM 
Ascofuranone 1.6 ± 0.1   
Colletochlorin B 2.6 ± 0.1   
Benzoxiborininol 64.2 ± 0.2  
Table 5-3:- IC50 Data collected from anti-proliferation assays against Trypanasoma brucei brucei. 
Data depicted is an average of 3 replications 
 
The efficacy of the compounds against trypanosomes was confirmed by anti-
proliferation assays performed by Dr Shane Wilkinson (Queen Mary University of 
London). Benzoxiborininol is currently a lead compound for the treatment of HAT 
[188], with an unknown mode of trypanosidal activity. This compound was tested 
against TAO, but was shown to not inhibit activity. Ascofuranone acts as a standard 
for trypanosidal activity via TAO inhibition, having already been demonstrated to be 
an effective treatment for infected mice [111, 112].  The data in Table 5-3 
demonstrates both Colletochlorin B and Ascofuranone are effective compounds 
against T. b. brucei, and that loss of the furanone ring does not affect the compounds 
ability to eradicate trypanosomes. 
When compared to the data in Table 5-1 the IC50 values for ascofuranone and 
colletochlorin B are much closer. This implies that either the binding site for TAO 
and plant AOX differ in the binding of the compounds, or that the location of the 
alternative oxidase within the trypanosomes is more accessible for colletochlorin B 
then in plant mitochondria.  
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5.4.1.3 AOX membrane – determination of Ki 
 
 
 
Figure 5-3:- Lineweaver Burke plots collected from membrane bound rSgAOX with varying inhibitor 
concentrations. Graph A inhibitor concentrations (square) 50nM CB, (triangle) 100nM CB (X) 25nM 
CB (diamond) no inhibitor. Graph B inhibitor concentrations (diamond) 5nM CB, (triangle) 30nM 
CB, (X) uninhibited 
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Figure 5-3 demonstrates that the inhibition profile for colletochlorin B is variable 
with respect to the alternative electron transport chain. NADH concentrations were 
decreased to ensure substrate concentration was rate limiting the production of 
quinol, allowing for a 1:1 conversion of NADH to quinol concentration.  
E + S
EI + S EIS
ES E + P
ks
ki
kp
ks
ki
 
Scheme 5-3:- accepted kinetic variables for a mixed inhibition type. E, I S and P refer to enzyme, 
inhibitor, substrate and product respectively. Ki and ks define the constants for formation of enzyme 
inhibitor and enzyme substrate complexes respectively, with αki and αks allowing for cases where the 
enzyme inhibitor complex is able form complexes with the substrate.  
 
Scheme 5-3 describes the kinetic variables that are part of a mixed type inhibition of 
an enzyme substrate complex. All details of the scheme and the following equations 
can be found in Atkins [189]. Each straight line generated in the double reciprocal 
plot is defined by the following equation:- 
 
1/V        = ks/Vmax(1+ [I]/ki)1/[s] + 1/vmax (1+ [I]/αki) 
Equation 1 
 
Where V is the inhibited rate, Vmax the uninhibited rate, [I] is the inhibitor 
concentration and [s] is substrate concentration. Equation 1 can further be split into 
two components to define the y-intercept and gradient respectively:- 
 
y-intercept = 1/Vmax·αki x 1/[I] + 1/Vmax 
 
gradient     = ks/Vmax·ki x 1/[I] + ks/Vmax 
 
Equation 2 
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Equation 2 allows for determination of ki values by plotting the gradients against 
inhibitor concentration, where the x intercept with be equal to –ki. While the Km 
values for NADH varies between samples (68µM and 150µM respectively), the Ki 
values are much closer in value (41nM and 61nM). This would indicate that while 
there are differences between preparations with respect to electron transport chain, 
these do not necessarily affect the binding of the inhibitor. Given the apparent 
problems with obtaining consistent specific activities for the membrane bound wild-
type SgAOX, the variability between samples of Kmapp is likely indicative of altered 
components within the quinone pool itself, with quinol and menaquinol presenting 
different Kmapp towards AOX.  
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5.5 Cytochrome bc1 complex 
5.5.1 Inhibition of isolated potato mitochondria  
 
Figure 5-4 :- Dose response curves for inhibitors against potato mitochondria. Assays run in 400 µl 
plant medium A, containing 0.3mg mitochondrial protein, 1.25 mM NADH as substrate and 1µM 
CCCP to uncouple the rate from ATP synthase.  
 
Inhibitor  IC50 µM Slope 
Ascochlorin  0.58 4 
Colletochlorin B  0.78  4 
Azoxystrobin  1.57  1.7 
Ascofuranone  30 0.6 
Table 5-4:- IC50 data collected from potato mitochondria. The slope is defined from the sigmoidal 
curve fitting defined in 5.3. 
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Mitochondria were harvested from commercial potato tubers, following the protocol 
outlined in chapter 2.As with the A. maculatum mitochondria, NADH dependant 
respiration was measured using an oxygen electrode. Potato mitochondria were 
selected due to their low levels of alternative oxidase expression within freshly sliced 
tuber [51] , allowing for the examination of the inhibitors on the plant cytochrome 
bc1 complex.   
The data in Table 5-4 demonstrates the efficacy of the compounds towards the plant 
bc1 complex, using azoxystrobin as a standard. Azoxystrobin was selected due to the 
its position as a leading fungicide, with a mode of action that targets Qo site in the 
bc1 complex [190]. As can be seen in the table, both ascochlorin and colletochlorin B 
show increased inhibition of the NADH dependant pathway relative to that of 
azoxystrobin. The data demonstrates that the furanone ring is detrimental to the 
inhibition of the bc1 complex, with ascofuranone requiring a higher concentration 
then was possible under experimental conditions used to achieve 100 % inhibition 
(as depicted in Figure 5-4).    
One of the more interesting features of the curves shown in Figure 5-4 was the 
increase in Hill co-efficient for both colletochlorin B and ascochlorin relative to 
inhibition of the alternative oxidase. While each compound had a coefficient of ~1 
for alternative oxidase titrations, colletochlorin B and ascochlorin have coefficients 
of 4, suggesting an increased binding affinity.  
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5.5.2 RAT liver 
 
 
Figure 5-5:- Dose response curves for compounds tested against isolated rat liver mitochondria. 
Assays were run in a rank-type oxygen electrode, containing 400µl medium A, 0.9mg mitochondrial 
protein and 1.25mM succinate. 
 
Compound IC50 nM Slope 
Ascochlorin 208 3 
Colletochlorin B 547 3 
Azoxystrobin 700 2 
Table 5-5 :- IC50 data collected from rat liver mitochondria. The slope is defined as the hill coefficient 
from the sigmoidal curve fitting defined in 5.3. 
 
Additional data was collected from mitochondria harvested from rat liver due to their 
high concentration of the cytochrome bc1complex, and lack of AOX allowing for 
definitive determination of complex III IC50 without potential AOX contamination. 
Succinate dependant respiration was measured due to the lack of external NADH 
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dehydrogenase in mammalian mitochondria, with an excess used to ensure continued 
turnover of the ETC.   
The relative inhibitory profile for these 3 compounds alters with respect to the 
mammalian bc1 complex. The data Table 5-5 demonstrates that the IC50 value for 
colletochlorin B is closer to that of Azoxystrobin, with ascochlorin being a superior 
inhibitor. The slope coefficient is shown to be superior for ascochlorin and 
colletochlorin B compared to azoxystrobin, indicating a difference between binding 
types. However values are closer, which could be due to the nature of the 
mitochondria within the preparation. More repeats would be necessary to confirm the 
validity of the data. 
 
5.5.3 Fungal bc1 complex 
 
 
 
 
 
 
Figure 5-6:- Growth of transformed S.cervisiae containing colletochlorin B (CB) and azoxystrobin 
(AZ) in marked concentrations. Colonies clockwise from the 12 position correspond to Wild type, 
G143A mutant, K228M mutant and the double mutant containing both G143A and K228M mutations.  
 
Inhibition of the fungal bc1 complex was assayed using a plate growth monitoring 
system. S.cervisiae cell lines contained wild type cytochrome bc1 alongside the 
Control 2 µM CB 
Control 2 µM Az 
10 µM CB 25 µM CB 50 µM CB 
50 µM Az 
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mutants G143A [191], K228M and a strain containing both mutants [192] were 
kindly provided by Dr. Brigitte Meunier (Centre de Génétique Moléculaire). The two 
mutants are known to decrease the fungicidal efficacy of compounds that target the 
Qo (G143A) or Qi site (K228M), allowing for qualitative assessment as to whether 
these mutations will affect the inhibitory properties of Colletochlorin B. 
Azoxystrobin is a known specific Qo site inhibitor, so acts as a control within this 
experiment and demonstrates that the mutations within the Qi site do not have a 
translational effect through to the Qo site.  
Figure 5-6 show that both Colletochlorin B and azoxystrobin prevented growth of 
the wild type and K228M mutant cell lines at concentrations of 2µM, indicating that 
this mutation has no effect upon the inhibitory properties of either compounds. 
However, it can be seen the G143A mutations increased the concentration of 
inhibitor required to prevent cell growth, with full growth visible on the 10 µM plate, 
and partial growth on the 25 µM. The inhibition at 50 µM cannot be directly 
attributed to inhibition at the Qo site, and could be indicative that inhibitor 
concentration has increased to a level where it is able to inhibit the Qi site, although 
it can be inferred from these results that the primary mode of inhibition is via 
binding at the Qo site and the G143A mutation reduces the binding efficacy of 
colletochlorin B.     
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5.6 Computational determination of inhibitor efficacy 
 
Compound Z-Score 
Quinol (QH2) -8.2 
Ascofuranone -9.7 
Azoxystrobin -9.3 
Colletochlorin B -8.9 
Colletochlorin D -7.9 
Ascochlorin -7.6 
SHAM -7.0 
Propyl gallate -7.3 
Octyl gallate -7.5 
Mesaquinone -8.5 
Acetylated -8.1 
Head group -6.4 
Reduced -8.9 
Table 5-6:- Docking results of alternative oxidase inhibitors into the hydrophobic cavity. Compounds 
were docked using VINA-autodock into the TAO crystal structure (PDB :3VVA). Z-score gives a fit 
value, whereby a more negative score indicates an increase in binding profile.   
Initial docking of compounds into the TAO crystal structure was completed using 
the VINA docking software [193] (implemented on www.mcule.com, using VINA-
Autodock) onto the crystal data containing ascofuranone derivatives (PDB 
code:3VVA) to ensure that the docking process would not be hindered by residue 
displacement. Docking was centred around the area of the hydrophobic cleft closest 
to the di-iron centre, and a box of 22 Å was defined as the area into which the 
binding ligands must fit. Poses were evaluated via both Z-score and by eye, 
discarding poses that were either facing the wrong direction or were binding within 
the di-iron centre. The validity of this docking method was confirmed using the 
crystal structure of TAO with colletochlorin B (PDB code: 3W54), whereby the 
docked inhibitor was binding to the same residues.  
The position of the aldehyde does not appear important for docking purposes, but 
could potentially be important for the inhibitory mechanism. 180° rotation of the 
head group for ascofuranone gave Z-scores or 9.7 and 9.6, demonstrating no 
selectivity between phenolic groups from an electronic standpoint. A rotation along 
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the axis retains the positions of the phenol groups in the 4 and 6 positions, which 
would suggest that these are more important for the docking then the position of the 
aldehyde.  
The values obtained for Z-scores roughly follow the trend for potency of inhibition, 
with the exception of ascochlorin. While ascochlorin contains the same 
pharmacophore as the other compounds, attempts to dock it into the same space 
proved unsuccessful. It is likely that this is a feature of computational attempts to 
bind the tail to residues towards the entrance of the cavity (Tail carbonyl → T186), 
as opposed to focusing on the binding of the head group.  
While experimental evidence has demonstrated that acetylation of the colletochlorin 
B reduces the inhibitory properties considerably (into the micromolar range) it does 
not affect the docking score by the same degree. Similar results were found with 
azoxystrobin, whereby a score of -9.3 should make it one of the more potent 
inhibitors, however assays against A. maculatum mitochondria indicated there was 
no inhibition of AOX in the µM range. These results are likely due to the fact that 
while the compound is able to fit into the internal cavity, it is unable to pass the 
cavity bottleneck caused by L177 and L267 except under unfavourable 
conformations. 
The docking process did not take into account regions which it considers ligands, 
such as the diiron core in AOX, and the haem groups in the bc1 complex. As such no 
electronic properties of metal ions are taken into account, which would affect the 
ability for the compounds to bind. Removal of the di-iron centre from AOX gave the 
docking programme access to the carboxylate cluster to which it was preferentially 
binding compounds. There were similar problems encountered with the docking in 
the bc1 complex, with a number of compounds binding into the large cavity where 
the haem would be located. As such, the results collected were unreliable and have 
not been included in this thesis. 
5.7 Summary 
 
The pharmacophore and function of the linker tail have recently been confirmed 
independently [115] with respect to the inhibition of TAO. This study indicates that 
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while the furanone ring is not necessary for inhibition, it aids in differentiation 
between AOX and the bc1 complex. While it does increase the potency of the 
compound towards the plant alternative oxidase, results from this study suggest that 
its primary function is to prevent ascofuranone from binding to the cytochrome bc1 
complex.  
Comparison of the plant AOX and TAO results suggest that there is a difference in 
binding sites. Using ascofuranone as the template, results from the trypanosomal 
assays demonstrated only a small increase in concentration required of colletochlorin 
B to reach the IC50, while the assays completed against plant mitochondria required a 
10-fold increase in concentration. These differences are unlikely to confer a 
difference in reactivity towards quinols, given that they are from the tail end of the 
compound and do not enter the active site themselves. The ascochlorin data for plant 
AOX is consistent with the 10-fold increase required in TAO [115] 
One of the more prominent uses of inhibitors for probing enzymatic systems is that 
the types of inhibition give insight into the binding site, and therefore the sites of 
substrate interaction. While colletochlorin B gives a mixed inhibition type, this could 
more be a function as to how it interacts with the protein itself. Analysis of the 
crystal structure with ascofuranone derivatives indicate that there are no covalent 
bond formation, while the aldehyde resides close to the proposed redox active 
tyrosine. Under the same assumptions found with the quinol binding discussed in 
chapter 3, it would suggest that colletochlorin B interacts in a similar way to quinol, 
in that it is only able to bind fully when the di-iron core is in the correct 
configuration. The loss of inhibitory efficacy with both acetylation of the hydroxyl 
groups and reduction of the aldehyde would suggest that both are important for 
binding within the active site, with the OH group para to the aldehyde allowing the 
compound to act as a mimentic to the quinol. 
Unfortunately colletochlorin B has been found to be lethal within the mouse model, 
and as such would not be suitable for treatment of HAT. This is likely due to the 
potency of the compound towards the cytochrome bc1 complex, and as such 
ascochlorin would likely also prove fatal towards the host. This does not preclude the 
two compounds from use as a fungicide, given that they both have increased 
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inhibition of cytochrome bc1 activity compared to azoxystrobin, while also 
conferring inhibitory efficacy towards alternative oxidases.  
The higher slope coefficient for ascochlorin and colletochlorin B relative to 
azoxystrobin could prove advantageous for use as a fungicide. The tighter curve 
reduces concentration differences from no inhibition to no activity, reducing the 
likelihood of necessitating point mutations within the cytochrome bc1 while in the 
field. From an evolutionary standpoint, if the protein exist in either a fully functional 
or inactive state, there is no selective driving force for point mutations to become a 
dominant species within the fungus until the respiratory chain is fully inhibited.  
Unfortunately preliminary plate assays demonstrate that the common G143A 
mutation within the cytochrome bc1 complex is detrimental to inhibition via 
colletochlorin B, but the nature of the assay system cannot demonstrate to what 
extent. Further testing on these mutations would prove useful insight as to whether it 
is as detrimental to the inhibitory properties of colletochlorin B as azoxystrobin.  
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6 The active site and mechanistic considerations for the 
alternative oxidase 
6.1 Introduction  
 
The recent success in crystallisation of the AOX [11] allows for a much more 
detailed investigation of the active site and highly conserved residues then has 
previously been possible. Structural predictions that the protein contains a non haem 
di-iron centre surrounded by a 4-helix bundle [134, 135] have proven to be correct, 
with the metal core ligated by 4 glutamates and 2 histidines. These structural features 
confirm the addition of AOX into the di-iron carboxylate superfamily, alongside 
other oxygen reductive species such as methane monooxygenase 
(MMO),ribonucleotide reductase (RNR) and rubrerythrin (RBR). Given the wealth 
of information available on these complexes, the discussion within this chapter will 
be focused on comparisons between AOX, MMO and RNR.  
While the structures of these proteins are similar they are able to undergo very 
different reactions. MMO uses the oxygen to generate a high valent Fe(IV) state for 
the conversion of methane to methanol, a reaction that has garnered much scientific 
interest due to its catalytic conversion of a volatile gas into a transportable liquid at 
room temperature, while RNR uses the core to reduce ribonucleotides through to 
deoxyribonucleotides for use in DNA synthesis.   
Full reduction of oxygen through to water requires 4 electrons and 4 protons. The 
use of a bimetallic centre allows for all 4 of the electrons to come from the metal 
centres themselves, from an Fe(II)/Fe(II) state to two Fe(IV) states.  
This chapter contains an overview of a selection of the di-iron family and their 
catalytic mechanisms. Comparison of the AOX structure to those of the known 
proteins allows for extrapolation of regions of potential mechanistic importance, 
thereby facilitating a prediction of the catalytic mechanism using data previously 
generated alongside the data generated throughout this thesis.  
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6.2 Function of the di-iron core in other proteins 
 
MMO 
CH4 + O2 + NAD(P)H + H
+
  → CH3OH + H2O + NAD
+
 
                        
The overall function of soluble MMO (sMMO) is to utilise molecular oxygen for 
conversion of a variety of hydrocarbons to alcohols, with a preference for methanol 
[194], with a reducing equivalent of NAD(P)H being utilised to provide the final 2 
protons and electrons for completing the cycle.  
The structure of sMMO consists of 3 subunits; a reductase (MMOR) a hydroxylase 
(MMOH) and a coupling subunit (MMOB). The di-iron core is contained within the 
MMOH protein arranged in an (αβγ)2 dimer configuration [195], and is the centre for 
reactivity for both oxygen and methane. More recent work on the MMOB protein 
suggests that it controls substrate entry into the MMOH active site, with binding of 
MMOB to MMOH causing conformational changes that allow access to the di-iron 
core for both methane and oxygen [196]. 
 
RNR 
 
NADH + O2 + H
+
 NDPox + Fe
II→ NAD+ + 2H2O + NDPdeoxy + Fe
III 
 
RNR catalyses the reduction of ribonucleotides to deoxyribonucleotides for use in 
DNA synthesis [197], using the reduction of oxygen in its metal centre to generate 2 
sulphur based radicals. The structure of RNR is divided into two sections, a substrate 
reactive centre (R1) with an oxygen reaction bimetallic centre (R2), with the most 
active form being a stoichiometric cluster of subunits.  
RNR can be divided into 3 main classes dependant on metal cofactors and their 
interaction with molecular oxygen. An extensive review on the differences between 
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classes from Tomter et al. [198] covers the differences between radical generating 
clusters in detail. Class 1 enzymes are the closest to AOX, since it uses a redox 
active tyrosine close to a metal centre. Class 1 can further be divided based on the 
metal cofactor in the R2 subunit, with class 1a containing 2 irons, class 1b 
containing both iron and manganese and class 1c with two manganese ions. The 
discussion of RNR will be focused on the class 1a subunit, given the similarities to 
AOX.  
 Within the class 1 enzymes, the R2 subunit is used as a radical generating cluster, 
utilising molecular oxygen to generate a tyrosyl radical within the iron core. The 
radical is transferred to subunit R1 via long range PCET to reduce a disulfide bond, 
which in turn acts as the reducing equivalent for ribonucleotides. The network itself 
consists of a tyr-asp-his-asp-tryp short range network within the R2 subunit, where 
transfer of the radical species is believed to be stable upon the tryptophan. The 
radical species is then transferred into the R1 unit via a series of tyrosines, where it is 
able to reduce the disulfide bond. While the transfer between subunits would be 
greater than the 14 Å maximal distance for electron tunnelling, docking models 
between the subunits suggest that there is transient movement that would shorten the 
distance to within electron tunnelling distance, but exact values depend on the 
docking procedure used. The PCET network is discussed in detail by Stubbe et 
al.[199]. 
 
Rubrerythrin 
H2O2 + NAD(P)H + H
 + → NAD+ + H2O 
 
Rubrerythrins (RBR) are involved in the oxidative stress response in anaerobic 
bacteria and archae, demonstrating an ability to reduce both oxygen and hydrogen 
peroxide through to water [200], with increased activity towards the later. 
Confirmation of an oxidative stress role was shown by deactivation of RBR 
increasing susceptibility of Porphyromonas gingivalis to both oxygen and peroxide 
[201].  
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A number of structures of rubrerythrin are available, and are the most simplistic of 
the di-iron proteins used in this thesis. The C terminal region contains a rubredoxin 
like FeS4 domain that is involved in single electron transfer, and the N terminal 
region is made solely of the common 4 helix bundle containing the di-iron core. 
Reverse RBR (revRBR) features a reversal of subunits within the structure, with the 
FeS4 domain in the Nterminal region [202]. As with RBR, revRBR demonstrates a 
preference for H2O2 over O2 [203], but also shows increased levels of activity 
towards oxygen compared with its RBR. The preference for H2O2 over O2 has been 
attributed to the location of additional glutamate within the active site of the protein 
[200], although there is no clear reason as to why this would affect catalytic 
preference.  
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6.3 Comparisons of the oxidised forms of di-iron proteins  
 
Figure 6-1:-Oxidised di-iron core of AOX aligned to; A: RNR (PDB:1RIB), B: RNR D84E 
(PBD:1PIU)and C : MMO (PDB: 1MTY). AOX is shown in red, RNR wild type in blue, RNR D84E 
in green and MMO in orange. Alignment performed according to best fit with respect to the iron 
binding ligands. Atoms coloured according to element, with oxygen shown in red and nitrogen in 
blue, with the exception of the di-iron core (large spheres) and ligating oxygens (smaller spheres), 
which were coloured according to crystal structure for visibility. Histidines removed from the top-
down view for clarity. TAO numbering added for orientation purposes. 
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Iron core ligation 
 
Monomer E123 
(Fe2/Fe2) 
E162 
(Fe1/Fe2) 
E213 
(Fe1/Fe1) 
E266 
(Fe1/Fe2) 
H165 H269 
AOX 2.2/2.0 2.5/2.3 2.3/2.5 2.0/2.1 3.3 4.4 
RNR 2.2/2.5 2.0/1.8 2.1/NB 2.1/NB 2.1 2.3 
RNR D84E 2.2/2.9 2.2/2.1 2.1/NB 2.0/NB 2.4 2.1 
MMO 2.0/NB 2.6/2.2 2.1/NB 2.0/NB 2.2 2.1 
RBR 2.1/2.3 2.0/2.2 2.2/2.2 2.1/2.0 4.1 2.2 
Table 6-1:- Bond distances in Angstroms for Iron ligation sphere relative to the TAO numbering 
system. NB signifies no second bond towards to metal centre for that ligand.  
 
While sequence comparison was a useful tool for identifying conserved residues 
within a protein family, alignment of the appropriate subunits of the di-iron family 
shared limited motifs. Structural alignment is a more useful tool for analysis of the 
protein configuration when compared to its closest relatives, with overlays of the 
AOX against MMO and RNR shown in Figure 6-1. While the primary ligation 
sphere of RNR differs by the use of a terminal bidentate aspartate ligand, a crystal 
structure is available of the D84E mutant, making it analogous to the other 
structures.  
One of the most immediate features that can be seen in Table 6-1 is that AOX is the 
only protein where the irons are not ligated to either histidines, with the RBR 
ligation sphere only containing 1 histidine. What is more apparent from the overlays 
is that the relative positions of the irons is much lower within the active site relative 
to MMO and RNR, indicating that lack of ligation is not due to movement of the 
histidines but of the iron molecules.   
One of the structural motifs discussed in Chapter 3 was the hydrogen bond network 
between W247, D265 and H165. This structural motif is also present RNR, where it 
has been demonstrated to be involved in a proton coupled electron transfer from 
subunit R1 into the di-iron core of R2 [199, 204]. The structural overlay shown in 
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Figure 6-1 shows relatively good overlap between these features in AOX and RNR, 
suggesting that this structural motif may play a similar role.  
While it would be tempting to speculate that a similar PCET would happen within 
AOX, there are a number of factors that would suggest that this is not the case. 
Migration of the iron away from the histidine coupled with the bidentate nature of 
the terminal glutamate effectively breaks the chain to the tyrosine. There is also a 
lack of an electron hole pair that would act as a driving force for electron transfer 
over long distances, which in the RNR system is provided by the disulphide bond. 
However it has been demonstrated in the purified R2 unit that it is able to hold a 
radical charge [205]. The mutation of Y246 in the SgAOX system also proved non-
fatal to protein activity [175] (Y299F from Chapter 4), and given the importance of 
the tyrosine in maintaining the position of the tryptophan it would suggest that even 
if this motif is present for PCET purposes it is a non-essential side reaction to normal 
AOX function. Removal of the tyrosine anchor point would effectively leave the 
tryptophan radical in limbo if it was to undergo PCET. It is also possible that the 
radical formation on the tryptophan is transient in nature, since in R2 there is 
evidence that W48+* forms and decays prior to the formation of Y* [205]. The 
disconnect of the histidine from the iron during the catalytic cycle would suggest that 
this motif is required for mediation of electron density changes during oxygen 
binding similar to that observed within RNR, with the iron migration preventing the 
generation of a tryptophan radical later in the cycle.  
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6.4 Potential reduced structures 
 
Fully reduced forms of known proteins 
 
 
Figure 6-2:- Di-iron core of fully reduced species. A: RNR-D84E mutant (PDB: 1PIM) in green, B: 
RNR wild type (1R56) in blue, C: MMO (PDB:1FYZ) in orange and D: RBR (PDB:1LKO) in wheat. 
Heteroatoms coloured with blue being nitrogen, oxygen being red, and iron as orange spheres. 
Numbering indicates amino acid position in respective protein.   
 
Figure 6-2 shows the fully reduced active sites of the di-iron carboxylate proteins 
discussed. While the fully reduced form of AOX is not available at present, 
examination of the known features available can allow for prediction of active site 
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configuration with respect to how they alter the structure around MMO. Alignment 
of the structures (not shown) revealed that the iron positions are not as variable as 
could be seen with the oxidised forms of the protein, with all iron atoms being 
ligated to their respective histidines.  
 
Figure 6-3:- Arrangement of carboxylates around the reduced MMO core, showing the bridging 
system and probable spin exchange for E243 
 
The MMO structure shown in Figure 6-3 contains 2 bridging carboxylate ligands, 
with E144 bridging monodentate to each iron, whereas E243 binds in a bidentate 
fashion to Fe1 and a monodentate to Fe2. Both terminal carboxylates are 
monodentate to their respective irons, with E114 ligating to the water within the 
active site. The octahedral geometry around both iron cores is capped with a bridging 
hydroxide ion.   
The RNR has significant differences from the MMO structure, in it contains two 
bridging ligands (E115 and E238) that are monodentate to each iron atom. E204 has 
also transferred to a bidentate binding mode, and D84 adopts a pseudo-bidentate 
binding mode, with one oxygen also in hydrogen bonding distance to the proximal 
tyrosine. Both irons are in a square based pyramidal geometry, with a lack of either 
water or hydroxide ions capping the structure.  
What is interesting about the D84E mutant is that the effects of mutation are 
translated through the active site. Increasing the carbon chain of the carboxylate by 
one increases the degrees of freedom, allowing for a bidentate binding mode. The 
effects of this can be seen in the position of the tyrosine, whereby it no longer 
appears hydrogen bonded to the glutamate. E204 has adopted a monodentate binding 
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mode, with the bridging E238 moving to bidentate around Fe1. Addition of a 
hydroxide forms an octahedral complex around the iron centre, thereby adopting 
geometry similar to that seen in MMO.  
What is apparent from the RBR structure is that the tyrosines in the secondary 
ligation sphere have little apparent effect on the primary ligands. While both 
tyrosines are within hydrogen bonding distance to their glutamate counterparts, both 
ligands are adopting a bidentate binding mode, demonstrating that the 
electronegativity of the iron atoms have a greater draw on carboxylate positions. The 
symmetry of the structure is also of note, with all carboxylate ligands binding in a 
bidentate fashion and a tyrosine found on either side of the core.  
Given the lack of effect that can be seen of the tyrosine in the RBR structure, it is 
highly likely that the core of the fully reduced AOX protein will resemble that of the 
RNR-D84E mutant. Comparison between the two RNR structures presented 
demonstrates that the increase of the carboxylic acid by a single CH2 unit has a 
greater effect on the overall architecture of the active site then the addition of the 
tyrosine in RBR. The PCET network is also likely to affect the electronic properties 
of the iron, making the D84E structure more representative then the MMO core.    
 
Relevance to AOX 
 
With only one oxygen visible in the active site of the crystal structure, it is more 
likely that there is a full 4 electron reduction of oxygen prior to addition of quinol. If 
the fully reduced form of the protein is closer to that or RNR, lacking the bridging 
hydroxide moiety, then the reduction of oxygen through to hydroxide and water still 
requires 3 electrons and 3 protons to reach the crystallised form. The conversion of 2 
mono-dentate to bi-dentate carboxylate ligands frees two protons and allows for the 
metal centre to mediate oxidation states via the loss of electrons. The proposed redox 
active tyrosine is also liable to donate a proton and electron into the reaction, with 
the fourth proton either being donated through the proton bonding network, or 
donated via a quinol. 
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6.5 Mechanism of oxygen activation 
6.5.1 MMO 
 
 
Figure 6-4:- Schematic representation of oxygen reaction cycle in soluble methane monooxygenase, 
adapted from [206]. Intermediates MMOH-P and MMOH-Q are predictions based on spectroscopic 
evidence, with MMOH-red and MMOH-OX from crystal structures 1FYZ  and 1MTY respectively. 
Only bridging ligands shown for clarity.  
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The mechanism of oxygen reduction within the MMOH subunit has been examined 
in detail by a number of groups, with a thorough review available from Tinberg and 
colleagues [206]. 
The fully reduced species is the oxygen reactive centre, generating a cis µ-1,2 
peroxodiiron(III) species (MMOH-P). MMOH-P has been well characterised, 
showing distinct bands at 420nm and 720nm [194] that correspond to a ligand to 
metal charge transfer from the peroxo species. Computational studies suggest that 
the initial reaction of MMOH and oxygen leads to the generation of a superoxo 
species [207]. MMOH-P is thought to be the methane reactive substrate, with 
generation of MMOH-Q being the result of a lack of hydrocarbon substrate.  
MMOH-Q is the product of O-O bind cleavage, signalling the full reduction of 
oxygen. The structure of MMOH-Q is less defined then that of MMOH-P, with the 
most commonly proposed arrangement being a “diamond core” of oxygen around 
two Fe(IV) centres, proposed due to a short inter-iron distance of 2.46 Å and short 
Fe-O bonds  of 1.77 Å determined via Mossbauer analysis [208].  MMOH-Q has two 
UV absorption peaks from stop flow spectrometry at 320nm and 420nm [209]. 
Interestingly computational studies of ToMOH-P in toluene monooxygenase suggest 
that the peroxoide species migrates from a cis µ-1,2 peroxodiiron(III) to a µ-1,2 
peroxo species that interacts with a threonine within the active site, preventing its 
degredation to a similar Q type intermediate [210].  MMOH-Q has been 
demonstrated to also be a reactive species, demonstrating an ability to react with a 
variety of hydrocarbon substrates [194, 211].MMOH-OX is the product of reaction 
of either MMOH-Q or MMOH-P with methane, and is also the form of the 
reconstituted apo protein with Fe(III). Regeneration of the fully reduced form from 
MMOH-OX is facilitated via electron transfer from NAD(P)H via a thioredoxin, 
although and exact mechanism has not been established.   
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6.5.2 RNR 
 
Figure 6-5:- Oxygen reductive cycle at the RNR-R2 subunit, adapted from [212]. RNR-red and RNR-
active from crystal structures 1R56 and 1RIB respectively. Terminal iron binding glutamates removed 
for clarity.  
 
The oxygen binding in RNR is thought to mimic that of the MMOH oxygen binding 
pathway, with RNR-U the intermediate generated after MMOH-P and MMOH-Q 
type intermediates have formed and decayed. While there is no direct evidence for 
this, there is indirect evidence in the form of a build up of a cis µ-1,2 peroxodiiron 
species in both the D84E [213] and W48F mutants [214]. Cleavage of the O-O bond 
to form RNR-U is thought to be a result of the electron and proton donation from 
W48. 
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RNR-U was characterised via reconstitution reactions with sub-stoichiometric 
amounts of iron, The electron provided for the conversion of RNR-U to RNR-X is 
provided by exogenous Fe(II), likely transferring directly to the W48 radical on the 
proteins surface [215]. The decoupling of the tryptophan radical from the di-iron 
centre allows for a carboxylate shift to form RNR-X, with transfer of a proton and 
electron from the neighbouring tyrosine allowing the active form of the protein to 
form. The radical formed on tyrosine is subsequently transferred via the PCET to a 
cysteine in R1 to catalyse the reaction with ribonucleotides.  The final reducing 
equivalents are provided via an NAD(P)H thioredoxin system to regenerate the 
reduced state [216], although the exact mechanism is unknown at present.  
 
A number of structural mutants of RNR which have been studied are relevant to 
AOX. The aforementioned D84E mutant led to a build-up of the cis µ-1,2 
peroxodiiron species similar to the MMOH-P intermediate. One potential for this 
buildup is the lack of co-ordination between the tyrosine and the glutamate prevents 
electron transfer towards the di-iron core.  
 
One of the more interesting mutations created was the F208Y [217]. The 
phenylalanine occupies the same special region as the tyrosine within AOX, 
conversion to tyrosine within the RNR structure generated DOPA, a meta-substituted 
oxygen onto the tyrosine species. While this is not directly analogous to AOX given 
that the RNR mutant still contained Y122, it implies that addition of the hydroxide 
moiety onto the phenylalanine leads to a definitive change in the reactivity of the 
oxygen reduction cycle in the direction of this spatial region.  
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6.5.3 Rubrerythrin 
 
Figure 6-6:- hydrogen peroxide reduction cycle for rubrerythrin, adapted from [218]. Peroxide 
initially binds to the fully reduced structure, with successive electron donation from the FeS4 
liberating two molecules of Water.  Iron binding glutamates have been removed for clarity. 
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The mechanism for oxidation of the di-iron site within rubrerythrin has been 
extremely well characterised via cryo-crystallographic time course studies upon a 
protein that is usually found active at 100°C [218]. While the mechanism studied is 
of hydrogen peroxide as opposed to oxygen, the migration of iron makes it an 
interesting case-study.  
Peroxide was shown to bind in a cis µ-1,2 fashion similar to that proposed in the 
activation of MMOH, but due to the lack of reduction remains in the diferrous state. 
The co-ordinating glutamate shown in Figure 6-6 is found in the same region as the 
tyrosine within AOX, and has been proposed as the basis for its preferential 
reactivity towards peroxides over oxygen [218]. Acidification of the peroxo species 
leads to the loss of water and ligation of the iron to the proximal glutamate. Dillard 
and colleagues do not make it clear as to whether this is the formation of a formal 
covalent bond, and therefore reduction around the carboxylate centre, or simple co-
ordination through the oxygen lone pair.   
The electron donations shown on the left hand side of the diagram are from the FeS4 
via the histidine, first forming the mixed valent Fe(III)Fe(II) species before 
regeneration of the fully reduced state. Electrons are donated to the cluster from 
NAD(P)H via a rubredoxin oxidoreductase (NROR) cofactor. 
The mechanism for oxygen reduction within rubrerythrin has not been studied in 
detail, as it is considered a side reaction for the protein. From a structural 
perspective, it is worth noting that there are two tyrosines in close proximity which 
are arranged symmetrically around the di-iron core that have not been utilised in the 
reaction with H2O2. These two tyrosines could potentially donate the two extra 
electrons required for the full reduction of oxygen. It could also be the case that only 
one of the tyrosines is used, and the second is there for redundancy purposes. Given 
the highly symmetric nature of the active site, there is no preferential driving force 
directing reaction of oxygen to either iron atom.  
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6.6 Proposed mechanism for reduction of oxygen via AOX 
 
Oxygen reactive species 
 
Parallel mode EPR has shown that the fully reduced state of plant AOX is spin 
coupled, with two high spin irons coupled via a hydroxo bridge [142] giving a g-
value of 16.4. Electrochemical FTIR studies [219] have demonstrated that this is the 
oxygen reactive species, which upon oxidation undergoes a conformational change 
around the irons resulting in the deprotonation of at least 1 iron binding carboxylates 
and the loss of ligation of at least one histidine via N-(π) to the metal centre. 
As previously discussed in section 6.4, the proposed fully reduced species of AOX 
would likely resemble that of RNR-D84E, given that ligand arrangement is the most 
similar to that of AOX and it contains the necessary features to agree with both EPR 
and FTIR data. The organisation of the ligands around the iron centre leaves one 
open ligation site on the underside of Fe1, allowing for initial reaction with oxygen 
generating a superoxo species, as has been demonstrated to be favourable in MMOH 
[207]. 
There is considerable evidence in favour of the mixed valent state that would be 
generated by the formation of a superoxo species. Upon oxidation of the fully 
reduced species of AOX1a from Arabidopsis thaliana, a mixed valent species was 
detected via EPR [139]. What sets this apart from the mixed valent species of RNR 
and MMOH is that it was found in the oxidative direction, as opposed to chemical 
reduction of Fe(III)/Fe(III) species in other di-iron systems [220, 221]. It is worth 
considering that this mixed valence species was stable enough to generate EPR data, 
and given the high reactivity of the superoxo species it would suggest that the 
terminal oxygen has been reduced in a manner that does not affect the oxidation state 
at the metal centres. The highly reactive nature of this species can be seen in the 
RNR-D84E/W48F double mutant, in which the lack of electron donation into the 
system causes hydroxylation at F208, a position which is occupied by Y220 in the 
AOX system. 
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Figure 6-7:- generation of the tyrosine radical via hydrogen atom extraction after initial binding of 
oxygen to form the superoxo species. 
 
An Fe(III)-O-O* superoxo species has been crystallised within dioxygenase, with 
bond distances of 1.99 Å (Fe-O) and 1.47 Å (O-O*) [222] . Given the Fe(1)-Tyr-O 
distance of 6 Å, (5 Å to the proton), a reactive distance of 1.5 Å allows for the 
required orbital overlap for hydrogen atom extraction as shown in Figure 6-7. 
Fe(III)O2•
- 
has also been shown to be more reactive then its Fe(IV)=O counterpart 
[223], existing in the singlet state permitting for spin allowed hydrogen atom 
abstraction. UV-Vis experiments performed by repeated reduction by ferricyanide 
and reintroduction of oxygen into the sample gave rise to a characteristic signal for a 
tyrosine radical at 410nm, similar to that found in RNR [224]. While this would 
suggest that the tyrosine radical is produced upon oxidation of the di-iron centre, it 
does not necessarily mean that it takes place this early in the mechanism and may 
well be induced further into the cycle.  
 
The newly generated Fe(III) ion would have a greater effect on the carboxylate 
ligating to both irons via a single oxygen, causing a carboxylate shift to a bidentate 
1,1 mode. This would decrease the inter-iron distance, increasing the acidity of the 
bridging OH and allow for the proton transfer onto the peroxo species. The shortened 
inter-iron distance would allow for ligation of O1 to Fe2, allowing for cleavage of 
the O-O bond, and forming a diamond core similar to that seen in MMOH. Proton 
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transfer from the ligating carboxylate into the system would allow for the generation 
of Fe-O-Fe-OH, likely to be a much more stable form of the core and analogous to 
that observed in RNR-U.  
 
One area that is interesting to consider is the apparent disconnection of the potential 
PCET at Fe1. If the generated tyrosine radical species is negatively charged as 
proposed, it is conceivable that the electronegativity presented is greater than that of 
the His-Asp-Tyrp region, causing apparent migration towards the tyrosine. For this 
to be the case the ligating OH would need to reside on Fe2 to prevent interaction 
with the tyrosine itself. It is also fully feasible from an Fe-O-Fe-OH species to 
generate the crystal structure under acidic conditions. Mechanistically this pathway 
would account for the lack of UV signals associated with the Fe(III) bridging peroxo 
species seen in MMOH-Q, given that it is not generated via this pathway.  
 
Alternative route – extraction from bridging hydroxide species. 
 
It is also feasible that a mechanism similar to that seen in MMOH is used by AOX. 
While the ligands around the active site would suggest that generation of a 1,2 
peroxo intermediate was unlikely, the fact that its generation can be seen in the RNR 
D84E mutant would suggest that it is allowable, and there is indeed circumstantial 
evidence that would support this mechanism.  
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Figure 6-8:- proposed oxygen binding reaction in [Fe2(µ -OH)2(6-Me3-TPA)2], adapted from [225]. 
Oxygen initial binds in an end-on fashion to a single iron, before abstracting an electron and proton to 
form a peroxide species.  
 
Once the superoxo has been formed a PCET similar to that seen in [Fe2(µ -OH)2(6-
Me3-TPA)2](OTf)2 [225] could occur, with the proton and electron coming instead 
from the bridging hydroxide species. What is interesting about comparisons to this 
system is the apparent correlation between concentrations; the EPR data collected by 
Berthold [139] gave a maximal concentration of the Fe(II)/Fe(III) species of 5% of 
total protein, with a value of 7% calculated for the superoxo species in the model 
system if the rearrangement is the rate limiting factor (complex 2 in Figure 6-8). 
Given that this is likely to involve the movement of carboxylate ligands within the 
protein, it is likely that this will be the rate determining step within a protein 
environment.  
Parallels to the ligation of oxygen within hemerythrin can be drawn with the PCET 
from the bridging hydroxide. Hemerythrin is one of the simplest di-iron proteins, and 
acts as an oxygen carrier by ligation of oxygen as a peroxide species ligated to 
bridging hydroxyl group[226], with no further reaction taking place. It is conceivable 
that donation of extra electron density from the PCET network would allow for the 
increased reactivity observable in the more advanced systems.  
 
1 2 
3 4 
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Figure 6-9: Mechanistic parallels to Figure 6-8, using a bridging carboxylate oxygen in lieu of a 
second bridging hydroxide species. 
 
It is also worth considering what the identity of the bridging oxygen would be in the 
case of AOX; within the fully reduced species a carboxylate can clearly be seen 
bridging via an oxygen, and while the mechanism calls for the generation of a water 
molecule as a leaving group, it is more likely that protonation of the bridging 
carboxylate will allow it to act as a pseudo leaving group, remaining bound in via the 
carbonyl oxygen (depicted in Figure 6-9). 
 
 
 
Figure 6-10: Scission of the [Fe2(μ-O)( μ O-O)] unit, adapted from [227]. 
 
The [Fe2(μ-O) ( μ O-O)] species has been demonstrated [227] to be able to undergo 
spontaneous rearrangement between an Fe(III)/Fe(III) species and Fe(IV)/Fe(IV) via 
reversible scission of the O-O bond (as shown in Figure 6-10). This reaction is 
dependent on surrounding acidity, with evidence that protonation of the bridging 
hydroxide bond increases scission rate. It is possible that the proton comes from an 
external source, such as via the water channel proposed in Chapter 3, or from a 
proximal protonated amino acid (such as the carboxylate protonated within the 
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previous step). The reaction could also be accelerated due to mechanical constraints 
on the active site; if the bridging species in the protein case is a carboxylate ligand, 
the increased energy provided by a ligand in a now unfavourable position may force 
equilibria to the Fe(IV)/Fe(IV) species.   
From this species, there are a number of ligand rearrangements that are necessary to 
reach the oxidised form seen in the crystal structure which are not available from 
model ligand systems. The bridging species would need to migrate to a more 
favoured 1,1 bridging mode, which would vacate a binding site for the terminal 
glutamic acid to switch from a monodentate to a bidentate binding mode, providing a 
proton to the active site. This carboxylate shift also has an effect upon the pKa 
values of H269; examination of the pKa values using PropKa [174] show that 
removal of the carboxylate interactions reduce the pKa from ~10.4 to 5.9, with 
rotational movement allowing for further reduction to 1.7, allowing for a reasonably 
concerted pathway for proton transfer from solvent to hisitidine, followed by 
delivery to the di-iron core at the correct time. A proton and electron are also still 
available from the tyrosine, although attempting to facilitate transfer without the 
length provided by the peroxo unit would prove difficult unless the transfer occurs 
via one of the carboxylate ligands.  
 
6.7 Reductive direction from crystal structure 
 
Reduction with Quinol 
Given the generation of water as part of the catalytic cycle, and evidence of the 
interaction between water and quinol in the cytochrome bc1 complex [228], there is 
also the possibility that the transfer of protons is mediated by water generation prior 
to quinol acceptance into the active site.  
 
129 | P a g e  
 
 
Figure 6-11:- electrochemical studies adapted from [219]. Redox potentials in both oxidative and 
reductive direction quoted for signal 1, with signal 2 operating under standard reversible redox 
conditions.  
 
Electrochemical work performed by Maréchal et.al. [219] gives insight into the 
reduction steps of the fully oxidised species and is shown in Figure 6-11. Under the 
assumption that the two 2 electron transfer steps would correlate to two quinols, this 
gives two distinct intermediates that would react with quinol sequentially rather than 
necessitating two quinol binding sites for concurrent reactivity. The FTIR work from 
the paper also gave indications as to ligation sphere modifications upon reduction, 
with signal 1 indicating a protonation of one carboxylate ligand and the ligation of 
iron to histidine.  
It is tempting to speculate that quenching of the tyrosyl radical would explain the 
electrochemical work performed. The high voltage necessary to reoxidise signal I 
(<500mM) coupled with the low midpoint potential in the reductive direction would 
be within the remit of tyrosine radical generation at pH7 (~750mV [229]). Use of the 
tyrosine radical would also be advantageous with respect to oxidation of the quinol, 
as generation of the QH* species would allow for energetically favourable 
decomposition of the semiquinone species to quinone with a much lower redox 
potential then via other oxidative pathways. Use of the tyrosine as an effective 
activator would also compensate for the lack of polar amino acids within the site, 
effectively allowing direct reduction at the iron site. Quenching of the tyrosyl radical 
would also rationalise the ligation of histidine seen in signal 1; if the previous 
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assumption that iron migration is caused by spin coupling between the iron and the 
tyrosine radical is correct, then quenching of the radical would decouple the spin and 
allow for ligation of histidine within the active site.   
One of the interesting questions would be whether the crystal structure is the primary 
quinol reactive species, or whether it is a stable degradation product of a more 
reactive core. The FTIR studies suggest that the fully oxidised core is able to 
decompose over time to form “signal 1”, but given that this could still be reduced via 
electrochemical means it suggests that the sources of electrons and protons are from 
an internal source/solvent that can be regenerated. The instability of the primary 
reactive core can be seen in MMO, where MMO-P will decompose to MMO-Q upon 
lack of substrate.  
Without a structure of the semi-reduced species, any predictions for the reactivity of 
the second equivalent of quinol would be speculative at best. Given that the initial 2 
electron reduction involves a movement of iron and protonation of a carboxylate, the 
large overall shift in ligand location could open up a second binding site that is 
impossible to predict. It is fully possible that the second binding cavity discussed in 
Chapter 3 is opened up, and if this is indeed accompanied by a roll on helix 1 then it 
may open additional options for reactivity. It is of course fully possible that the 
second equivalent uses the same tyrosine, with the iron migration opening room 
within the active site to allow for hydrogen abstraction by the iron to initiate the 
reaction with quinol. 
 
Figure 6-12:- potential quinol reduction mechanism based on the docked quinol species. Proton 
translocation towards the solvent facilitated via R96 and D100, with the second proton entering the di-
iron active site, with a potential final resting place between E123 and Y220.  Electrons transferred to 
the di-iron core and tyrosine respectively.  
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Using the docking of quinol from Chapter 3 as a model system, it would suggest that 
the reaction with quinol would only facilitate the transfer of 1 proton towards the 
iron core, with the proton likely being transferred to solvent via R118, D100 and 
R96, with schematic representation shown in Figure 6-12. If this is the case for both 
molecules of quinol, then there must be an outside source of protons that would 
balance the reaction stoichiometry. The water channels highlighted in Chapter 3 
could facilitate the proton transfer, with the PCET network solvent accessible could 
potentially allow for a tryptophan radical quench to be separated from its 
reprotonation. Only additional experimentation will determine whether these protons 
are used during the oxygen reduction or quinol oxidation part of the cycle.  
 
6.8 Summary 
 
A number of oxidative pathways have been proposed based on other di-iron proteins 
that have been studied extensively by other groups. While they are presented as 
separate mechanisms, they share a number of intermediates and it is likely that the 
true oxidative pathway is a combination of the two.  
The use of the PCET network has also not been used within the mechanism, as I 
believe that this is used to mediate the oxidative burst upon the single electron 
binding of oxygen, and that while the oxidation states of the metals have been stated 
to change, in actuality it is likely that the increase in oxidation state is buffered by 
the use of a tryptophan radical via this network. There is also the potential for a 
second transfer event from W65, which could explain the generation of a resting 
state from the fully oxidised form that was seen in [219]. If a proton is transferred 
from this region, the proximity to solvent could potentially allow it to be quenched 
without need for a “return trip” from the di-iron core.  
A number of experiments could be performed to clarify the oxidative pathway of 
AOX. Stop flow spectrometry has revealed a number of salient features of the 
MMOH-P and RNR intermediates, and while AOX has no known UV-VIS features, 
use of the stop flow would shed light on whether oxidation goes via a P-type 
intermediate or via another pathway. It would also be interesting to determine 
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exactly how early in the oxidative cycle the tyrosine radical is formed, and whether a 
tryptophan radical is indeed generated. 
The reductive pathway has also been given some consideration, but given the 
unpredictable nature of quinols and the transient nature of the active site upon 
reduction a full mechanistic prediction is impossible at this time. Docking studies 
that have been performed would suggest a non-concerted mechanism would take 
place, with 2 electrons and 1 proton being used by the protein per quinol molecule, 
with the remaining proton being transferred to solvent. If this is the case, then the 
oxygen reduction part of the cycle should demonstrate a dependency upon solvent 
acidity, as protons must be supplied during this part of the cycle to satisfy the 
reaction stoichiometry.  
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7 Summary 
The work presented within Chapter 3 is a reasonable starting point for the 
examination of key residues within AOX and their potential functions within the 
protein. What was clear is that a considerable number of the fully conserved residues 
are for structural purposes but may also offer a dual role that will be difficult to 
probe solely using site directed mutagenesis based techniques. One region not fully 
explored is the nature of residues that are conserved within family groups, i.e. amino 
acids that are fully conserved solely across the plant species, but lack conservation 
within the trypanosomal or fungal variants. Examination of these residues may well 
give more insight into regions that are responsible for allosteric activation, 
specifically with respect to pyruvate activation within the plant AOX. Another 
comparison not fully drawn was contrasting AOX to its other di-iron ancestors, 
especially with respect to the PCET network. Given this region is responsible for 
transferring electrons from the di-iron core in RNR [199] and towards the di-iron 
core from an FeS4  cluster in RBR [218],this may shed light on the nature of the 
network, allowing us to discern whether it has a genuine function within the protein, 
or an ancestral artefact that is not detrimental to the overall catalytic cycle. 
While the catalytic cycle proposed within Chapter 6 has a scientific grounding within 
the current evidence available for AOX, there are a number of available pathways for 
the initial oxygen binding and cleavage that it is impossible to determine between 
with the currently accumulated data. One of the major problems that needs to be 
addressed with purified AOX is its lack of solubility above 5 mg ml
-1
. This makes 
the use of analytical techniques such as stop flow and EPR unreliable due to the low 
concentration of sample. Given the transient nature of the tryptophan based radical 
within RNR [205], stop flow techniques would be necessary to confirm that the 
PCET network is part of the regular pathway.  
There is also a distinct possibility that the correct pathway cannot be determined 
without the use of computational methods. Given the distinct differences between 
sMMOH and ToMOH [210] that were caused by a change as subtle as adding a polar 
contact into the active site, the difference in positions of the tyrosine between RNR 
and AOX could potentially alter the reaction mechanism more than has been 
predicted within this thesis. Further mutagenesis studies within the pocket would 
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allow for dissemination as to whether the main determinant on altered reactivity is 
due to the position of the tyrosine, the use of an iron binding aspartic acid as opposed 
to a glutatmic acid, or a subtle combination of the two. It is fully plausible that the 
tyrosine position within AOX is to allow for improved reaction kinetics with respect 
to quinol, which has been taken into account with the initiation of reactivity between 
substrate and protein being due to a tyrosine based radical.  
The analysis from Chapter 3 also allows for the development of a better class of 
inhibitors for AOX. Given that there is full conservation within the quinol binding 
pocket of the polar residues, namely R96, R118, T219,Y220 (TAO numbering), a 
scaffold can be designed that would fit within these residues, but would not 
necessarily interact within the cytochrome bc1 Qi or Qo sites to allow for increased 
specificity over that demonstrated with colletochlorin B. Mutagenesis studies 
presented within this thesis and in the literature [138, 145, 230] have demonstrated 
that the aforementioned residues are critical for continued turnover of the protein, 
therefore making resistance due to a single point mutation of these residues an 
unlikely outcome. 
The differences determined within Chapter 5 in inhibition of the cytochrome bc1 
complex with respect to ascofuranone and colletochlorin B, presumably due to 
unfavourable interactions between the furanone moiety and the binding pocket, open 
up the possibility that altering functionality of the tail would improve specificity of 
the compound. The ability to design a suitably functionalised tail for this purpose 
while still remaining cost effective would likely require a different synthetic route 
that would allow for an increased yield for the alkylation step. While work is 
available within the literature as to the affects of tail functionality on inhibition of 
TAO [115], the same compounds were not tested against the cytochrome bc1 
complex, and may well improve specificity.  
A second route that could be utilised for specific inhibitor design could be taken 
from the catalytic cycle itself. Given the high likelihood of a tyrosine radical within 
the binding pocket, the addition of a radical leaving group onto the compound could 
potentially allow for the design of a suicide inhibitor that would permanently reside 
within the active site. This would also prove advantageous with respect to 
specificity; given that current predictions for the quinol reaction mechanism within 
135 | P a g e  
 
the Qo site suggest that removal of protons and electrons occur as separate events, 
rather than the hydrogen atom extraction that has been postulated here.  
 
  
136 | P a g e  
 
8 References 
1. Nicholls, D.G. and S.J. Ferguson, Bioenergetics 4. [Fourth edition] ed. 2013. 
xiv, 419 pages. 
2. Kim, B.H., Bacterial physiology and metabolism. 2007, Cambridge: 
Cambridge University Press. xxii, 529 p. 
3. Rich, P.R., The molecular machinery of Keilin's respiratory chain. Biochem 
Soc Trans, 2003. 31(Pt 6): p. 1095-105. 
4. Porter, R.K. and M.D. Brand, Mitochondrial Proton Conductance and H+/O 
Ratio Are Independent of Electron-Transport Rate in Isolated Hepatocytes. 
Biochemical Journal, 1995. 310: p. 379-382. 
5. Mitchell, P., Coupling of phosphorylation to electron and hydrogen transfer 
by a chemi-osmotic type of mechanism. Nature, 1961. 191: p. 144-8. 
6. Efremov, R.G., R. Baradaran, and L.A. Sazanov, The architecture of 
respiratory complex I. Nature, 2010. 465(7297): p. 441-U61. 
7. Ren, A.M., K.R. Rajashankar, and D.J. Patel, Fluoride ion encapsulation by 
Mg2+ ions and phosphates in a fluoride riboswitch. Nature, 2012. 
486(7401): p. 85-U1501. 
8. Zhang, Z.L., et al., Electron transfer by domain movement in cytochrome 
bc(1). Nature, 1998. 392(6677): p. 677-684. 
9. Yoshikawa, S., et al., Redox-coupled crystal structural changes in bovine 
heart cytochrome c oxidase. Science, 1998. 280(5370): p. 1723-1729. 
10. Iwata, M., et al., The structure of the yeast NADH dehydrogenase (Ndi1) 
reveals overlapping binding sites for water- and lipid-soluble substrates. 
Proceedings of the National Academy of Sciences of the United States of 
America, 2012. 109(38): p. 15247-15252. 
11. Shiba, T., et al., Structure of the trypanosome cyanide-insensitive alternative 
oxidase. Proceedings of the National Academy of Sciences of the United 
States of America, 2013. 110(12): p. 4580-5. 
12. Rastogi, V.K. and M.E. Girvin, Structural changes linked to proton 
translocation by subunit c of the ATP synthase. Nature, 1999. 402(6759): p. 
263-268. 
13. Gibbons, C., et al., The structure of the central stalk in bovine F-1-ATPase at 
2.4 angstrom resolution. Nature Structural Biology, 2000. 7(11): p. 1055-
1061. 
14. Wilkens, S., et al., Structural characterization of the interaction of the delta 
and alpha subunits of the Escherichia coli F1F0-ATP synthase by NMR 
spectroscopy. Biochemistry, 2005. 44(35): p. 11786-11794. 
15. Moore, A.L., et al., Unraveling the heater: new insights into the structure of 
the alternative oxidase. Annu Rev Plant Biol, 2013. 64: p. 637-63. 
16. Brandt, U., A two-state stabilization-change mechanism for proton-pumping 
complex I. Biochim Biophys Acta, 2011. 1807(10): p. 1364-9. 
17. Efremov, R.G. and L.A. Sazanov, Structure of the membrane domain of 
respiratory complex I. Nature, 2011. 476(7361): p. 414-U62. 
18. Brandt, U., Energy converting NADH:quinone oxidoreductase (complex I). 
Annu Rev Biochem, 2006. 75: p. 69-92. 
19. Sazanov, L.A. and P. Hinchliffe, Structure of the hydrophilic domain of 
respiratory complex I from Thermus thermophilus. Science, 2006. 311(5766): 
p. 1430-6. 
137 | P a g e  
 
20. Sazanov, L.A., Respiratory complex I: mechanistic and structural insights 
provided by the crystal structure of the hydrophilic domain. Biochemistry, 
2007. 46(9): p. 2275-88. 
21. Hirst, J., Towards the molecular mechanism of respiratory complex I. 
Biochemical Journal, 2010. 425: p. 327-339. 
22. Iverson, T.M., Catalytic mechanisms of complex II enzymes: A structural 
perspective. Biochim Biophys Acta, 2013. 1827(5): p. 648-57. 
23. Crofts, A.R., et al., Mechanism of ubiquinol oxidation by the bc(1) complex: 
Different domains of the quinol binding pocket and their role in the 
mechanism and binding of inhibitors. Biochemistry, 1999. 38(48): p. 15807-
15826. 
24. Crofts, A.R., The cytochrome bc(1) complex: Function in the context of 
structure. Annual Review of Physiology, 2004. 66: p. 689-733. 
25. Cooley, J.W., A structural model for across membrane coupling between the 
Q(o) and Q(l) active sites of cytochrome bc(1). Biochimica Et Biophysica 
Acta-Bioenergetics, 2010. 1797(12): p. 1842-1848. 
26. Swierczek, M., et al., An Electronic Bus Bar Lies in the Core of Cytochrome 
bc(1). Science, 2010. 329(5990): p. 451-454. 
27. Gorbikova, E.A., M. Wikstrom, and M.I. Verkhovsky, The protonation state 
of the cross-linked tyrosine during the catalytic cycle of cytochrome c 
oxidase. Journal of Biological Chemistry, 2008. 283(50): p. 34907-12. 
28. Gorbikova, E.A., et al., The proton donor for O-O bond scission by 
cytochrome c oxidase. Proceedings of the National Academy of Sciences of 
the United States of America, 2008. 105(31): p. 10733-7. 
29. Kaila, V.R.I., M.I. Verkhovsky, and M. Wikstrom, Proton-Coupled Electron 
Transfer in Cytochrome Oxidase. Chemical Reviews, 2010. 110(12): p. 
7062-7081. 
30. James, W.O. and D.C. Elliott, Cyanide-Resistant Mitochondria from the 
Spadix of an Arum. Nature, 1955. 175(4445): p. 89-89. 
31. Millar, A.H. and D.A. Day, Nitric oxide inhibits the cytochrome oxidase but 
not the alternative oxidase of plant mitochondria. Febs Letters, 1996. 398(2-
3): p. 155-158. 
32. Rich, P.R. and A.L. Moore, The involvement of the protonmotive ubiquinone 
cycle in the respiratory chain of higher plants and its relation to the 
branchpoint of the alternate pathway. Febs Letters, 1976. 65(3): p. 339-44. 
33. Storey, B.T., Respiratory Chain of Plant Mitochondria: XVIII. Point of 
Interaction of the Alternate Oxidase with the Respiratory Chain. Plant 
Physiology, 1976. 58(4): p. 521-5. 
34. Huq, S. and J.M. Palmer, Superoxide and Hydrogen-Peroxide Production in 
Cyanide Resistant Arum-Maculatum Mitochondria. Plant Science Letters, 
1978. 11(3-4): p. 351-358. 
35. Moore, A.L., W.D. Bonner, and P.R. Rich, Determination of Proton-Motive 
Force during Cyanide-Insensitive Respiration in Plant-Mitochondria. 
Archives of Biochemistry and Biophysics, 1978. 186(2): p. 298-306. 
36. Douce, R., C.A. Mannella, and W.D. Bonner, Jr., The external NADH 
dehydrogenases of intact plant mitochondria. Biochim Biophys Acta, 1973. 
292(1): p. 105-16. 
37. Eubel, H., L. Jansch, and H.P. Braun, New insights into the respiratory chain 
of plant mitochondria. Supercomplexes and a unique composition of complex 
II. Plant Physiology, 2003. 133(1): p. 274-286. 
138 | P a g e  
 
38. Sunderhaus, S., et al., Supramolecular structure of the OXPHOS system in 
highly thermogenic tissue of Arum maculatum. Plant Physiology and 
Biochemistry, 2010. 48(4): p. 265-272. 
39. Kakizaki, Y., A.L. Moore, and K. Ito, Different molecular bases underlie the 
mitochondrial respiratory activity in the homoeothermic spadices of 
Symplocarpus renifolius and the transiently thermogenic appendices of Arum 
maculatum. Biochemical Journal, 2012. 445: p. 237-246. 
40. Vanlerberghe, G.C., Alternative Oxidase: A Mitochondrial Respiratory 
Pathway to Maintain Metabolic and Signaling Homeostasis during Abiotic 
and Biotic Stress in Plants. Int J Mol Sci, 2013. 14(4): p. 6805-47. 
41. Millar, A.H., et al., Organization and Regulation of Mitochondrial 
Respiration in Plants. Annual Review of Plant Biology, 2011. 62: p. 79-104. 
42. McDonald, A.E., S.M. Sieger, and G.C. Vanlerberghe, Methods and 
approaches to study plant mitochondrial alternative oxidase. Physiol Plant, 
2002. 116(2): p. 135-143. 
43. Meeuse, B.J.D., Thermogenic respiration in aroids. Annu Rev Plant physio, 
1975. 26: p. 117-126. 
44. Seymour, R.S., M. Gibernau, and K. Ito, Thermogenesis and respiration of 
inflorescences of the dead horse arum Helicodiceros muscivorus, a pseudo-
thermoregulatory aroid associated with fly pollination. Functional Ecology, 
2003. 17(6): p. 886-894. 
45. Seymour, R.S., Scaling of heat production by thermogenic flowers: limits to 
floral size and maximum rate of respiration. Plant Cell Environ, 2010. 33(9): 
p. 1474-85. 
46. Miller, R.E., et al., In the heat of the night - alternative pathway respiration 
drives thermogenesis in Philodendron bipinnatifidum. New Phytologist, 
2011. 189(4): p. 1013-1026. 
47. Grant, N.M., et al., Synchronicity of thermogenic activity, alternative 
pathway respiratory flux, AOX protein content, and carbohydrates in 
receptacle tissues of sacred lotus during floral development. J Exp Bot, 2008. 
59(3): p. 705-14. 
48. Affourtit, C., et al., Functional expression of the plant alternative oxidase 
affects growth of the yeast Schizosaccharomyces pombe. Journal of 
Biological Chemistry, 1999. 274(10): p. 6212-6218. 
49. Moore, A.L., et al., Function of the alternative oxidase: is it still a 
scavenger? Trends in Plant Science, 2002. 7(11): p. 478-481. 
50. Kaneko, I. and H. Ishii, Effect of azoxystrobin on activities of antioxidant 
enzymes and alternative oxidase in wheat head blight pathogens Fusarium 
graminearum and Microdochium nivale. Journal of General Plant Pathology, 
2009. 75(5): p. 388-398. 
51. Hiser, C. and L. McIntosh, Alternative Oxidase of Potato Is an Integral 
Membrane Protein Synthesized de Novo during Aging of Tuber Slices. Plant 
Physiology, 1990. 93(1): p. 312-8. 
52. Murphy, M.P., How mitochondria produce reactive oxygen species. 
Biochemical Journal, 2009. 417: p. 1-13. 
53. Harman, D., The biologic clock: the mitochondria? J Am Geriatr Soc, 1972. 
20(4): p. 145-7. 
54. Hirst, J., M.S. King, and K.R. Pryde, The production of reactive oxygen 
species by complex I. Biochemical Society Transactions, 2008. 36: p. 976-
980. 
139 | P a g e  
 
55. Adam-Vizi, V. and C. Chinopoulos, Bioenergetics and the formation of 
mitochondrial reactive oxygen species. Trends in Pharmacological Sciences, 
2006. 27(12): p. 639-645. 
56. Kudin, A.P., et al., Characterization of superoxide-producing sites in isolated 
brain mitochondria. Journal of Biological Chemistry, 2004. 279(6): p. 4127-
4135. 
57. Votyakova, T.V. and I.J. Reynolds, Delta psi(m)-dependent and -independent 
production of reactive oxygen species by rat brain mitochondria. Journal of 
Neurochemistry, 2001. 79(2): p. 266-277. 
58. Cadenas, E., et al., Production of Superoxide Radicals and Hydrogen-
Peroxide by Nadh-Ubiquinone Reductase and Ubiquinol-Cytochrome C 
Reductase from Beef-Heart Mitochondria. Archives of Biochemistry and 
Biophysics, 1977. 180(2): p. 248-257. 
59. Maxwell, D.P., Y. Wang, and L. McIntosh, The alternative oxidase lowers 
mitochondrial reactive oxygen production in plant cells. Proceedings of the 
National Academy of Sciences of the United States of America, 1999. 
96(14): p. 8271-6. 
60. Day, D.A., et al., Regulation of Alternative Pathway Activity in Plant-
Mitochondria - Deviations from Q-Pool Behavior during Oxidation of Nadh 
and Quinols. Plant Physiology, 1991. 95(3): p. 948-953. 
61. Dry, I.B., et al., Regulation of Alternative Pathway Activity in Plant-
Mitochondria - Nonlinear Relationship between Electron Flux and the Redox 
Poise of the Quinone Pool. Archives of Biochemistry and Biophysics, 1989. 
273(1): p. 148-157. 
62. Raha, S. and B.H. Robinson, Mitochondria, oxygen free radicals, disease and 
ageing. Trends Biochem Sci, 2000. 25(10): p. 502-8. 
63. Gupta, K.J., A. Zabalza, and J.T. van Dongen, Regulation of respiration 
when the oxygen availability changes. Physiologia Plantarum, 2009. 137(4): 
p. 383-391. 
64. Ribas-Carbo, M., et al., The Reaction of the Plant Mitochondrial Cyanide-
Resistant Alternative Oxidase with Oxygen. Biochimica Et Biophysica Acta-
Bioenergetics, 1994. 1188(3): p. 205-212. 
65. Millar, A.H., F.J. Bergersen, and D.A. Day, Oxygen-Affinity of Terminal 
Oxidases in Soybean Mitochondria. Plant Physiology and Biochemistry, 
1994. 32(6): p. 847-852. 
66. Weisiger, R.A. and I. Fridovich, Superoxide dismutase. Organelle specificity. 
Journal of Biological Chemistry, 1973. 248(10): p. 3582-92. 
67. Wagner, A.M. and A.L. Moore, Structure and function of the plant 
alternative oxidase: Its putative role in the oxygen defence mechanism. 
Bioscience Reports, 1997. 17(3): p. 319-333. 
68. Popov, V.N., et al., Inhibition of the alternative oxidase stimulates H2O2 
production in plant mitochondria. Febs Letters, 1997. 415(1): p. 87-90. 
69. Millar, A.H., et al., Organic acid activation of the alternative oxidase of 
plant mitochondria. Febs Letters, 1993. 329(3): p. 259-62. 
70. Hoefnagel, M.H.N., et al., Substrate kinetics of the plant mitochondrial 
alternative oxidase and the effects of pyruvate. Plant Physiology, 1997. 
115(3): p. 1145-1153. 
71. Feasey, N., Wansbrough-Jones,M., Mabey, D.C.W., Solomon A.W., 
Neglected tropical diseases. Br. Med. Bull., 2010. 93: p. 179-200. 
140 | P a g e  
 
72.  Fact sheet N°259: Trypanosomiasis, Human African (sleeping sickness), in 
WHO Media centre. 2012. 
73. Vickerman, K., Developmental cycles and biology of pathogenic 
trypanosomes. Br Med Bull, 1985. 41(2): p. 105-14. 
74. Nok, A.J., Arsenicals (melarsoprol), pentamidine and suramin in the 
treatment of human African trypanosomiasis. Parasitology Research, 2003. 
90(1): p. 71-9. 
75. Barrett, M.P., Problems for the chemotherapy of human African 
trypanosomiasis. Curr Opin Infect Dis, 2000. 13(6): p. 647-651. 
76. Milord, F., et al., Efficacy and toxicity of eflornithine for treatment of 
Trypanosoma brucei gambiense sleeping sickness. Lancet, 1992. 340(8820): 
p. 652-5. 
77. Mccann, P.P. and A.E. Pegg, Ornithine Decarboxylase as an Enzyme Target 
for Therapy. Pharmacology & Therapeutics, 1992. 54(2): p. 195-215. 
78. Burri, C., et al., Efficacy of new, concise schedule for melarsoprol in 
treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a 
randomised trial. Lancet, 2000. 355(9213): p. 1419-25. 
79. Priotto, G., et al., Nifurtimox-eflornithine combination therapy for second-
stage African Trypanosoma brucei gambiense trypanosomiasis: a 
multicentre, randomised, phase III, non-inferiority trial. Lancet, 2009. 
374(9683): p. 56-64. 
80. Grant, P.T., J.R. Sargent, and J.F. Ryley, Respiratory systems in the 
Trypanosomidae. Biochem J, 1961. 81: p. 200-6. 
81. Bienen, E.J., et al., Non-cytochrome mediated mitochondrial ATP production 
in bloodstream form Trypanosoma brucei brucei. Eur J Biochem, 1993. 
216(1): p. 75-80. 
82. Clarkson, A.B., Jr., et al., Respiration of bloodstream forms of the parasite 
Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. 
Journal of Biological Chemistry, 1989. 264(30): p. 17770-6. 
83. Nihei, C., Y. Fukai, and K. Kita, Trypanosome alternative oxidase as a target 
of chemotherapy. Biochimica Et Biophysica Acta-Molecular Basis of 
Disease, 2002. 1587(2-3): p. 234-239. 
84. Berthold, D.A., Isolation of mutants of the Arabidopsis thaliana alternative 
oxidase (ubiquinol : oxygen oxidoreductase) resistant to salicylhydroxamic 
acid. Biochimica Et Biophysica Acta-Bioenergetics, 1998. 1364(1): p. 73-83. 
85. Kay, C.J. and J.M. Palmer, Solubilization of the Alternative Oxidase of 
Cuckoo-Pint (Arum-Maculatum) Mitochondria - Stimulation by High-
Concentrations of Ions and Effects of Specific Inhibitors. Biochemical 
Journal, 1985. 228(2): p. 309-318. 
86. Schonbau.Gr, et al., Specific Inhibition of Cyanide-Insensitive Respiratory 
Pathway in Plant Mitochondria by Hydroxamic Acids. Plant Physiology, 
1971. 47(1): p. 124-&. 
87. Rich, P.R., et al., Studies on Mechanism of Inhibition of Redox Enzymes by 
Substituted Hydroxamic Acids. Biochimica Et Biophysica Acta, 1978. 
525(2): p. 325-337. 
88. Opperdoes, F.R., et al., Trypanosoma brucei: an evaluation of 
salicylhydroxamic acid as a trypanocidal drug. Exp Parasitol, 1976. 40(2): p. 
198-205. 
141 | P a g e  
 
89. Vandermeer, C., et al., Pitfalls of Salicylhydroxamic Acid Plus Glycerol 
Treatment of T-Vivax Infected Goats. Tropenmedizin Und Parasitologie, 
1980. 31(3): p. 275-282. 
90. Evans, D.A., C.J. Brightman, and M.F. Holland, Salicylhydroxamic-
acid/glycerol in experimental trypanosomiasis. Lancet, 1977. 2(8041): p. 
769. 
91. Van Der Meer, C. and J.A. Versluijs-Broers, Trypanosoma brucei: 
trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats. 
Exp Parasitol, 1979. 48(1): p. 126-34. 
92. Clarkson, A.B., et al., Trypanosoma-Brucei-Brucei - a Systematic Screening 
for Alternatives to the Salicylhydroxamic Acid Glycerol Combination. 
Molecular and Biochemical Parasitology, 1981. 3(5): p. 271-291. 
93. Grady, R.W., E.J. Bienen, and A.B. Clarkson, P-Alkyloxybenzhydroxamic 
Acids, Effective Inhibitors of the Trypanosome Glycerol-3-Phosphate 
Oxidase. Molecular and Biochemical Parasitology, 1986. 19(3): p. 231-240. 
94. Grady, R.W., E.J. Bienen, and A.B. Clarkson, Jr., Esters of 3,4-
dihydroxybenzoic acid, highly effective inhibitors of the sn-glycerol-3-
phosphate oxidase of Trypanosoma brucei brucei. Molecular and 
Biochemical Parasitology, 1986. 21(1): p. 55-63. 
95. Grady, R.W., et al., N-n-alkyl-3,4-dihydroxybenzamides as inhibitors of the 
trypanosome alternative oxidase: activity in vitro and in vivo. Antimicrob 
Agents Chemother, 1993. 37(5): p. 1082-5. 
96. Pollakis, G., et al., Competition between Inhibitors of the Trypanosome 
Alternative Oxidase (Tao) and Reduced Coenzyme Q(9). Biochemical 
Pharmacology, 1995. 50(8): p. 1207-1210. 
97. Ott, R., et al., Novel inhibitors of the trypanosome alternative oxidase inhibit 
Trypanosoma brucei brucei growth and respiration. Acta Tropica, 2006. 
100(3): p. 172-184. 
98. Janes, H.W. and S.C. Wiest, Inhibition of O2 Consumption Resistant to 
Cyanide and Its Development by N-Propyl Gallate and Salicylhydroxamic 
Acid. Plant Physiology, 1982. 70(3): p. 853-857. 
99. Siedow, J.N. and D.M. Bickett, Structural features required for inhibition of 
cyanide-insensitive electron transfer by propyl gallate. Arch Biochem 
Biophys, 1981. 207(1): p. 32-9. 
100. Sasaki, H., et al., Ascofuranone, a New Antibiotic from Ascochyta-Viciae. 
Tetrahedron Letters, 1972(25): p. 2541-&. 
101. Sasaki, H., et al., Isolation and Structure of Ascofuranone and Ascofranol, 
Antibiotics with Hypolipidemic Activity. Journal of Antibiotics, 1973. 26(11): 
p. 676-680. 
102. Sawada, M., et al., Hypolipidemic Property of Ascofuranone. Journal of 
Antibiotics, 1973. 26(11): p. 681-686. 
103. Hosokawa, T., et al., Alteration of Cholesterol-Metabolism by 4-0-
Methylascochlorin in Rats. Lipids, 1981. 16(6): p. 433-438. 
104. Magae, J., et al., Antitumor protective property of an isoprenoid antibiotic, 
ascofuranone. J Antibiot (Tokyo), 1982. 35(11): p. 1547-52. 
105. Magae, J., et al., Antitumor and Antimetastatic Activity of an Antibiotic, 
Ascofuranone, and Activation of Phagocytes. Journal of Antibiotics, 1988. 
41(7): p. 959-965. 
142 | P a g e  
 
106. Hosokawa, T., K. Ando, and G. Tamura, An Ascochlorin Derivative, as-6, 
Reduces Insulin Resistance in the Genetically-Obese Diabetic Mouse, Db Db. 
Diabetes, 1985. 34(3): p. 267-274. 
107. Hosokawa, T., K. Ando, and G. Tamura, Structural and Functional 
Abnormalities in the Adipocyte Plasma-Membrane from Db/Db Mouse, and 
the Effect on the Abnormalities of Oral Treatment with as-6. Biochemical 
and Biophysical Research Communications, 1984. 125(1): p. 64-69. 
108. Coleman, J.J., et al., Antifungal Activity of Microbial Secondary Metabolites. 
Plos One, 2011. 6(9). 
109. Kawaguchi, M., et al., A new ascochlorin derivative from Cylindrocarpon sp. 
FKI-4602. J Antibiot (Tokyo), 2013. 66(1): p. 23-9. 
110. Minagawa, N., et al., An antibiotic, ascofuranone, specifically inhibits 
respiration and in vitro growth of long slender bloodstream forms of 
Trypanosoma brucei brucei. Molecular and Biochemical Parasitology, 1996. 
81(2): p. 127-136. 
111. Yabu, Y., et al., Chemotherapeutic efficacy of ascofuranone in Trypanosoma 
vivax-infected mice without glycerol. Parasitology International, 2006. 55(1): 
p. 39-43. 
112. Yabu, Y., Oral and intraperitoneal treatment of Trypanosoma brucei brucei 
with a combination of ascofuranone and glyercol in mice. Parasitology 
International, 1998. 47: p. 131-137. 
113. Berry, E.A., et al., Ascochlorin is a novel, specific inhibitor of the 
mitochondrial cytochrome bc1 complex. Biochim Biophys Acta, 2010. 
1797(3): p. 360-70. 
114. Mogi, T., et al., Antibiotics LL-Z1272 identified as novel inhibitors 
discriminating bacterial and mitochondrial quinol oxidases. Biochim 
Biophys Acta, 2009. 1787(2): p. 129-33. 
115. Saimoto, H., et al., Pharmacophore identification of ascofuranone, potent 
inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei. 
Journal of Biochemistry, 2013. 153(3): p. 267-273. 
116. Joullie, M., A simple total synthesis of (+-)-ascofuranone. Tetrahedron 
Letters, 1984. 25(35): p. 3795-3796. 
117. Guthrie, A.E., J.E. Semple, and M.M. Joullie, Synthetic Studies of Fungal 
Metabolites - Ascofuranone and Colletochlorin-D. Journal of Organic 
Chemistry, 1982. 47(12): p. 2369-2376. 
118. Mori, K. and T. Fujioka, Synthetic Microbial Chemistry .4. Synthesis of (+/-)-
Ascochlorin, (+/-)-Ascofuranone and Ll-Z1272-Alpha. Tetrahedron, 1984. 
40(14): p. 2711-2720. 
119. Mori, K. and S. Takechi, Synthetic Microbial Chemistry .10. Synthesis of the 
Natural Enantiomers of Ascochlorin, Ascofuranone and Ascofuranol. 
Tetrahedron, 1985. 41(15): p. 3049-3062. 
120. Saimoto, H., Y. Kusano, and T. Hiyama, A Mild Procedure for Hydrolysis of 
Alkoxymethyl Aryl Ethers to Give Hydroxyarenes - a Rational Synthesis of 
Ascofuranone. Tetrahedron Letters, 1986. 27(14): p. 1607-1610. 
121. Saimoto, H. and T. Hiyama, A General Highly Efficient Access to Prenylated 
Phenolic Natural-Products - Synthesis of Colletochlorin-B and 
Colletochlorin-D. Tetrahedron Letters, 1986. 27(5): p. 597-600. 
122. Saimoto, H., et al., A General-Approach for the Synthesis of Phenolic 
Natural-Products - Facile Syntheses of Grifolin and Colletochlorin-B and 
143 | P a g e  
 
Colletochlorin-D. Bulletin of the Chemical Society of Japan, 1994. 67(4): p. 
1178-1185. 
123. Ziogas, B.N., B.C. Baldwin, and J.E. Young, Alternative respiration: A 
biochemical mechanism of resistance to azoxystrobin (ICIA 5504) in Septoria 
tritici. Pesticide Science, 1997. 50(1): p. 28-34. 
124. Clough, J.M., The Strobilurins, Oudemansins, and Myxothiazols, Fungicidal 
Derivatives of Beta-Methoxyacrylic Acid. Natural Product Reports, 1993. 
10(6): p. 565-574. 
125. Huh, W.K. and S.O. Kang, Characterization of the gene family encoding 
alternative oxidase from Candida albicans. Biochemical Journal, 2001. 356: 
p. 595-604. 
126. Minagawa, N. and A. Yoshimoto, The induction of cyanide-resistant 
respiration in Hansenula anomala. J Biochem, 1987. 101(5): p. 1141-6. 
127. Lambowit.Am and C.W. Slayman, Cyanide-Resistant Respiration in 
Neurospora-Crassa. Journal of Bacteriology, 1971. 108(3): p. 1087-&. 
128. Murphy, A.D. and N. Lang-Unnasch, Alternative oxidase inhibitors 
potentiate the activity of atovaquone against Plasmodium falciparum. 
Antimicrobial Agents and Chemotherapy, 1999. 43(3): p. 651-654. 
129. Avila-Adame, C. and W. Koller, Disruption of the alternative oxidase gene 
in Magnaporthe grisea and its impact on host infection. Molecular Plant-
Microbe Interactions, 2002. 15(5): p. 493-500. 
130. Wood, P.M. and D.W. Hollomon, A critical evaluation of the role of 
alternative oxidase in the performance of strobilurin and related fungicides 
acting at the Q(o) site of Complex III. Pest Management Science, 2003. 
59(5): p. 499-511. 
131. Vincelli, P. and E. Dixon, Resistance to Q(o)I (strobilurin-like) fungicides in 
isolates of Pyricularia grisea from perennial ryegrass. Plant Disease, 2002. 
86(3): p. 235-240. 
132. Fisher, N., et al., Modeling the Qo site of crop pathogens in Saccharomyces 
cerevisiae cytochrome b. Eur J Biochem, 2004. 271(11): p. 2264-71. 
133. Chin, K.M., et al., Characterizing resistance risk of Erysiphe graminis f.sp 
tritici to strobilurins. Crop Protection, 2001. 20(2): p. 87-96. 
134. Moore, A.L., A.L. Umbach, and J.N. Siedow, Structure-Function-
Relationships of the Alternative Oxidase of Plant-Mitochondria - a Model of 
the Active-Site. Journal of Bioenergetics and Biomembranes, 1995. 27(4): p. 
367-377. 
135. Siedow, J.N., A.L. Umbach, and A.L. Moore, The Active-Site of the Cyanide-
Resistant Oxidase from Plant-Mitochondria Contains a Binuclear Iron 
Center. Febs Letters, 1995. 362(1): p. 10-14. 
136. Andersson, M.E. and P. Nordlund, A revised model of the active site of 
alternative oxidase. Febs Letters, 1999. 449(1): p. 17-22. 
137. Berthold, D.A., M.E. Andersson, and P. Nordlund, New insight into the 
structure and function of the alternative oxidase. Biochimica Et Biophysica 
Acta-Bioenergetics, 2000. 1460(2-3): p. 241-254. 
138. Albury, M.S., et al., Structure of the plant alternative oxidase. Site-directed 
mutagenesis provides new information on the active site and membrane 
topology. Journal of Biological Chemistry, 2002. 277(2): p. 1190-4. 
139. Berthold, D.A., et al., EPR studies of the mitochondrial alternative oxidase. 
Evidence for a diiron carboxylate center. Journal of Biological Chemistry, 
2002. 277(46): p. 43608-14. 
144 | P a g e  
 
140. Ajayi, W.U., M. Chaudhuri, and G.C. Hill, Site-directed mutagenesis reveals 
the essentiality of the conserved residues in the putative diiron active site of 
the trypanosome alternative oxidase. Journal of Biological Chemistry, 2002. 
277(10): p. 8187-93. 
141. Nakamura, K., et al., Mutational analysis of the Trypanosoma vivax 
alternative oxidase: The E(X)(6)Y Motif is conserved in both mitochondrial 
alternative oxidase and plastid terminal oxidase and is indispensable for 
enzyme activity. Biochemical and Biophysical Research Communications, 
2005. 334(2): p. 593-600. 
142. Moore, A.L., et al., Compelling EPR evidence that the alternative oxidase is 
a diiron carboxylate protein. Biochimica Et Biophysica Acta-Bioenergetics, 
2008. 1777(4): p. 327-330. 
143. Solomon, E.I., et al., Geometric and electronic structure/function 
correlations in non-heme iron enzymes. Chemical Reviews, 2000. 100(1): p. 
235-349. 
144. McDonald, A.E., Alternative oxidase: what information can protein sequence 
comparisons give us? Physiol Plant, 2009. 137(4): p. 328-41. 
145. Albury, M.S., C. Elliott, and A.L. Moore, Ubiquinol-binding site in the 
alternative oxidase Mutagenesis reveals features important for substrate 
binding and inhibition. Biochimica Et Biophysica Acta-Bioenergetics, 2010. 
1797(12): p. 1933-1939. 
146. Fisher, N. and P.R. Rich, A motif for quinone binding sites in respiratory and 
photosynthetic systems. J Mol Biol, 2000. 296(4): p. 1153-62. 
147. Rhoads, D.M., et al., Regulation of the cyanide-resistant alternative oxidase 
of plant mitochondria. Identification of the cysteine residue involved in 
alpha-keto acid stimulation and intersubunit disulfide bond formation. 
Journal of Biological Chemistry, 1998. 273(46): p. 30750-6. 
148. Umbach, A.L. and J.N. Siedow, Covalent and Noncovalent Dimers of the 
Cyanide-Resistant Alternative Oxidase Protein in Higher Plant Mitochondria 
and Their Relationship to Enzyme Activity. Plant Physiology, 1993. 103(3): 
p. 845-854. 
149. Vanlerberghe, G.C., et al., Alternative Oxidase Activity in Tobacco Leaf 
Mitochondria (Dependence on Tricarboxylic Acid Cycle-Mediated Redox 
Regulation and Pyruvate Activation). Plant Physiology, 1995. 109(2): p. 353-
361. 
150. Gelhaye, E., et al., A specific form of thioredoxin h occurs in plant 
mitochondria and regulates the alternative oxidase. Proceedings of the 
National Academy of Sciences of the United States of America, 2004. 
101(40): p. 14545-50. 
151. Umbach, A.L. and J.N. Siedow, The reaction of the soybean cotyledon 
mitochondrial cyanide-resistant oxidase with sulfhydryl reagents suggests 
that alpha-keto acid activation involves the formation of a thiohemiacetal. 
Journal of Biological Chemistry, 1996. 271(40): p. 25019-26. 
152. Umbach, A.L., et al., Activation of the plant mitochondrial alternative 
oxidase: insights from site-directed mutagenesis. Biochim Biophys Acta, 
2002. 1554(1-2): p. 118-28. 
153. Djajanegara, I., et al., A single amino acid change in the plant alternative 
oxidase alters the specificity of organic acid activation. Febs Letters, 1999. 
454(3): p. 220-4. 
145 | P a g e  
 
154. Carre, J.E., C. Affourtit, and A.L. Moore, Interaction of purified alternative 
oxidase from thermogenic Arum maculatum with pyruvate. Febs Letters, 
2011. 585(2): p. 397-401. 
155. Holtzapffel, R.C., et al., A tomato alternative oxidase protein with altered 
regulatory properties. Biochim Biophys Acta, 2003. 1606(1-3): p. 153-62. 
156. Vanlerberghe, G.C., L. McIntosh, and J.Y. Yip, Molecular localization of a 
redox-modulated process regulating plant mitochondrial electron transport. 
Plant Cell, 1998. 10(9): p. 1551-60. 
157. Crichton, P.G., et al., Constitutive activity of Sauromatum guttatum 
alternative oxidase in Schizosaccharomyces pombe implicates residues in 
addition to conserved cysteines in alpha-keto acid activation. Febs Letters, 
2005. 579(2): p. 331-336. 
158. Ito, K., et al., Identification of a gene for pyruvate-insensitive mitochondrial 
alternative oxidase expressed in the thermogenic appendices in Arum 
maculatum. Plant Physiology, 2011. 157(4): p. 1721-32. 
159. Umbach, A.L. and J.N. Siedow, The cyanide-resistant alternative oxidases 
from the fungi Pichia stipitis and Neurospora crassa are monomeric and lack 
regulatory features of the plant enzyme. Arch Biochem Biophys, 2000. 
378(2): p. 234-45. 
160. Fukai, Y., et al., Overproduction of highly active trypanosome alternative 
oxidase in Escherichia coli heme-deficient mutant. Parasitology International, 
2003. 52(3): p. 237-41. 
161. Elliott, C., The overexpression, purification and crystalisation of the 
Alternative oxidase. 2013, University of Sussex. 
162. Mandel, M. and A. Higa, Calcium-Dependent Bacteriophage DNA Infection. 
Journal of Molecular Biology, 1970. 53(1): p. 159-&. 
163. Kido, Y., et al., Purification and kinetic characterization of recombinant 
alternative oxidase from Trypanosoma brucei brucei. Biochim Biophys Acta, 
2010. 1797(4): p. 443-50. 
164. Elthon, T.E., R.L. Nickels, and L. McIntosh, Monoclonal antibodies to the 
alternative oxidase of higher plant mitochondria. Plant Physiology, 1989. 
89(4): p. 1311-7. 
165. Whittington, D.A. and S.J. Lippard, Crystal structures of the soluble methane 
monooxygenase hydroxylase from Methylococcus capsulatus (Bath) 
demonstrating geometrical variability at the dinuclear iron active site. J Am 
Chem Soc, 2001. 123(5): p. 827-38. 
166. Rosenzweig, A.C., et al., Crystal structures of the methane monooxygenase 
hydroxylase from Methylococcus capsulatus (Bath): implications for 
substrate gating and component interactions. Proteins, 1997. 29(2): p. 141-
52. 
167. Voegtli, W.C., et al., Variable coordination geometries at the diiron(II) 
active site of ribonucleotide reductase R2. J Am Chem Soc, 2003. 125(51): p. 
15822-30. 
168. Nordlund, P. and H. Eklund, Structure and function of the Escherichia coli 
ribonucleotide reductase protein R2. J Mol Biol, 1993. 232(1): p. 123-64. 
169. Voegtli, W.C., et al., Crystal structure of the ribonucleotide reductase R2 
mutant that accumulates a mu-1,2-peroxodiiron(III) intermediate during 
oxygen activation. Journal of the American Chemical Society, 2000. 122(14): 
p. 3255-3261. 
146 | P a g e  
 
170. Esser, L., et al., Crystallographic studies of quinol oxidation site inhibitors: 
A modified classification of inhibitors for the cytochrome bc(1) complex. 
Journal of Molecular Biology, 2004. 341(1): p. 281-302. 
171. Jin, S., et al., X-ray crystal structures of reduced rubrerythrin and its azide 
adduct: a structure-based mechanism for a non-heme diiron peroxidase. J 
Am Chem Soc, 2002. 124(33): p. 9845-55. 
172. Chovancova, E., et al., CAVER 3.0: a tool for the analysis of transport 
pathways in dynamic protein structures. PLoS Comput Biol, 2012. 8(10): p. 
e1002708. 
173. Sakamoto, K., et al., Probing substrate binding site of the Escherichia coli 
quinol oxidases using synthetic ubiquinol analogues. Journal of Biological 
Chemistry, 1996. 271(47): p. 29897-902. 
174. Li, H., A.D. Robertson, and J.H. Jensen, Very fast empirical prediction and 
rationalization of protein pKa values. Proteins, 2005. 61(4): p. 704-21. 
175. Crichton, P.G., et al., Mutagenesis of the Sauromatum guttatum alternative 
oxidase reveals features important for oxygen binding and catalysis. Biochim 
Biophys Acta, 2010. 1797(6-7): p. 732-7. 
176. Kita, K., K. Konishi, and Y. Anraku, Terminal oxidases of Escherichia coli 
aerobic respiratory chain. I. Purification and properties of cytochrome b562-
o complex from cells in the early exponential phase of aerobic growth. 
Journal of Biological Chemistry, 1984. 259(5): p. 3368-74. 
177. Reid, G.A. and W.J. Ingledew, Characterization and phenotypic control of 
the cytochrome content of Escherichia coli. Biochem J, 1979. 182(2): p. 465-
72. 
178. Suzuki, T., et al., Molecular cloning and characterization of Trypanosoma 
vivax alternative oxidase (AOX) gene, a target of the trypanocide 
ascofuranone. Parasitology International, 2004. 53(3): p. 235-45. 
179. Bekker, M., et al., Changes in the redox state and composition of the quinone 
pool of Escherichia coli during aerobic batch-culture growth. Microbiology, 
2007. 153(Pt 6): p. 1974-80. 
180. Chaudhuri, M., et al., The trypanosome alternative oxidase exists as a 
monomer in Trypanosoma brucei mitochondria. Parasitology Research, 
2005. 96(3): p. 178-83. 
181. Millar, A.H., et al., Expression and kinetics of the mitochondrial alternative 
oxidase in nitrogen-fixing nodules of soybean roots. Plant Cell and 
Environment, 1997. 20(10): p. 1273-1282. 
182. Chaudhuri, M., R. Sharan, and G.C. Hill, Trypanosome alternative oxidase is 
regulated post-transcriptionally at the level of RNA stability. J Eukaryot 
Microbiol, 2002. 49(4): p. 263-9. 
183. Helfert, S., et al., Roles of triosephosphate isomerase and aerobic 
metabolism in Trypanosoma brucei. Biochem J, 2001. 357(Pt 1): p. 117-25. 
184. Adams, R. and I. Levine, Simplification of the Gattermann synthesis of 
hydroxy aldehydes. Journal of the American Chemical Society, 1923. 45: p. 
2373-2377. 
185. Cottingham, I.R. and A.L. Moore, Ubiquinone Pool Behavior in Plant-
Mitochondria. Biochimica Et Biophysica Acta, 1983. 724(2): p. 191-200. 
186. Berthold, D.A., Isolation of mutants of the Arabidopsis thaliana alternative 
oxidase (ubiquinol:oxygen oxidoreductase) resistant to salicylhydroxamic 
acid. Biochim Biophys Acta, 1998. 1364(1): p. 73-83. 
147 | P a g e  
 
187. Kawashima, H., et al., Inhibitory effects of alkyl gallate and its derivatives on 
fatty acid desaturation. Biochimica Et Biophysica Acta-Lipids and Lipid 
Metabolism, 1996. 1299(1): p. 34-38. 
188. Jacobs, R.T., et al., SCYX-7158, an orally-active benzoxaborole for the 
treatment of stage 2 human African trypanosomiasis. PLoS Negl Trop Dis, 
2011. 5(6): p. e1151. 
189. Atkins, P.W. and J. De Paula, Physical chemistry for the life sciences. 2006, 
Oxford: Oxford University Press. 
190. Godwin, J.R., et al., Icia5504 - a Novel, Broad-Spectrum, Systemic Beta-
Methoxyacrylate Fungicide. Brighton Crop Protection Conference : Pests and 
Diseases - 1992, Vols 1-3, 1992: p. 435-442. 
191. Fisher, N. and B. Meunier, Re-examination of inhibitor resistance conferred 
by Q(o)-site mutations in cytochrome b using yeast as a model system. Pest 
Management Science, 2005. 61(10): p. 973-978. 
192. Vallieres, C., et al., HDQ, a Potent Inhibitor of Plasmodium falciparum 
Proliferation, Binds to the Quinone Reduction Site of the Cytochrome bc(1) 
Complex. Antimicrobial Agents and Chemotherapy, 2012. 56(7): p. 3739-
3747. 
193. Seeliger, D. and B.L. de Groot, Ligand docking and binding site analysis 
with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular 
Design, 2010. 24(5): p. 417-422. 
194. Valentine, A.M., S.S. Stahl, and S.J. Lippard, Mechanistic studies of the 
reaction of reduced methane monooxygenase hydroxylase with dioxygen and 
substrates. Journal of the American Chemical Society, 1999. 121(16): p. 
3876-3887. 
195. Rosenzweig, A.C., et al., Crystal-Structure of a Bacterial Nonheme Iron 
Hydroxylase That Catalyzes the Biological Oxidation of Methane. Nature, 
1993. 366(6455): p. 537-543. 
196. Lee, S.J., et al., Control of substrate access to the active site in methane 
monooxygenase. Nature, 2013. 494(7437): p. 380-384. 
197. Reichard, P., From Rna to DNA, Why So Many Ribonucleotide Reductases. 
Science, 1993. 260(5115): p. 1773-1777. 
198. Tomter, A.B., et al., Ribonucleotide reductase class I with different radical 
generating clusters. Coordination Chemistry Reviews, 2013. 257(1): p. 3-26. 
199. Stubbe, J., et al., Radical initiation in the class I ribonucleotide reductase: 
long-range proton-coupled electron transfer? Chemical Reviews, 2003. 
103(6): p. 2167-201. 
200. Coulter, E.D., et al., Rubrerythrin-catalyzed substrate oxidation by dioxygen 
and hydrogen peroxide. Inorganica Chimica Acta, 2000. 297(1-2): p. 231-
241. 
201. Sztukowska, M., et al., Role of rubrerythrin in the oxidative stress response 
of Porphyromonas gingivalis. Molecular Microbiology, 2002. 44(2): p. 479-
488. 
202. May, A., et al., A rubrerythrin-like oxidative stress protein of Clostridium 
acetobutylicum is encoded by a duplicated gene and identical to the heat 
shock protein Hsp21. Fems Microbiology Letters, 2004. 238(1): p. 249-254. 
203. Riebe, O., et al., Pathway for H2O2 and O-2 detoxification in Clostridium 
acetobutylicum. Microbiology-Sgm, 2009. 155: p. 16-24. 
148 | P a g e  
 
204. Chang, M.C., et al., Turning on ribonucleotide reductase by light-initiated 
amino acid radical generation. Proceedings of the National Academy of 
Sciences of the United States of America, 2004. 101(18): p. 6882-7. 
205. Saleh, L. and J.M. Bollinger, Jr., Cation mediation of radical transfer 
between Trp48 and Tyr356 during O2 activation by protein R2 of 
Escherichia coli ribonucleotide reductase: relevance to R1-R2 radical 
transfer in nucleotide reduction? Biochemistry, 2006. 45(29): p. 8823-30. 
206. Tinberg, C.E. and S.J. Lippard, Dioxygen Activation in Soluble Methane 
Monooxygenase. Accounts of Chemical Research, 2011. 44(4): p. 280-288. 
207. Gherman, B.F., et al., Dioxygen activation in methane monooxygenase: A 
theoretical study. Journal of the American Chemical Society, 2004. 126(9): 
p. 2978-2990. 
208. Shu, L., et al., An Fe2IVO2 diamond core structure for the key intermediate 
Q of methane monooxygenase. Science, 1997. 275(5299): p. 515-8. 
209. Tinberg, C.E. and S.J. Lippard, Revisiting the Mechanism of Dioxygen 
Activation in Soluble Methane Monooxygenase from M. capsulatus (Bath): 
Evidence for a Multi-Step, Proton-Dependent Reaction Pathway. 
Biochemistry, 2009. 48(51): p. 12145-12158. 
210. Bochevarov, A.D., et al., Insights into the Different Dioxygen Activation 
Pathways of Methane and Toluene Monooxygenase Hydroxylases. Journal of 
the American Chemical Society, 2011. 133(19): p. 7384-7397. 
211. Ambundo, E.A., R.A. Friesner, and S.J. Lippard, Reactions of methane 
monooxygenase intermediate Q with derivatized methanes. Journal of the 
American Chemical Society, 2002. 124(30): p. 8770-8771. 
212. Kolberg, M., et al., Structure, function, and mechanism of ribonucleotide 
reductases. Biochimica Et Biophysica Acta-Proteins and Proteomics, 2004. 
1699(1-2): p. 1-34. 
213. Bollinger, J.M., et al., Engineering the diiron site of Escherichia coli 
ribonucleotide reductase protein R2 to accumulate an intermediate similar to 
H-peroxo, the putative peroxodiiron(III) complex from the methane 
monooxygenase catalytic cycle. Journal of the American Chemical Society, 
1998. 120(5): p. 1094-1095. 
214. Baldwin, J., et al., Rational reprogramming of the R2 subunit of Escherichia 
coli ribonucleotide reductase into a self-hydroxylating monooxygenase. J Am 
Chem Soc, 2001. 123(29): p. 7017-30. 
215. Baldwin, J., et al., Mechanism of rapid electron transfer during oxygen 
activation in the R2 subunit of Escherichia coli ribonucleotide reductase. 1. 
Evidence for a transient tryptophan radical. Journal of the American 
Chemical Society, 2000. 122(49): p. 12195-12206. 
216. Avval, F.Z. and A. Holmgren, Molecular Mechanisms of Thioredoxin and 
Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide 
Reductase. Journal of Biological Chemistry, 2009. 284(13): p. 8233-8240. 
217. Aberg, A., et al., Autocatalytic Generation of Dopa in the Engineered 
Protein-R2 F208y from Escherichia-Coli Ribonucleotide Reductase and 
Crystal-Structure of the Dopa-208 Protein. Biochemistry, 1993. 32(37): p. 
9845-9850. 
218. Dillard, B.D., et al., A cryo-crystallographic time course for peroxide 
reduction by rubrerythrin from Pyrococcus furiosus. Journal of Biological 
Inorganic Chemistry, 2011. 16(6): p. 949-959. 
149 | P a g e  
 
219. Marechal, A., et al., Three Redox States of Trypanosoma brucei Alternative 
Oxidase Identified by Infrared Spectroscopy and Electrochemistry. Journal of 
Biological Chemistry, 2009. 284(46): p. 31827-31833. 
220. Atta, M., et al., Epr Studies of Mixed-Valent [(Fefeiii)-Fe-Ii] Clusters 
Formed in the R2 Subunit of Ribonucleotide Reductase from Mouse or 
Herpes-Simplex Virus - Mild Chemical-Reduction of the Diferric Centers. 
Journal of the American Chemical Society, 1994. 116(14): p. 6429-6430. 
221. Hendrich, M.P., et al., Integer-Spin Epr Studies of the Fully Reduced 
Methane Monooxygenase Hydroxylase Component. Journal of the American 
Chemical Society, 1990. 112(15): p. 5861-5865. 
222. Kovaleva, E.G. and J.D. Lipscomb, Crystal structures of Fe2+ dioxygenase 
superoxo, alkylperoxo, and bound product intermediates. Science, 2007. 
316(5823): p. 453-457. 
223. Cho, K.B., et al., Nonheme iron-oxo and -superoxo reactivities: O2 binding 
and spin inversion probability matter. Chem Commun (Camb), 2012. 48(16): 
p. 2189-91. 
224. Atkin, C.L., et al., Iron and Free-Radical in Ribonucleotide Reductase - 
Exchange of Iron and Mossbauer-Spectroscopy of Protein-B2 Subunit of 
Escherichia-Coli Enzyme. Journal of Biological Chemistry, 1973. 248(21): p. 
7464-7472. 
225. Shan, X. and L. Que, Jr., Intermediates in the oxygenation of a nonheme 
diiron(II) complex, including the first evidence for a bound superoxo species. 
Proceedings of the National Academy of Sciences of the United States of 
America, 2005. 102(15): p. 5340-5. 
226. Holmes, M.A., et al., Structures of deoxy and oxy hemerythrin at 2.0 A 
resolution. J Mol Biol, 1991. 218(3): p. 583-93. 
227. Kodera, M., et al., Reversible O-O Bond Scission of Peroxodiiron(III) to 
High-Spin Oxodiiron(IV) in Dioxygen Activation of a Diiron Center with a 
Bis-tpa Dinucleating Ligand as a Soluble Methane Monooxygenase Model. 
Journal of the American Chemical Society, 2012. 134(32): p. 13236-13239. 
228. Postila, P.A., et al., Key role of water in proton transfer at the Qo-site of the 
cytochrome bc1 complex predicted by atomistic molecular dynamics 
simulations. Biochim Biophys Acta, 2013. 1827(6): p. 761-8. 
229. Tommos, C., et al., De novo proteins as models of radical enzymes. 
Biochemistry, 1999. 38(29): p. 9495-507. 
230. Young, L., et al., Probing the ubiquinol-binding site of recombinant 
Sauromatum guttatum alternative oxidase expressed in E. coli membranes 
through site-directed mutagenesis. Biochim Biophys Acta, 2014. 
 
 
 
 
150 | P a g e  
 
9 Appendix I 
1
H and 
13
C NMR for synthesised compounds. Assignments can be found in Chapter 
2. 
 
2,4-dihydroxy-5-methyl-benzaldehyde (1)  
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3-chloro-4,6-dihydroxy-2-methyl-benzaldehyde (2) 
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(E)-3-chloro-5-(3,7-dimethylocta-2,6-dienyl)-4,6-dihydroxy-2-ethylbenzaldehyde 
(4) 
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(E)-4-chloro-2-(3,7-dimethylocta-2,6-dienyl)-6-formyl-5-methyl-1,3-phenylene 
diacetate (Acetylated) (5) 
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(E)-4-chloro-2-(3,7-dimethylocta-2,6-dienyl)-6-(hydroxymethyl)-5-
methylbenzene-1,3-diol –reduced colletochlorin B (6) 
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3-chloro-4,6-dimethoxy-2-methylbenzaldehyde (7) 
 
